<SEC-DOCUMENT>0001552781-22-000167.txt : 20220216
<SEC-HEADER>0001552781-22-000167.hdr.sgml : 20220216
<ACCEPTANCE-DATETIME>20220216145006
ACCESSION NUMBER:		0001552781-22-000167
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220216
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220216
DATE AS OF CHANGE:		20220216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COCA COLA CO
		CENTRAL INDEX KEY:			0000021344
		STANDARD INDUSTRIAL CLASSIFICATION:	BEVERAGES [2080]
		IRS NUMBER:				580628465
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-02217
		FILM NUMBER:		22643164

	BUSINESS ADDRESS:	
		STREET 1:		ONE COCA COLA PLAZA
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30313
		BUSINESS PHONE:		404-676-2121

	MAIL ADDRESS:	
		STREET 1:		ONE COCA COLA PLAZA
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30313
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>e22073_ko-8k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ko="http://ko/20220216">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_ko_ko_20220216 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20220216_20220216 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000021344 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:EntityCentralIndexKey">0000021344</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ko-20220216.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-02-16to2022-02-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:CommonStock0.25ParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.500NotesDue2024Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.875NotesDue2026Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.750NotesDue2026Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.125NotesDue2027Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.125NotesDue2029Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.125NotesDue20291Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.400NotesDue2030Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.250NotesDue2031Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.375NotesDue2033Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.500NotesDue2033Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.625NotesDue2035Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.100NotesDue2036Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.950NotesDue2036Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.800NotesDue2040Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.000NotesDue2041Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-16</xbrli:startDate>
        <xbrli:endDate>2022-02-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>





<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1pt solid; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->



<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-size: 12pt">UNITED
STATES</span><br />
<span style="font-size: 12pt">SECURITIES AND EXCHANGE COMMISSION</span><br />
<span style="text-transform: none; font-size: 10pt">WASHINGTON, D.C. 20549</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><span style="font-size: 12pt">FORM
<span id="xdx_90E_edei--DocumentType_c20220216__20220216_zU9du9jNvgUb"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><span style="font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><span style="font-size: 10pt">Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><span style="font-weight: normal">Date of Report (Date of earliest event reported):</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--DocumentPeriodEndDate_c20220216__20220216_zQbqcJUm8mT1"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">February 16, 2022</ix:nonNumeric></span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: center"><img src="ko_bw-logo.jpg" alt="(LOGO)" />
</p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: white"><span id="xdx_909_edei--EntityRegistrantName_c20220216__20220216_z2g0yuJwUcR9"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:EntityRegistrantName">COCA COLA CO</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">(Exact name of Registrant as specified
in its charter)</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20220216__20220216_zb6fdYuH3Mv3"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20220216__20220216_zQ4TxFVi8rPa"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:EntityFileNumber">001-02217</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20220216__20220216_zplV29kVdYrk"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:EntityTaxIdentificationNumber">58-0628465</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(I.R.S. Employer Identification No.)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20220216__20220216_zpGeXxjSgZua"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:EntityAddressAddressLine1">One Coca-Cola Plaza</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20220216__20220216_zuR6cYKs0CY7"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:EntityAddressPostalZipCode">30313</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressCityOrTown_c20220216__20220216_zJDT4IJfGKuk"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:EntityAddressCityOrTown">Atlanta</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20220216__20220216_zGe5Q3iwW1E4"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Georgia</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
</table>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><span style="font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span id="xdx_90A_edei--CityAreaCode_c20220216__20220216_zI8qaOCULph5"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:CityAreaCode">(404)</ix:nonNumeric></span> <span id="xdx_902_edei--LocalPhoneNumber_c20220216__20220216_zphqUcQdL2K3"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" name="dei:LocalPhoneNumber">676-2121</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><span style="font-size: 10pt">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under
any of the following provisions:</span></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><span style="font-family: Wingdings"><span id="xdx_903_edei--WrittenCommunications_c20220216__20220216_zQGQOVwcTob5"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt:booleanfalse" name="dei:WrittenCommunications">o</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%"><span style="font-size: 10pt">Written communications pursuant
    to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20220216__20220216_z2HcHl2tK0fk"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt:booleanfalse" name="dei:SolicitingMaterial">o</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12
    under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementTenderOffer_c20220216__20220216_zTWI6o9phaUj"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">o</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Pre-commencement communications pursuant
    to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Wingdings"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20220216__20220216_zPay9ux1aInb"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">o</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Pre-commencement communications pursuant
    to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><span style="font-size: 10pt">Securities registered
pursuant to Section 12(b) of the Act:</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 45%"><span style="text-decoration: underline">Title of each class</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 16%"><span style="text-decoration: underline">Trading Symbol(s)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 39%"><span style="text-decoration: underline">Name of each exchange
    on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.25ParValueMember_z3kJtYGtYTOk"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember" name="dei:Security12bTitle">Common Stock, $0.25 Par Value</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.25ParValueMember_zwHjDeMf4Iz9"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember" name="dei:TradingSymbol">KO</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.25ParValueMember_zmgQFEeFwGz1"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_909_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.500NotesDue2024Member_zYQA4empbBSf"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member" name="dei:Security12bTitle">0.500% Notes Due 2024</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.500NotesDue2024Member_zYWdAEC17SI6"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member" name="dei:TradingSymbol">KO24</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.500NotesDue2024Member_zeeO2rjWntJc"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.875NotesDue2026Member_z1jAdOVy52r9"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member" name="dei:Security12bTitle">1.875% Notes Due 2026</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.875NotesDue2026Member_zo6HeegH6Pk1"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member" name="dei:TradingSymbol">KO26</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.875NotesDue2026Member_zw1wWCg6DIB6"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.750NotesDue2026Member_zHbeBzmOLchl"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member" name="dei:Security12bTitle">0.750% Notes Due 2026</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.750NotesDue2026Member_zbQ6Vaf0C55l"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member" name="dei:TradingSymbol">KO26C</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.750NotesDue2026Member_zU0JSFLNqLk8"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.125NotesDue2027Member_zVbwOTPYOC9b"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member" name="dei:Security12bTitle">1.125% Notes Due 2027</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.125NotesDue2027Member_zDuloI7u3KZ2"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member" name="dei:TradingSymbol">KO27</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.125NotesDue2027Member_zPnWfuJ0ZKYj"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.125NotesDue2029Member_zxChTl0EwvGa"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member" name="dei:Security12bTitle">0.125% Notes Due 2029</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.125NotesDue2029Member_zRbZew6tuVy4"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member" name="dei:TradingSymbol">KO29A</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.125NotesDue2029Member_zz4Lj5J36aKk"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.125NotesDue20291Member_zYvDHDNkoB91"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member" name="dei:Security12bTitle">0.125% Notes Due 2029</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.125NotesDue20291Member_zvePIfPQXTCc"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member" name="dei:TradingSymbol">KO29B</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_900_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.125NotesDue20291Member_zan3Wm6MiJN"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.400NotesDue2030Member_zjlRaLUreKNg"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member" name="dei:Security12bTitle">0.400% Notes Due 2030</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.400NotesDue2030Member_zm8DN8XoYn25"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member" name="dei:TradingSymbol">KO30B</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.400NotesDue2030Member_ztUlEATPRTQe"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.250NotesDue2031Member_zirU5in42N6k"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member" name="dei:Security12bTitle">1.250% Notes Due 2031</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.250NotesDue2031Member_ztEuSL2jGEvf"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member" name="dei:TradingSymbol">KO31</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.250NotesDue2031Member_zsFfNAOwrc8k"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.375NotesDue2033Member_zNFA1wqCMXG8"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member" name="dei:Security12bTitle">0.375% Notes Due 2033</ix:nonNumeric></span> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.375NotesDue2033Member_z7mAWroZPPIg"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member" name="dei:TradingSymbol">KO33</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_909_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.375NotesDue2033Member_zkNoHHJH6op2"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.500NotesDue2033Member_zoIZEAV8Abei"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member" name="dei:Security12bTitle">0.500% Notes Due 2033</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.500NotesDue2033Member_zOQmIqsgF2X3"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member" name="dei:TradingSymbol">KO33A</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.500NotesDue2033Member_zDtA1Ok1Y26g"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.625NotesDue2035Member_z3Rm8iqe0vRc"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member" name="dei:Security12bTitle">1.625% Notes Due 2035</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.625NotesDue2035Member_zmKjq4ryPzic"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member" name="dei:TradingSymbol">KO35</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.625NotesDue2035Member_zAQ0aGXRRpYi"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.100NotesDue2036Member_zrtjaXEiKWx5"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member" name="dei:Security12bTitle">1.100% Notes Due 2036</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_906_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.100NotesDue2036Member_zoZtuGCUsYz1"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member" name="dei:TradingSymbol">KO36</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.100NotesDue2036Member_zZzV9JH4paag"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.950NotesDue2036Member_zU1ekJYMt7s5"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member" name="dei:Security12bTitle">0.950% Notes Due 2036</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.950NotesDue2036Member_zJWHq64jLzoc"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member" name="dei:TradingSymbol">KO36A</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.950NotesDue2036Member_z9hfRnxhtLwk"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.800NotesDue2040Member_zY0QioUJjxQ4"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member" name="dei:Security12bTitle">0.800% Notes Due 2040</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.800NotesDue2040Member_zullIphv4rHf"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member" name="dei:TradingSymbol">KO40B</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec0.800NotesDue2040Member_z8iVtPBb7ztc"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--Security12bTitle_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.000NotesDue2041Member_z61MzjOdWGoi"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member" name="dei:Security12bTitle">1.000% Notes Due 2041</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.000NotesDue2041Member_zE0Sr0dvfIu7"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member" name="dei:TradingSymbol">KO41</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--SecurityExchangeName_c20220216__20220216__us-gaap--StatementClassOfStockAxis__custom--Sec1.000NotesDue2041Member_zw2AGQDqA2Wi"><ix:nonNumeric contextRef="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt">Indicate
by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Emerging growth company&#160;&#160;&#160;&#160;<span style="font: 10pt Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20220216__20220216_zSsUve4bsS94"><ix:nonNumeric contextRef="From2022-02-16to2022-02-16" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">o</ix:nonNumeric></span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt">If an emerging
growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">o</span></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 4pt solid; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->


<!-- Field: Page; Sequence: 1 -->

    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 1in; text-align: left"><span style="font-size: 10pt"><b>Item 5.02.</b></span></td><td style="text-align: left"><span style="font-size: 10pt"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On February 16, 2022, the Talent and Compensation Committee of the Board
of Directors (the Committee&#8221;) of The Coca-Cola Company (the &#8220;Company&#8221;) adopted amended form award agreements for performance
share units, stock options and restricted stock units (the &#8220;Award Agreements&#8221;) to be granted under The Coca-Cola Company 2014
Equity Plan, as amended (the &#8220;Equity Plan&#8221;). The Award Agreements were amended to reduce the exercise time at death to one
year for options, to allow vesting to continue if an individual transfers to an affiliate of the Company in certain situations, to remove
proration for certain involuntary termination events and to remove the service requirement for certain vesting provisions after age 60
for all termination events, in addition to immaterial administrative updates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In addition, on February 16, 2022, the Committee approved the 2022 performance
measures, weighting and metrics for executive officers under each of The Coca-Cola Company Performance Incentive Plan (the &#8220;Performance
Incentive Plan&#8221;) and The Coca-Cola Company Long-Term Incentive Plan (the &#8220;Long-Term Incentive Plan.&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">With respect to the 2022 annual incentive award under the Performance Incentive
Plan, the Committee determined to include certain goals to promote employee diversity, equity and inclusion. The new goals will collectively comprise 10% of the executives&#8217; 2022 annual incentive under the Performance Incentive Plan, with
the prior year&#8217;s measures (Net Operating Revenue Growth and Operating Income Growth) equally comprising the remaining 90%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">With respect to the 2022 long-term incentive award under the Long-Term
Incentive Program, the Committee determined to include certain measures to promote achievement of the Company&#8217;s environmental sustainability
priorities. The new measures will collectively comprise 10% of the executives&#8217; performance share unit award under the Long-Term
Incentive Program, with the prior year&#8217;s measures (Net Operating Revenue Growth, Earnings per Share Growth and Cumulative Free Cash
Flow) equally comprising the remaining 90%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The foregoing descriptions of the Award Agreements are qualified in their
entirety by reference to the Award Agreements, copies of which are attached hereto as Exhibits 10.1 through 10.3 and incorporated herein
by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><span style="font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; width: 1in"><span style="font-size: 10pt"><b>Item 9.01(d).</b></span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0; text-indent: 0">EXHIBIT INDEX</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 5%"><span style="font-size: 10pt"><span style="text-decoration: underline">Exhibit No.</span></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 93%"><span style="font-size: 10pt"><span style="text-decoration: underline">Description</span></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="e22073_ex10-1.htm">Form of Performance Share Agreement for grants under the 2014 Equity Plan, as adopted February 16, 2022</a></p></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">10.2</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="e22073_ex10-2.htm">Form of Stock Option Agreement for grants under the 2014 Equity Plan, as adopted February 16, 2022</a></p></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">10.3</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="e22073_ex10-3.htm">Form of Restricted Stock Unit Agreement for grants under the 2014 Equity Plan, as adopted February 16, 2022</a></p></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-size: 10pt"> 104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (the cover page XBRL tags are embedded
within the iXBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Silver 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"><span style="font-size: 10pt">SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"><span style="font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">&#160;</span></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-weight: bold; font-size: 10pt">THE COCA-COLA COMPANY</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-weight: bold; font-size: 10pt">(REGISTRANT)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt">Date: February 16, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 10pt">By:&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">/s/ Monica Howard Douglas</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Monica Howard Douglas</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Senior Vice President and Global General Counsel</span></td></tr>
</table>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Silver 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>e22073_ex10-1.htm
<TEXT>
<HTML STYLE="font: 10pt Times New Roman, Times, Serif">
<HEAD STYLE="font: 10pt Times New Roman, Times, Serif">
     <TITLE STYLE="font: 10pt Times New Roman, Times, Serif"></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Award Notification
&ndash; Performance Share</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Congratulations
[INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Company</B></FONT>)
granted you an award (your <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Award</B></FONT>) under The Coca-Cola Company
2014 Equity Plan, as amended from time to time (the <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Plan</B></FONT>). Your
Award is a great opportunity to share in the long-term success of the Company and contribute to its future growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">This document
provides details of the key terms of your Award. Your Award is subject to the formal rules of the Plan, plus the additional terms and
conditions (including country specific terms) as set out in a document called the &ldquo;Additional Terms&rdquo;. The Additional Terms
is available to review as part of the Award acceptance process. The Plan is available on your plan administrator website. This Award
Notification (including the appendices), the Plan and the Additional Terms together form your Award Agreement. You are being asked to
confirm that you understand and agree to be bound by these documents as part of the Award acceptance process, so we recommend you read
them carefully.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: black">
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 6pt; padding-bottom: 6pt; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: white"><B>Details
    of Award</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type
    of Award</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; width: 81%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Performance
    Award (sometimes called Growth Share Units)] </B>-This is a conditional right to receive $0.25 par value common stock of the Company
    (<B>Stock</B>) in the future. You will not receive the Stock (or have any shareholder rights) unless your Award vests.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Target
    number of shares of Stock subject to your Award</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT]
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Continuing
    employment</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
    Award is subject to your continuing employment, as set out in the Employment Events Appendix to this document and the Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Performance
    conditions</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Performance
    conditions apply to your Award, which are set out in the Performance Criteria Appendix to this document. The performance conditions
    must be met in order for your Award to vest.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Performance
    period</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT]</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">The performance
    conditions are measured during this period. See the Performance Criteria Appendix for more details.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
    your Award normally vests</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT DATE],
    or if later when the performance conditions are certified.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">When your
    Award vests, you become entitled to the Stock subject to your Award. You do not need to purchase that Stock - it is delivered automatically
    to you.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">The number
    of shares of Stock that vest will be calculated based upon the target number of shares of Stock set forth above and the provisions
    of the Performance Criteria Appendix.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">The number
    of shares of Stock that vest will normally be delivered to you as soon as administratively possible following vesting, unless a different
    timing for delivering the Stock applies under the Employment Events Appendix.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">Your Award
    will generally be settled in Shares, except where the Employment Events Appendix applies and specifies otherwise.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">You are liable
    for any tax, fees and costs due on vesting, which may be withheld.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Remember</B></FONT><FONT STYLE="font-size: 10pt">:
    your Award will only vest if and to the extent that all of the terms and conditions of your Award are satisfied. To the extent that
    your Award does not vest, it will be forfeited.</FONT></P></TD></TR>
</TABLE>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->





<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: Black">
    <TD COLSPAN="2" STYLE="padding-top: 0.05in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: White"><B>Details
    of Award</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 19%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prohibited
    Activities</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; text-align: justify; width: 81%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you engage in certain activities (called Prohibited Activities), your Award will be forfeited and you will be required to pay back
    any gain from your Award. Refer to the Prohibited Activities Appendix to this document.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Malus
    and clawback</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
    Award is subject to additional malus and clawback provisions which means your Award will be subject to reduction, cancellation, repayment
    or forfeiture in the circumstances set out in the Additional Terms.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Finally, certain
data privacy provisions apply to you in connection with your Award, as set out in the Data Privacy Appendix to this document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">In the event
of any conflict between this Award Notification (including the appendices), the Additional Terms and the Plan, the Plan takes precedence.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; background-color: black">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 0.1in; padding-right: 0.1in; font: 10pt Times New Roman, Times, Serif; padding-left: 0.1in; text-align: justify; width: 100%"><FONT STYLE="color: White"><B>Action
    required</B>!</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0.1in"><FONT STYLE="color: White">If you wish to accept your Award,
    you must accept it online by May 31, 2022. If you fail to do so by this deadline, then the Company may declare your Award grant null
    and void at any time. If this happens, your Award will be forfeited, and you will have no right to the underlying Stock.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Interpretation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning given in the
Plan, unless otherwise specified. For the purposes of the Prohibited Activities Appendix, references to your employer include your former
employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current local employing entity
or former local employing entity and the Company (where applicable). References to the <B>Committee</B> mean The Compensation Committee
of the Board of Directors of the Company, unless otherwise specified.</I></FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">Employment
Events Appendix &ndash; Performance Share</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify"><FONT STYLE="font-size: 10pt">The table below
sets out the impact to your Award (if any) upon certain employment events. The terms of the table below apply to vested and unvested
portions of an Award equally, unless otherwise stated. Except as otherwise specified herein, all other terms and conditions of your Award
continue to apply.<BR STYLE="font: 10pt Times New Roman, Times, Serif">
<BR STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: black">
    <TD STYLE="padding: 6pt 6pt 6pt 0.1in; border-right: white 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: white"><B>Event</B></FONT></TD>
    <TD STYLE="padding-top: 6pt; border-right: white 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 81%; padding-bottom: 6pt; padding-left: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: white"><B>Impact
    to your Award</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disability</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">Whether
    your employment with the Company or a Subsidiary terminates because of Disability or whether you remain employed, there is no impact
    to your Award.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Death</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt 0.1in 0.05in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Any Award that
    has not been accepted terminates immediately upon your death and may not be transferred to your heirs.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">If you die
    while employed with the Company or a Subsidiary, your Award immediately vests, and your estate will be paid, within 90 days after
    your death, a cash amount equal to the value of (1) the target number of shares of Stock subject to the Award, if you die before
    the end of the performance period, or (2) the shares of Stock earned, if you die after the end of the performance period. The value
    shall be determined based on the closing price of the Stock on the date of death (or in the case of a non-trading day, the next trading
    day).</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leave
    of absences</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">If you are
    on (1) US military leave, (2) a Company-paid leave of absence (meaning paid under Company payroll), or (3) an unpaid leave of absence
    (approved pursuant to a published Company policy available to all employees covered under the policy) of 12 months or less, there
    is no impact to your Award.</FONT>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">For all other
    leaves of absence not specified in the paragraph above, including all approved unpaid leaves that extend beyond 12 months:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 24.3pt; text-align: justify; text-indent: -14.2pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;
    </FONT><FONT STYLE="font-size: 10pt">any portion of your Award that is unvested is immediately forfeited<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT>;
    or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 24.3pt; text-align: justify; text-indent: -14.2pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">if the Committee identifies a valid business interest in doing otherwise, it may specify what provisions
it deems appropriate at its sole discretion (provided that the Committee shall have no obligation to consider any such matters).</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">If
    you transfer (1) between the Company and any Subsidiary or, (2) at the Committee&rsquo;s discretion, to an Affiliate that is not
    a Subsidiary, there is no impact to your Award.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD ROWSPAN="3" STYLE="padding: 0.05in 6pt 6pt 0.1in; border-right: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination<SUP>2</SUP></B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; text-indent: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 20.3pt; text-align: justify; text-indent: -20.2pt"><FONT STYLE="font-size: 10pt">A.&nbsp;&nbsp;&nbsp;&nbsp;If your employment with the Company or a Subsidiary terminates after attaining age 60:</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 0.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 24.3pt; text-align: justify; text-indent: -14.2pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;
    </FONT><FONT STYLE="font-size: 10pt">Awards held less than 12 months are immediately forfeited, and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 24.3pt; text-align: justify; text-indent: -14.2pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;
    </FONT><FONT STYLE="font-size: 10pt">there is no impact on Awards held at least 12 months.</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>If an approved unpaid leave of absence extends beyond 12 months, the portion of your Award that is unvested as of the end of the
12<SUP>th</SUP> month is forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP>If required by Section 409A of the Code, the payment may not be made (if applicable) until at least six months following the termination
date. </FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: Black">
    <TD STYLE="padding: 6pt 6pt 6pt 0.1in; width: 18%; font: 10pt Times New Roman, Times, Serif; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: white"><B>Event</B></FONT></TD>
    <TD STYLE="width: 82%; font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: white"><B>Impact
    to your Award</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 6pt; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 0.5pt solid; border-left: Black 0.5pt solid; border-right: Black 0.5pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 20.3pt; text-align: justify; text-indent: -20.2pt"><FONT STYLE="font-size: 10pt">B.&nbsp;&nbsp;&nbsp;&nbsp;
    If your employment with the Company or a Subsidiary terminates involuntarily for any reason other than for cause within one
    year after a Change in Control, your Award will be treated as described in the Plan.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 6pt; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 0.5pt solid; border-left: Black 1pt solid; border-right: Black 0.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 20.3pt; text-align: justify; text-indent: -20.2pt"><FONT STYLE="font-size: 10pt">C.&nbsp;&nbsp;&nbsp;&nbsp;
                                         If your employment (1) with the Company or a Subsidiary terminates for any other reason,
                                         or (2) with an Affiliate (that is not a Subsidiary) terminates for any reason<SUP>3</SUP>,
                                         your Award is immediately forfeited.</FONT></P>
        <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Notwithstanding anything
        herein, if your employment with an Affiliate terminates and you immediately become employed by the Company or a Subsidiary,
        there is no impact on your Award.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">For the purposes
of your Award, you are deemed to have terminated employment on the date you are no longer actively providing services to the relevant
entity or entities, regardless of the reasons for termination and whether or not later found to be invalid or in breach of your employment
agreement, if any, or employment laws in the jurisdiction where you are employed. The Committee has exclusive discretion to decide when
you are considered to be no longer actively providing services for the purposes of your Award. However, you will not be considered to
be actively providing services during any contractual notice period or any period of &ldquo;garden leave&rdquo; or similar period mandated
under employment laws in the jurisdiction where you are employed or in your employment agreement, if any, unless the Committee decides
otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP></SUP></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>3
</SUP>This would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award. If
your employer no longer meets the definition of &ldquo;Affiliate&rdquo;, you are deemed to have terminated employment for the purposes
of the Plan.</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center">Prohibited Activities Appendix</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Engaging in Prohibited Activity </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Timing</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Section 1.2 (Implications) applies
if you engage in a Prohibited Activity (as defined in section 5 (Types of Prohibited Activity) below) at any time during the term of your
Award or within one year after the later of:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">1.1.1</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">the termination of your employment with the Company,
your employer or any Affiliate; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">1.1.2</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">the last date of vesting or exercise of all or any
portion of your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Implications</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">If this section 1.2 applies:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">1.2.1</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">your Award will immediately terminate, be forfeited
and (if relevant) cease to be exercisable; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">1.2.2</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">within 10 days after receiving written notice from
the Company that this section applies, you must pay in cash to the Company:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(i)</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">any and all gains associated with any previous vesting
or exercise of all or any portion of your Award; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(ii)</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">interest calculated from the time of the notice
until the date of repayment to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Implications for settled Awards</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Calculation of gain</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">For the purposes of section 1.2.2,
each gain associated with the vesting or exercise of all or any portion of your Award will be calculated as:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt">2.1.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">where your Award is in the form of an Option, the
closing price per share of Stock on the date of exercise as reported on the New York Stock Exchange Composite Transactions listing minus
the exercise price per share of Stock, multiplied by the number of shares of Stock over which the Award was exercised;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt">2.1.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">where your Award is in the form of Restricted Stock
Units or Growth Share Units, the closing price per share of Stock on the date of vesting as reported on the New York Stock Exchange Composite
Transactions listing, multiplied by the number of shares of Stock that vested; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">2.1.3</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">where your Award is in the form of Performance Cash,
the gross amount of the cash payment that vested. </FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Alternative payment</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Return of Stock</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">If all or any part of this Prohibited
Activities Appendix is held to be invalid, illegal or unenforceable for any reason by any court with jurisdiction:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">3.1.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">you will transfer to the Company all of the shares
of Stock that you acquired on vesting or exercise of your Award that you still hold (and if your Award is an Option, the Company will
pay to you the exercise price you paid for that Stock in exchange); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">3.1.2</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">where you have already sold, transferred or disposed
of any shares of Stock you acquired on vesting or exercise of your Award, you must pay to the Company:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(i)</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">any and all gains associated with each sale, transfer
or disposal; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">interest calculated from the date of each sale,
transfer or disposal until the date of repayment to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Calculation of gain</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">For the purposes of section 3.1.2,
the gain associated with the sale, transfer or disposal will in each case be calculated as the closing price per share of Stock on the
date of the sale, transfer or disposal as reported on the New York Stock Exchange Composite Transactions listing (minus, where your Award
is an Option, the exercise price per share of Stock), multiplied by the number of shares of Stock sold, transferred or disposed of.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Interest</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Any interest payable under this Prohibited
Activities Appendix will be calculated using the weighted prime rate at SunTrust Bank, Atlanta.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Types of Prohibited Activity</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">The term <B>Prohibited Activity</B>
includes any and all of the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Disparagement </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Making any statement, written or verbal,
in any forum or media, or taking any action in disparagement of the Company, your employer and/or any Affiliate, including but not limited
to negative references to the Company or its products, services, corporate policies, or current or former officers or employees, customers,
suppliers, or business partners or associates.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Publicity</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Publishing any opinion, fact, or material,
delivering any lecture or address, participating in the making of any film, radio broadcast or television transmission, or communicating
with any representative of the media relating to confidential matters regarding the business or affairs of the Company, your employer
and/or any Affiliate which you were involved with during your employment.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Disclosure of a Trade Secret</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Failure to hold in confidence any
and all Trade Secrets of the Company that came into your knowledge during your employment with the Company, your employer and/or any Affiliate,
or disclosing, publishing, or making use of, at any time, such Trade Secrets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">For these purposes, <B>Trade Secret</B>
means any technical or non-technical data, formula, pattern, compilation, program, device, method, technique, drawing, process, financial
data, financial plan, product plan, list of actual or potential customers or suppliers or other information similar to any of the foregoing,
which:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">5.3.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">derives economic value, actual or potential, from
not being generally known to and not being readily ascertainable by proper means by other persons who can derive economic value from its
disclosure or use; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">5.3.2</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">is the subject of efforts that are reasonable under
the circumstances to maintain its secrecy.</FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Disclosure of Confidential Information</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Failure to hold in confidence all
Confidential Information of the Company, your employer and/or any Affiliate that came into your knowledge during your employment with
the Company, your employer or any Affiliate, or disclosing, publishing, or making use of such Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">For these purposes, <B>Confidential
Information</B> means any data or information, other than Trade Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)), that
is valuable to the Company and not generally known to the public or to competitors of the Company.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Failing to return materials</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Your failure, in the event of your
termination of employment for any reason, promptly to deliver to the Company all memoranda, notes, records, manuals or other documents,
including all copies of such materials and all documentation prepared or produced in connection therewith, containing Trade Secrets (as
defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential Information (as defined in section 5.4 (Disclosure of Confidential
Information)) regarding the Company&rsquo;s business, whether made or compiled by you or furnished to you by virtue of your employment
with the Company, your employer or any Affiliate, or failure promptly to deliver to the Company all vehicles, computers, credit cards,
telephones, handheld electronic devices, office equipment, and other property furnished to you by virtue of your employment with the Company,
your employer or any Affiliate.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Competing</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Rendering services for any organization
which, or engaging directly or indirectly in any business which, in the sole judgment of the Committee or the Chief Executive Officer
of the Company or any senior officer designated by the Committee, is or becomes competitive with the Company.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Solicitation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Soliciting or attempting to solicit
for employment, for or on behalf of any corporation, partnership, or other business entity, any employee of the Company, your employer
or an Affiliate with whom you had professional interaction during the last twelve months of your employment with the Company, your employer
or the Affiliate.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.8</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Violation of Company policies</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">Violating any written policies of
the Company or your employer applicable to you, including, without limitation, The Coca-Cola Company Global Insider Trading Compliance
Policy.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Release</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0pt 0pt 28.35pt; text-align: justify">You may be released from the effects
of this Prohibited Activities Appendix if the Committee determines in its sole discretion that such action is in the best interest of
the Company and its stockholders.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Other rights apply</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">Nothing in this Prohibited Activities
Appendix is intended to or will be interpreted as diminishing or otherwise limiting the Company&rsquo;s right under applicable state
or local law or any prior agreement you have signed or made with the Company regarding trade secrets, confidential information, or intellectual
property.</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Data Privacy Appendix</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">General</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Introduction</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This Data Privacy Appendix sets out
certain data privacy provisions that apply to you in connection with your Award.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Meaning of Data</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">For the purposes of this Data Privacy
Appendix, <B>Data</B> means personal information that directly or indirectly identifies you, including: your name, home address and telephone
number, your date of birth, your government identification number, your salary information, nationality, job title and employment location,
any shares or directorships you hold or held in the Company or any Affiliate, details of your Award and any equity or cash awards or any
other entitlements to stock or cash granted (regardless of whether or not exercised, vested or settled, and including any cancelled or
forfeited awards), any information necessary to process your Award or any other award (e.g. your mailing address for a check payment or
bank account wire transfer information), any other information necessary to process mandatory tax withholding and reporting and/or, where
applicable, your employment or service termination date and the reason for the termination.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">For Award recipients not located in the EEA or UK</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This section applies if you reside
anywhere in the world except the European Economic Area (EEA) or the United Kingdom (UK). By accepting your Award, you confirm the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consent</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You voluntarily consent to the collection,
use and transfer, in electronic or other form, of your Data by and between the Company, your employer or any Affiliate for the purpose
of implementing, administering, and managing your participation in the Plan.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Data collected</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand that the Company and
its Affiliates may hold Data for the exclusive purpose of implementing, administering, and managing the Plan.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Purposes of collection </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand that Data will be transferred
to one or more stock or incentive plan service providers selected by the Company, which may assist the Company with the implementation,
administration, and/or management of the Plan.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Recipients of Data</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand that the recipients
of Data may be located in the United States or elsewhere. The Company also uses third party service providers who may assist with the
implementation, administration or management of the Plan. These service providers are bound by contract to handle Data in a way that aligns
with this Data Privacy Appendix and applicable law. If you have any questions about the local entities or services providers who may access
or handle your Data, please contact your local human resources representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">By consenting at section 2.1 (Consent)
above, you authorize the Company and any other possible recipients that do or may assist the Company with implementing, administering
or managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing,
administering and/or managing your participation in the Plan.</P>
<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Data retention</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand that Data will be held
only as long as is necessary to implement, administer and manage your participation in the Plan. In some cases, your information will
be retained for the Company or your employer to comply with a legal or tax obligation.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Your rights </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand that if you reside
in certain jurisdictions, to the extent required by applicable laws, you may, at any time and without cost:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">2.6.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">request access to Data;
</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">2.6.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">request additional information
about the storage and processing of Data; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">2.6.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">require any necessary amendments
to Data; or </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">2.6.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">refuse or withdraw the consents
you give by accepting the Award, </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">by
contacting your local human resources representative in writing. </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Implications of not consenting or withdrawing
consent</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">You understand that you provide these
consents on a purely voluntary basis. If you do not consent, or if you later withdraw your consent, your employment or service contract
with the Company or an Affiliate will not be adversely affected. Refusing or withdrawing your consent will mean that the Company will
not be able to grant new awards or administer or maintain any existing awards (including this Award) under the Plan. You understand that
refusing or withdrawing your consent may affect your ability to participate in the Plan (including the right to retain an award, such
as this Award). You understand that you may contact a local human resources representative for more information on the consequences of
refusal to consent or withdrawal of consent.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">For Award recipients located in the EEA and/or UK</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This section applies if you reside
inside the United Kingdom (UK) and/or the European Economic Area (EEA). By accepting your Award, you confirm the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Data collected </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand that the your employer
(acting as controller) and the Company may collect, to the extent permissible under applicable law, Data for the exclusive purpose of
implementing, administering, and managing the Plan. The Data is collected from you, the employer, and the Company for the exclusive purpose
of implementing, administering, and managing the Plan in accordance with the terms of your Award.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Purposes of collection/processing</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">You acknowledge the legal basis for
Data processing is performance of the contract comprising your Award. The Data must be provided in order for you to participate in the
Plan and for the parties to your Award to perform their respective obligations as set out in your Award documents. If you do not provide
Data, you will not be able to participate in the Plan or continue to hold your Award.</P>
<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transfers and retention of Data </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand that your employer
will transfer Data to the Company for Plan administration purposes. The Company and your employer may also transfer your Data to other
service providers (such as accounting firms, payroll processing firms or tax firms), as may be selected by the Company now or in the future,
to assist the Company and your employer with the implementation, administration and/or management of your Award. You understand that recipients
of the Data may be located in a country that does not benefit from an adequacy decision issued by the European Commission. When your information
is transferred outside the EEA or the UK (as applicable), it is done in accordance with data protection laws and regulations requiring
adequate transfer mechanisms. For further information as to the transfer of your Data, please contact <U>privacy@coca-cola.com</U>. Your
Data will be held only as long as is necessary to implement, administer and manage your rights and obligations under the terms of your
Award documents, as well as in compliance with other laws requiring a longer retention period.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accuracy</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand the Company and your
employer will take steps in accordance with applicable legislation to keep Data accurate, complete and up to date.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Your rights</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">You
understand you are entitled to: </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">3.5.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">have any inadequate, incomplete
or incorrect Data corrected;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">3.5.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">request access to your Data
and additional information about the processing of that Data;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">3.5.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">object to the processing
of Data or have your Data erased, under certain circumstances; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">3.5.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">subject to applicable law:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">restrict the processing of your Data so that it
is stored but not actively processed (e.g. while the Company assesses whether you are entitled to have Data erased); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">receive a copy of the Data provided in connection
with your Award or generated by you, in a common machine-readable format,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">and you may exercise these rights
by contacting a local human resources representative.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other contacts</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand you have the right
to contact, and may lodge a complaint with, the relevant data protection supervisory authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: left; text-indent: 0in"><FONT STYLE="font-weight: normal">You
may also contact the EU Data Protection Officer:<BR>
Nicola Aliperti Coca-Cola Italia s.r.l.<BR>
Viale Edison 110<BR>
Building B<BR>
20099 Sesto San Giovanni (Milan)<BR>
Italy<BR>
<U>DPO-Europe@coca-cola.com</U></FONT></P>
<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Country specific provisions </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">The provisions below supplement section
2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. By accepting your Award, you confirm the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">If
you are subject to the laws of Canada</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">You authorize the Company, your employer, and your employer&rsquo;s
representatives to discuss with and obtain all relevant information from all personnel (professional or not) involved in the administration
and operation of the Plan. You authorize your employer, the Company, any Affiliates and any stock or incentive plan service provider that
may be selected by the Company to assist with the Plan to disclose and discuss the Plan with their respective advisors. You further authorize
your employer, the Company and any Affiliates to record this information and to keep it in your employee file.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If you are subject to the laws of Russia </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">You acknowledge that you have read,
understood and agree to the terms regarding the collection, processing and transfer of data described in section 2 (For Award recipients
not located in the EEA or UK) of this Data Privacy Appendix. Upon request of the Company or your employer, you agree to provide an executed
data privacy consent form or any similar agreements or consents that the Company or your employer may deem necessary to obtain under the
data privacy laws in Russia, either now or in the future. You understand that you will not be able to participate in the Plan if you fail
to execute any such consent or agreement that may be requested.</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">2022 Awards made under<BR>
The Coca-Cola Company
2014 Equity Plan</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center">Additional Terms</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: justify">By accepting your Award you:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Plan Documents</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Agree that you have been given all
relevant information and materials regarding the terms and conditions of your Award, which are set out in the rules of The Coca-Cola Company
2014 Equity Plan, as amended from time to time (the <B>Plan</B>), your Award Notification (including any appendices attached to it) and
these Additional Terms (including the Global Appendix set out below) (collectively, the <B>Plan Documents</B>).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Employment</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the grant of your Award does
not form part of and does not affect or change your employment contract or your employment relationship with your employer (which is entirely
separate from the Plan). The grant of your Award and your participation in the Plan does not create a right to employment or continued
service and will not be interpreted as forming an employment or service contract with The Coca-Cola Company (the <B>Company</B>), your
employer or any <B>Affiliate</B> (as defined in the Plan). The Award does not impact the ability of the Company, your employer or any
Affiliate to terminate that employment or service relationship. All benefits granted by your Award will constitute an occasional extraordinary
payment and may not, in any way or for any purpose, be considered part of your normal remuneration or constitute consideration for any
services you provide to the Company, your employer or any Affiliate, including when calculating any other benefits. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the Company&rsquo;s decision
to grant your Award is voluntary and discretionary, and that you have no right to participate in the Plan. Acceptance of your Award and
participation in the Plan does not create any right to, or expectation of, future employment or service, future participation in the Plan
or the grant of future awards (on the same basis, or at all). The Company may at any time decide to cease offering awards under the Plan,
or amend, modify, suspend, cancel or terminate the Plan and any benefits under it.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that you are not entitled to the
exercise of any discretion under the Plan in your favor, that decisions with respect to your Award and any future awards are at the sole
discretion of the Company and are final, binding and conclusive, and that you do not have any claim or right of action in respect of any
decision, omission, or discretion, which may in each case operate to your disadvantage.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree, in consideration for and as a condition
of your Award, to waive all rights which might arise in connection with the Plan, including:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">2.4.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the right to institute any claim against the
Company, your employer or any Affiliate; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">2.4.2</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the right to pursue any claim that is allowed
by a court,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in">other than the right
to acquire, as relevant, $0.25 par value shares of common stock of the Company (<B>Stock</B>) or cash (subject to and in accordance with
the Plan).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that you do not have any right to
compensation or damages for any loss (actual or potential) in relation to the Plan or your Award, including where it is forfeited on termination
of employment or cessation of services for any reason, whether or not lawful or in breach of employment laws or the terms of your employment
or service agreement, if any. </FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No transfer</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Accept that you must not pledge, encumber,
assign, transfer, charge or otherwise dispose of your Award or any rights in respect of it, whether voluntarily or involuntarily (other
than to your personal representatives on death).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Modifications and additional requirements</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that the Company may modify any of the
terms of your Award to be consistent with any applicable law or applicable government agency regulation where, in the opinion of the Company,
that term might otherwise conflict or be inconsistent.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that the Company may impose additional
conditions, requirements and restrictions on your Award, your participation in the Plan and any Stock or cash you acquire on vesting or
exercise of your Award, and that you will comply with them, including signing any additional agreements or undertakings.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree to any amendment made to the Plan or any
term of your Award (including an amendment with retroactive effect) where the amendment is necessary or advisable to ensure the Plan or
your Award complies with any future law relating to plans of this nature or their administration (including Section 409A of the U.S. Internal
Revenue Code of 1986, as amended).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree to any amendment made to any of the terms
of your Award (including rescinding your Award entirely) to correct any error that occurred in connection with the grant or documentation
of your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that your Award may be adjusted to
reflect a change in capital structure, in accordance with the terms of the Plan, and agree that, where your Award is over Stock and an
adjustment results in a fractional share, the fractional share may be disregarded at the Company&rsquo;s discretion.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Tax</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that participating in the Plan will
probably have tax consequences for you and that all payments made with respect to your Award (including payments in Stock or cash) may
be subject to tax, social security and any similar charges in any country where you are employed, reside, or are otherwise subject to
tax (<B>Tax</B>).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that you (or your personal representative)
are ultimately responsible for and will bear any liability for any Tax in respect of your Award and your participation in the Plan, and
understand that this liability may exceed any amounts withheld and paid on your behalf. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the Company, your employer,
an Affiliate, any trustee of any employee benefit trust and any third party service provider (each, a <B>Withholding Person</B>) is entitled
to do any, all or a combination of the following methods (where relevant) to enable a Withholding Person to raise an amount it considers
necessary or desirable to recover the Liabilities:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">5.3.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">sell or procure the sale on your behalf of a
sufficient number of the Stock you acquire on vesting or exercise of your Award;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">5.3.2</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reduce the number of Stock you acquire on vesting
or exercise of your Award accordingly and settle the balance in cash; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">5.3.3</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">withhold amounts from:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(i)</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">proceeds of sale under section 5.3.1;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(ii)</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">the balance settled in cash under section 5.3.2;
and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 28.35pt">(iii)</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other cash payments of any kind owed to you.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">For these purposes,
<B>Liabilities </B>means any obligation on the Withholding Person to pay or account for Tax, any unpaid exercise price, any associated
costs (including under section 7 (Costs)) and any amount you owe to the Company, your employer or any Affiliate due to any obligation
of any nature whatsoever (including under a loan, the Company&rsquo;s tax equalization program or any travel or expenses policy) to the
extent that the Company, the employer or any Affiliate in its reasonable judgement determines you owe them that amount.</P>
<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that, for tax purposes, and where allowed
by applicable law, you are deemed to have received the full number of Stock where the number of Stock you acquire is reduced under section
5.3.2.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that, where permitted by the Company, you
may elect to satisfy Tax and/or pay any exercise price by delivering (including by attestation) Stock to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that if a Withholding Person&rsquo;s obligation
to pay or account for Tax cannot or has not been fully satisfied by the above methods, you must pay to the Withholding Person an amount
sufficient to enable them to discharge that obligation.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree to enter any tax elections for particular
tax and/or social security treatment, execute any documents, give any directions and take any action as may be requested by the Company,
your employer or any Affiliate in relation to any Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.8</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the Company, your employer and
any Affiliate do not guarantee or warrant any particular Tax treatment in relation to your Award, the cash or Stock you acquire in connection
with your Award (including any dividends on Stock), or your participation in the Plan and that they are not under any obligation to structure
the Award in a Tax favorable way or avoid adverse Tax treatment in any jurisdiction. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.9</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that neither the Company, your employer
nor any Affiliate will be liable for any Tax, interest, penalties or other amounts owed by any taxpayer as a consequence of the Plan or
an Award and that any Tax information provided is for guidance purposes only. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.10</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that the cash or Stock subject to your
Award may only vest or be exercised (as applicable) if satisfactory arrangements are in place to enable all Withholding Persons to obtain
the funds needed to satisfy any Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.11</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the vested (and, if applicable,
exercised) Stock or cash subject to your Award may not be delivered or paid to you unless you have complied with your obligation to pay
the Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Internationally mobile employees</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that if you are a mobile employee,
meaning that you are based in different jurisdictions during the course of your employment or service that you are or may be subject to
Tax in more than one country, you are strongly encouraged to inform the Company and your employer, and to speak with your personal tax
adviser regarding the tax treatment of your participation in the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that, if you are a mobile employee, the
Company or your employer may be required to withhold for Tax in more than one jurisdiction.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that if you are a &ldquo;Global Mobility
Associate&rdquo; as defined in the Company&rsquo;s Global Mobility Policy (or the equivalent under any applicable international service
policy from time to time), you remain responsible for all Tax except where expressly stated otherwise in that policy and/or the Company&rsquo;s
tax equalization program. A copy of the Company&rsquo;s Global Mobility Policy is available on the Company&rsquo;s intranet.</FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Costs</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Agree that you are responsible for
the payment of any fees, dealing, commission or currency conversion costs or any other costs associated with your Award, including costs
associated with the payment of any cash and the sale of any Stock.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Notices </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that any notice or other communication
required in relation to your Award will be given in writing, which may include electronic means.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that any notice or other communication
to be given to you in connection with your Award may be delivered by electronic means (including by email, or through the Company or your
employer&rsquo;s intranet or a share plan portal), personally delivered, or sent by ordinary post to the principal address on file for
you from time to time with the Company, your employer, an Affiliate or the Company&rsquo;s agents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that any notice or other communication
to be given to the Company or its agents in connection with your Award may be delivered or sent to its registered office or to such other
place and by such means as communicated to you by or on behalf of the Company from time to time.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that notices or other communications:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">8.4.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">sent electronically will be deemed to have been
received immediately (if sent during usual business hours) or at the opening of business on the next business day (if sent outside usual
business hours);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">8.4.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">that are personally delivered will be deemed
to have been received when left at the relevant address (if left during usual business hours) or at the opening of business on the next
business day (if left outside usual business hours); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">8.4.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">sent by post will be deemed to have been received
24 hours after posting to a U.S. address or 3 days after posting to an address outside the U.S.,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">unless there is evidence to the contrary.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that all notices or communications to be
given to you are given and sent at your risk and that neither the Company, your employer nor any Affiliate has any liability in respect
of any notice or communication given or sent, nor need they be concerned to see that you actually receive it.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">9.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Insider trading and market abuse</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that rules on insider trading, dealing
notification requirements, and market abuse laws may apply in relation to any actions or decisions taken relating to your Award, including
in relation to the acceptance, vesting, exercise or settlement of your Award, the delivery or payment of any Stock or cash, and the sale
of any Stock. These rules, requirements and laws:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">9.1.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are separate from and in addition to the requirements
that apply to you under The Coca-Cola Company Global Insider Trading Compliance Policy; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">9.1.2</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">may prohibit or delay your actions or decisions.
</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that it is your responsibility to comply
with the rules, requirements and laws referred to in section 9.1. You should consult with your personal legal adviser on these matters.</FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">10.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Currency risk</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that if any Stock relating to your
Award is traded in a currency that is not the currency in your jurisdiction, the value of the Stock may also be affected by movements
in the exchange rate.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that neither the Company, your employer
nor any Affiliate is liable for any loss due to movements in the exchange rate nor any charges imposed in relation to the conversion or
transfer of money.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">11.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No advice</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Confirm you are accepting your Award and participating
in the Plan voluntarily and understand that the Company is not making any recommendations regarding your Award or any Stock or cash relating
to your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that neither the Company, your employer,
any Affiliate nor any person or entity acting on their behalf has provided you with any legal, investment, tax (including reporting) or
financial advice with respect to your participation in the Plan, your Award or any Stock or cash acquired upon vesting or exercise of
your Award. You should consult with your own suitably qualified advisers before taking any action under the Plan. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the information and materials
provided do not take into account your objectives, financial situation or needs and that if you do not understand the contents of the
Plan Documents, or you are in any doubt, you should consult an independent authorized financial adviser.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree you will have no remedies for any statement,
representation, assurance or warranty that is not set out in your Plan Documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">12.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No guarantee</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>12.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that neither the Company, your employer
nor any Affiliate guarantees a specified level of return in respect of your Award or any Stock.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>12.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge
                                            that there is a risk that any Stock relating to your Award may fall as well as rise in value,
                                            that the future value of Stock cannot be predicted with certainty and that market forces
                                            will impact the price of any Stock relating to your Award and, in the worst case, the market
                                            value of the Stock may become zero. More information in relation to the Company, including
                                            its share price, can be found at <U>https://www.coca-colacompany.com/</U>. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">13.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">No public offer</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that your Award is being offered
to you in your capacity as an employee of the Company&rsquo;s group and that the offer is not intended for the general public and may
not be used for any public offer.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the Company is not required
to deliver any Stock or cash on settlement of your Award before it completes, on terms to its satisfaction, any registration, listing,
exemption or qualification or other legal requirements or obtains any clearance or approval that the Company considers is necessary or
desirable, and you agree to provide any information, make any agreements and give any representations that the Company requests as part
of this process.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that the Company may (whether under Section
17.7(b) of the Plan or otherwise) refuse to deliver any Stock or cash where the Company considers the delivery of Stock or cash may conflict
or be inconsistent with applicable law or applicable government agency regulation.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that neither the Company, your employer
nor any Affiliate is under any obligation to register, exempt or qualify, or seek clearance or approval for, your Award or any Stock or
cash that you may acquire in connection with your Award.</FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that your Award may not have been
authorized or approved by any applicable securities authorities and may have been offered pursuant to an exemption from registration in
your local jurisdiction. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that the regulatory bodies in your
jurisdiction accept no responsibility for the accuracy and completeness of the statements and information contained in the Plan Documents
and take no liability whatsoever for any loss arising from reliance upon the whole or any part of the contents of those documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.7</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that a prospectus or similar offering
or registration document may not have been prepared, authorized or approved by any applicable authority in any jurisdiction outside the
United States.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">14.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Exchange controls and any reporting requirements</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>14.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that exchange control regulations and/or
foreign asset reporting requirements may apply to you in respect of your Award and/or any Stock or cash acquired in connection with your
Award, and that you are solely responsible for complying with those regulations and requirements. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>14.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that neither the Company, your employer
nor any Affiliate are responsible for obtaining exchange control approval or making any reports on your behalf, nor for monitoring compliance
with those regulations and requirements and that if you fail to obtain any required exchange control approval or make the necessary reports,
neither the Company, your employer nor any Affiliate will be liable in any way for any resulting fines or penalties. You should seek independent
professional advice if you are unsure about the obligations that apply to you as a result of your participation in the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>14.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that you are solely responsible for complying
with any filing, notification or reporting requirements in respect of: </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">14.3.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">your participation in the Plan and/or </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">14.3.2</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">benefits received under the Plan, </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in">as required by the
local law in any jurisdiction. The Company accepts no responsibility for your failure or delay in complying with such requirements. If
you are in any doubt as to what actions you should take, you should consult a duly authorized independent adviser.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">15.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">General</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consent to the use of electronic communications
in connection with the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Confirm that references to &ldquo;employer&rdquo;
throughout these Additional Terms include your former employer, where applicable.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.3</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that all determinations and decisions on
questions of interpretation in respect of your Award and the Plan Documents will be made by the Company (or any committee on its behalf)
in its sole and absolute discretion. Those determinations and decisions will be final, binding and conclusive. Any references to determinations
or decisions made, or actions taken, by the &ldquo;Company&rdquo; as referred to in these Additional Terms include any committee acting
on its behalf.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.4</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that if any provision of your Plan Documents
is held to be invalid, illegal or unenforceable for any reason by any court in any jurisdiction then, for the purposes of that jurisdiction
only:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">15.4.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">such provision will be deleted; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-weight: normal">15.4.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the remaining provisions will continue in full
force and effect.</FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.5</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that if the Company waives a breach of
one or more provisions in the Plan Documents, this does not constitute a waiver of any other provision of the Plan Documents, or a waiver
of any subsequent breach of the Plan Documents (by you or anyone else).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.6</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">15.6.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the federal laws of the United States of America
and the state laws of the State of Delaware, United States of America, govern your Plan Documents and your Award without regard to the
conflict of law provisions; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">15.6.2</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the courts of the United States District Court
for the District of Delaware or the Delaware Superior Court, New Castle County have exclusive jurisdiction in respect of disputes arising
under or in connection with the Plan or your Award,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in">and you waive any
current or future objection you may have to this choice of law and jurisdiction.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">16.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">English language (<I>this applies if you have received an English language
version only of any Plan Document</I>)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>16.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that you fully understand the contents
of the English language version of the Plan Documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>16.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that you do not need a translation
of the Plan Documents and that you are fluent and regularly conduct business in the English language as part of your duties and responsibilities
to your employer.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">17.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Translations (<I>this applies if you have received a Plan Document in a language
other than English</I>)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>17.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that if there is any conflict between the
terms of the English language version of the Plan Documents and a version in any other language, the English language version will prevail.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">18.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Options (<I>this applies if your Award Notification specifies that your Award
is an Option</I>)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>18.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Understand that, in order to exercise your Award,
you will need to pay the exercise price. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>18.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acknowledge that you will be informed of the
acceptable forms and methods of paying the exercise price when you come to exercise your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">19.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Restricted resale (<I>this applies if your Award is over Stock</I>)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Acknowledge that any Stock you may
acquire upon settlement of your Award may be subject to restrictions on transfer and resale in your local jurisdiction and you agree that
you will comply with those restrictions, including that you will not offer, sell, advertise or otherwise market the Stock (or cause any
of these to occur) in circumstances which constitute any type of public offering of securities, unless an exemption applies.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">20.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Performance conditions (<I>this applies if your Award Notification specifies
that your Award is subject to performance conditions</I>)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>20.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that the vesting of your Award is conditional
on the satisfaction of one or more performance conditions as set out in the Performance Criteria Appendix to your Award Notification (the
<B>Performance Criteria</B>) and, to the extent the Performance Criteria are not satisfied, your Award may be forfeited.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>20.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that the Performance Criteria may be altered
in the circumstances specified in Section 10.2 of the Plan.</FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">21.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Malus and clawback (<I>this applies if your Award Notification specifies that
your Award is subject to &ldquo;Malus and clawback&rdquo;</I>)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>21.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Agree that any benefits
you may receive with respect to your Award will be subject to reduction, cancellation, repayment, forfeiture or recoupment if there is
a determination that the vesting of, or amount realized from, your Award was based on:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">21.1.1</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">materially inaccurate financial statements; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 28.35pt"></TD><TD STYLE="width: 42.55pt">21.1.2</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other materially inaccurate performance metric
criteria,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">and you acknowledge that this applies
regardless of whether you caused or contributed to the material inaccuracy.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>21.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agree that the Company may also seek to recover
your Award where required by the provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act or any other &ldquo;clawback&rdquo;
provision required by applicable law, regulation or listing standards, including the listing standards of the New York Stock Exchange,
and you authorize such recovery.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">22.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Stock ownership guidelines (this only applies if you are subject to the Company&rsquo;s
stock ownership guidelines)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>22.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that if you have not met the Company&rsquo;s
stock ownership guidelines <U>before</U> the applicable compliance deadline but you are a &ldquo;Section 16 officer&rdquo; under the U.S.
Securities Exchange Act of 1934, you are prohibited from selling 50% of any Stock you obtain upon vesting or exercise of your Award until
you meet the relevant guidelines, except for any Stock that is sold or cash settled to cover Tax and any exercise price.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>22.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accept that if you have not met the guidelines
by the applicable compliance deadline, you are prohibited at all times <U>after</U> that compliance deadline from selling any Stock you
obtain on vesting or exercise of your Award, except for any Stock that is sold or cash settled to cover Tax, commissions and fees and
any exercise price. Once you meet the guidelines, you can sell Stock in excess of the guidelines.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global Appendix &ndash; Equity Awards<B><SUP>4</SUP></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">If you are subject to the laws of the European Union</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This offer is being made to selected
employees as part of an employee incentive program in order to provide an additional incentive and to encourage employee share ownership
and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company. The Stock which
is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company including
the stock price can be found at the following web address: <U>https://investors.coca-colacompany.com/</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">The obligation to publish a prospectus
does not apply because of Article 1(4)(i) of the EU Prospectus Regulation. The total maximum number of Stock which is the subject of this
offer is [total number of stock awarded for this offer].</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Argentina</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Neither the Award nor the underlying
Stock are publicly offered or listed on any stock exchange in Argentina.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This provision applies if your Award
Notification specifies that your Award is an Option:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><I>Depending upon the method of exercise
chosen for the Option, you may be subject to restrictions with respect to the purchase and/or remittance of U.S. dollars pursuant to Argentine
currency exchange regulations. The Company reserves the right to restrict the methods of exercise if required or advisable to comply with
Argentine laws. </I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Australia</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">The grant of Awards under the Plan
is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000. Additional
details are set forth in the Australia Offer Document, which is available on the plan administrator website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The offer is intended to receive tax deferred treatment under
Subdivision 83A-C of the Income Tax Assessment Act 1997(Cth). The conditions to receive such treatment are contained in the Award Agreement.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">If you are subject to the laws of Belgium</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">If your Award Notification specifies
that your Award is an Option, you confirm you have read and understood the information regarding the Belgian taxation of Options which
has been separately made available to you by email and/or on the plan administrator website. You should review this information thoroughly
before accepting your Option grant.</P>
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>4
</SUP></FONT><FONT STYLE="font-size: 10pt">If you are subject to the laws of any of the following countries, there are no country-specific
provisions for your country in this appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador, Egypt, Japan, Kenya, Korea, Malaysia,
Nigeria, Puerto Rico, Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Brazil</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">By accepting the Award, you agree
that you are (i) making an investment decision, and (ii) the value of the underlying Stock is not fixed and may increase or decrease in
value over the vesting or exercise period without compensation to you.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Canada</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 27pt; text-align: justify">For purposes of your Award, your employment
will be considered terminated and your right (if any) to vest in any Award or exercise any Option after such termination (regardless of
the reason for such termination and whether or not later found to be invalid, unlawful or in breach of the employment laws in the jurisdiction
where you are employed or the terms of your employment agreement, if any) will be measured as of the earlier of: (a) the date your employment
with the Company or one of its Subsidiaries (as defined in the Plan) or Affiliates is terminated, (b) the date you receive written notice
of termination from the Company or a Subsidiary or Affiliate, regardless of any notice period or period of pay in lieu of such notice
mandated under the employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any, or (c)
the date you are no longer employed by the Company or any of its Subsidiaries or Affiliates. You will not be entitled to a pro-rata portion
of the Award for any time before the date on which your right to vest terminates, nor will you be entitled to any compensation for lost
vesting. In the event the date on which you are no longer actively providing services cannot be reasonably determined under the terms
of your Award, the Company, in its sole discretion, shall determine when you are no longer employed for purposes of the Award (including
whether you may still be considered employed or actively providing services while on a leave of absence).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify">Notwithstanding the foregoing, if applicable
employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to
vest in the Award under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you
will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you
be entitled to any compensation for lost vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">In
addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired pursuant to the Plan will be subject to
certain restrictions on resale imposed by Canadian provincial securities laws (in general, you may not resell your Stock to Canadian purchasers).
Accordingly, you are encouraged to seek legal advice prior to any resale of the Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Furthermore, notwithstanding anything
to the contrary in the Plan or the Award Agreement, Awards granted to Canadian residents shall only be settled in Stock and shall not
be settled in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">The
following terms and conditions apply if you are resident in Quebec:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>You agree that you wish the Plan Documents
to be drawn up in English.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><I>Vous confirmez que vous souhaitiez
que les Documents du Plan soient r&eacute;dig&eacute;s en anglais</I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Chile</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">Neither the Company, the Plan nor
the Stock have been registered in the <I>Registro de Valores</I> (Securities Registry) or in the <I>Registro de Valores Extranjeros</I>
(Foreign Securities Registry) of the <I>Comisi&oacute;n para el Mercado Financiero de Chile</I> (Chilean Commission for the Financial
market or CMF) and they are not subject to the control of the CMF. The Plan is governed by General Regulation 336. As the Stock is not
registered, the Company has no obligation under Chilean law to deliver public information regarding the Stock in Chile. Shares of Stock
cannot be publicly offered in Chile unless they are registered with the CMF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Ni
The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de Valores o en el Registro de Valores Extranjeros
que lleva la Comisi&oacute;n para el Mercado Financiero de Chile (CMF) y ninguno de ellos est&aacute; sujeto a la fiscalizaci&oacute;n
de la CMF. Esta oferta de Acciones se acoge a la Norma de Car&aacute;cter General 336. Por tratarse de valores no inscritos, el emisor
de las Acciones no tiene obligaci&oacute;n bajo la ley chilena de entregar en Chile informaci&oacute;n p&uacute;blica acerca de las Acciones.
Las Acciones no pueden ser ofrecidas p&uacute;blicamente en Chile en tanto &eacute;stas no se inscriban en el Registro de Valores correspondiente.</I></FONT><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">If you are subject to exchange control restrictions imposed by the China State
Administration of Foreign Exchange (SAFE), as determined by the Company in its sole discretion</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">Notwithstanding
any other provision in the Plan Documents, the following provisions apply in the event of the termination of your employment (as interpreted
in accordance with the Employment Events Appendix) with the Company or a Subsidiary (as defined in the Plan) (1) because of your Disability,
or (2) after attaining age 55:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>Awards that are Options and Awards
held at least 12 months will immediately vest and will be settled in cash. The cash amount will be determined based on the closing price
of the Stock on the date of your termination of employment (or, if a non-trading day, the next trading day) or the exercise of your Option
(if applicable) within the post-termination exercise period stated below. Awards that are not Options and that are held less than 12 months
from the date of grant are forfeited.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>Where Performance Criteria apply,
the Performance Criteria will be measured over a shortened performance period, ending at the end of the year prior to your termination
of employment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>If your Award is an Option, the period
over which you may exercise your Option expires upon earlier of (1) six months from your termination of employment or (2) the Option expiration
date provided in the Plan Documents.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">The Company has the discretion to
arrange for the sale of any Stock issued upon settlement of your Award, either immediately upon settlement or at any time thereafter.
In any event, if you terminate employment, you will be required to sell all Stock acquired upon settlement of the Award within such time
period as required by the Company in accordance with SAFE requirements. Any Stock remaining in your brokerage account at the end of this
period shall be sold by the broker (on your behalf pursuant to this authorization and without further consent). In addition, any Award
that has not vested by the end of this period will then immediately be forfeited. The Company shall have the exclusive discretion to determine
when your employment has been terminated for the purposes of the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">You agree to sign any additional agreements,
forms and/or consents that reasonably may be requested by the Company (or the Company&rsquo;s designated broker) to effectuate the sale
of the Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange control matters noted below) and
shall otherwise cooperate with the Company with respect to such matters. You acknowledge that neither the Company nor the designated broker
is under any obligation to arrange for the sale of Stock at any particular price (it being understood that the sale will occur in the
market) and that broker&rsquo;s fees and similar expenses may be incurred in any such sale. In any event, when the Stock is sold, the
sale proceeds, less any withholding for applicable taxes, any broker&rsquo;s fees or commissions, and any similar expenses of the sale
will be remitted to you in accordance with applicable exchange control laws and regulations.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">By accepting the Award, you acknowledge
that you understand and agree that you are not permitted to transfer any Stock acquired under the Plan out of your account established
with the Company&rsquo;s designated broker until the Stock is sold. The limitation applies to all Stock issued to you under the Plan,
whether or not you remained employed with the Company or a Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You understand and agree that you will
be required to immediately repatriate to China the proceeds from the sale of any Stock acquired under the Plan and any such dividends
paid on such shares. You further understand that such repatriation proceeds may need to be effected through a special bank account established
by the Company (or a Subsidiary or Affiliate in China), and you hereby consent and agree that any sale proceeds and cash dividends may
be transferred to such special account by the Company (or a Subsidiary or Affiliate in China) on your behalf prior to being delivered
to you and that no interest shall be paid with respect to funds held in such account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">The proceeds may be paid to you in
U.S. dollars or local currency at the Company&rsquo;s discretion. If the proceeds are paid to you in U.S. dollars, you understand that
a U.S. dollar bank account in China must be established and maintained so that the proceeds may be deposited into such account. If the
proceeds are paid to you in local currency, you acknowledge that the Company (and its Subsidiaries and Affiliates) are under no obligation
to secure any particular exchange conversion rate and that the Company (and its Subsidiaries and Affiliates) may face delays in converting
the proceeds to local currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time
the Stock is sold and the net proceeds are converted into local currency and distributed to you. You further agree to comply with any
other requirements that may be imposed by the Company in the future in order to facilitate compliance with exchange control requirements
in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">In addition to the vesting schedule
for your Award, settlement of the Award is also conditioned on the continued effectiveness of the Company&rsquo;s registration of the
Plan with SAFE (the <B>SAFE Registration Requirement</B>). If or to the extent the Company is unable to maintain the registration, no
Stock for which a registration cannot be maintained shall be issued. In this case, the Company retains the discretion to settle any Award
for which the vesting schedule, but not the SAFE Registration Requirement, has been met in cash paid through local payroll in an amount
equal to the market value of the Stock subject to the Award less any withholding for applicable taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">The Company (and its Subsidiaries and
Affiliates) shall not be liable for any costs, fees, lost interest or dividends or other losses that you may incur or suffer resulting
from the enforcement of the foregoing terms or otherwise from the Company&rsquo;s operation and enforcement of the Plan, the Award Agreement,
and the Award in accordance with any applicable laws, rules, regulations and requirements.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Colombia</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 28.35pt; text-align: justify">You acknowledge that pursuant to Article
128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of &ldquo;salary&rdquo; for any legal purpose.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of France</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">By accepting the Award, you confirm
that you have read and understood the Plan Documents, which were provided in English. You accept the terms of those Plan Documents and
confirm that you have a good knowledge of the English language.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><I>En acceptant ce paiement, vous confirmez
avoir lu et compris les documents relatifs &agrave; ce plan d&rsquo;incitation &agrave; long terme (qui vous ont &eacute;t&eacute; fournis
en anglais) et que vous acceptez les termes de ce plan.&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Hong Kong</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><B>WARNING:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">The contents of the Plan Documents
have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you
are in any doubt about any of the contents of the Plan Documents, you should obtain independent professional advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This offer to receive an Award under
the Plan (the <B>Offer</B>) is strictly private and only available to eligible employees of [name of Hong Kong company]. The Offer has
also not been approved by the Securities and Futures Commission in Hong Kong and it should not be made in whole or in part to the public
or any third-party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">No Awards granted under the Plan may
be transferred or assigned, except as expressly permitted by the Company in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><U>Sale of Stock.</U> Any Stock received
at vesting is accepted as a personal investment. In the event that any portion of this Award vests within six months of the grant date,
you agree that you will not offer to the public or otherwise dispose of the Stock acquired prior to the six-month anniversary of the grant
date.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of India</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">You must repatriate to India all funds resulting from the sale
of Stock acquired in relation to your Award within 90 days, and all proceeds from the receipt of any dividends within 180 days. You should
receive a foreign inward remittance certificate (<B>FIRC</B>) from your bank where you deposit the foreign currency. You should maintain
the FIRC as evidence of the repatriation of funds in the event that the Reserve Bank of India or your employer requests proof of repatriation.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">13.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">If you are subject to the laws of Indonesia &#9;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">A translation of the documents relating
to this grant into Bahasa Indonesia can be provided to you upon request to your local human resources representative. By accepting the
grant of the Award, you (i) confirm having read and understood the documents relating to this grant which were provided in the English
language, (ii) accept the terms of those documents accordingly, and (iii) agree not to challenge the validity of this document based on
Law No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><I>Terjemahan dari dokumen-dokumen terkait
dengan pemberian ini ke Bahasa Indonesia dapat disediakan bagi anda berdasarkan permintaan kepada perwakilan sumber daya manusia lokal
anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah membaca dan mengerti dokumen-dokumen yang terkait dengan
pemberian ini yang disediakan dalam Bahasa Inggris, (ii) menerima syarat-syarat dari dokumen-dokumen tersebut, dan (iii) setuju untuk
tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-Undang No. 24 Tahun 2009 tentang Bendera, Bahasa, dan Lambang
Negara, Serta Lagu Kebangsaan atau Peraturan Presiden pelaksananya (ketika diterbitkan).</I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Italy</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">By accepting the grant of the Award,
you acknowledge that you have received a copy of the Plan Documents, you have reviewed the Plan Documents in their entirety and you fully
understand and accept all provisions of the Plan Documents. You further acknowledge that you have read and expressly approve the following
sections of the Additional Terms: section 2 (Employment); section 4 (Modifications and additional requirements); section 5 (Tax); and
section 15 (General).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Mexico</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt 27pt; text-align: justify">By participating in the Plan, you acknowledge
that you have received a copy of the Plan, reviewed the Plan in its entirety and fully understand and accept all provisions of the Plan.
You further acknowledge that you have read and expressly approve the terms and conditions set forth in section 2 (Employment) of the Additional
Terms, in which the following is clearly described and established: (i) your participation in the Plan does not constitute an acquired
right; (ii) the Plan and your participation in the Plan are offered by the Company on a wholly discretionary basis; (iii) your participation
in the Plan is voluntary; and (iv) the Company and its Subsidiaries (as defined in the Plan) are not responsible for any decrease in the
value of the underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt 27pt; text-align: justify">By participating in the Plan, you expressly
recognize that The Coca Cola Company, with registered offices at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA, is solely responsible
for the administration of the Plan and that your participation in the Plan and acquisition of Stock does not constitute an employment
relationship between you and the Company since you are participating in the Plan on a wholly commercial basis. Based on the foregoing,
you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights
between you and the Company and do not form part of the employment conditions and/or benefits provided by the Company and any modification
of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt 27pt; text-align: justify">You further understand that your participation
in the Plan is as a result of a unilateral and discretionary decision of the Company; therefore, the Company reserves the absolute right
to amend and/or discontinue your participation at any time without any liability to you.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt 27pt; text-align: justify">Finally, you hereby declare that you
do not reserve any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the
Plan or the benefits derived under the Plan, and you therefore grant a full and broad release to the Company, its Subsidiaries, branches,
representation offices, its shareholders, officers, agents or legal representatives with respect to any claim that may arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>Al participar en el Plan, usted reconoce
que ha recibido una copia del Plan, que ha revisado el Plan en su totalidad, y que entiende y acepta en su totalidad, todas y cada una
de las disposiciones del Plan. Asimismo reconoce que ha le&iacute;do y aprueba expresamente los t&eacute;rminos y condiciones se&ntilde;alados
en el p&aacute;rrafo titulado Naturaleza de la Oferta en el Convenio, en lo que claramente se describe y establece lo siguiente: (i) su
participaci&oacute;n en el Plan no constituye un derecho adquirido; (ii) el Plan y su participaci&oacute;n en el Plan son ofrecidos por
la Compa&ntilde;&iacute;a sobre una base completamente discrecional; (iii) su participaci&oacute;n en el Plan es voluntaria; y (iv) la
Compa&ntilde;&iacute;a y sus Afiliadas no son responsables de ninguna por la disminuci&oacute;n en el valor de las Acciones subyacentes.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>Al participar en el Plan, usted reconoce
expresamente que The Coca-Cola Company, con oficinas registradas en One Coca-Cola Plaza, Atlanta, Georgia 30313, Estados Unidos de Am&eacute;rica,
es la &uacute;nica responsable por la administraci&oacute;n del Plan, y que su participaci&oacute;n en el Plan, as&iacute; como la adquisici&oacute;n
de las Acciones, no constituye una relaci&oacute;n laboral entre usted y la Compa&ntilde;&iacute;a, debido a que usted participa en el
plan sobre una base completamente mercantil. Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que pudiera
obtener por su participaci&oacute;n en el Plan, no establecen derecho alguno entre usted y la Compa&ntilde;&iacute;a, y no forman parte
de las condiciones y/o prestaciones laborales que la Compa&ntilde;&iacute;a ofrece, y que las modificaciones al Plan o su terminaci&oacute;n,
no constituir&aacute;n un cambio ni afectar&aacute;n los t&eacute;rminos y condiciones de su relaci&oacute;n laboral.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>Asimismo usted entiende que su participaci&oacute;n
en el Plan es el resultado de una decisi&oacute;n unilateral y discrecional de la Compa&ntilde;&iacute;a; por lo tanto, la Compa&ntilde;&iacute;a
se reserva el derecho absoluto de modificar y/o suspender su participaci&oacute;n en cualquier momento, sin que usted incurra en responsabilidad
alguna.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><I>Finalmente, usted declara que no se
reserva acci&oacute;n o derecho alguno para interponer reclamaci&oacute;n alguna en contra de la Compa&ntilde;&iacute;a, por concepto
de compensaci&oacute;n o da&ntilde;os relacionados con cualquier disposici&oacute;n del Plan o de los beneficios derivados del Plan, y
por lo tanto, usted libera total y ampliamente de toda responsabilidad a la Compa&ntilde;&iacute;a, a sus Afiliadas, sucursales, oficinas
de representaci&oacute;n, sus accionistas, funcionarios, agentes o representantes legales, con respecto a cualquier reclamaci&oacute;n
que pudiera surgir.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The Stock underlying your Award has not been registered with
the National Register of Securities maintained by the Mexican Banking and Securities Commission and may not be offered or sold publicly
in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing
relationship with the Company and its Subsidiaries and may not be reproduced or copied in any form. The offer contained in these materials
is addressed solely to the present employees of the Company and its Subsidiaries in Mexico and any rights under the Plan may not be assigned
or transferred. The Stock underlying your Award will be offered pursuant to a private placement exception under the Mexican Securities
Law.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">16.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">If you are subject to the laws of New Zealand</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify">You are being offered an Award which,
if vested, will entitle you to acquire Stock in accordance with the terms of the Plan Documents. The Stock, if issued, will give you a
stake in the ownership of the Company. You may receive a return if dividends are paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify">If the Company runs into financial difficulties
and is wound up, you will be paid only after all creditors and holders of preference shares (if any) have been paid. You may lose some
or all of your investment, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">New Zealand law normally requires people
who offer financial products to give information to investors before they invest. This information is designed to help investors to make
an informed decision. The usual rules do not apply to this offer because it is made under an employee share scheme. As a result, you may
not be given all the information usually required. You will also have fewer other legal protections for this investment. You are advised
to ask questions, read all documents carefully, and seek independent financial advice before committing.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">The Stock is quoted on the New York Stock
Exchange. This means that if you acquire Stock under the Plan, you may be able to sell the Stock on the New York Stock Exchange if there
are interested buyers. You may get less than you invested. The price will depend on the demand for the Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt 27pt; text-align: justify">For information on risk factors impacting
the Company&rsquo;s business that may affect the value of the Stock, you should refer to the risk factors discussion on the Company&rsquo;s
Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are
available online at <U>www.sec.gov</U>, as well as on the Company&rsquo;s &ldquo;Investor Relations&rdquo; website at <U>https://investors.coca-colacompany.com/.</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Peru</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 11pt 27pt; text-align: justify">The grant of the Award is considered
a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning the offer, please refer
to the Plan Documents and any other materials or documentation made available by the Company. For more information regarding the Company,
please refer to the Company&rsquo;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities
and Exchange Commission and are available at <U>www.sec.gov</U>, as well as the Company&rsquo;s &ldquo;Investor Relations&rdquo; website
at <U>https://investors.coca-colacompany.com/</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">By accepting the Award, you acknowledge
that the Award is being granted <I>ex gratia</I> with the purpose of rewarding you.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Philippines</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><B>The following wording is hereby
made a part of the Plan Documents: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify">The securities being offered or sold
under the Plan have not been registered with the Philippine Securities and Exchange Commission under the Philippine Securities Regulation
Code. Any future offer or sale of the securities in the Philippines is subject to registration requirements under the Securities Regulation
Code unless such offer or sale qualifies as an exempt transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This applies if your Award Notification
specifies that your Award is an Option:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><I>Notwithstanding any terms or conditions
of the Plan Documents, you acknowledge and agree that you will be restricted to the cashless sell-all method of exercise. To complete
a cashless sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued upon exercise of the Option; (ii) use
the proceeds to pay the exercise price, any applicable Liabilities and brokerage fees or commissions; and (iii) remit the balance in cash
to you. You will not be permitted to hold the Stock after exercise. Depending on the development of local laws, the Company reserves the
right to modify the methods of exercising the Option and, in its sole discretion, to permit cash exercise, cashless sell-to cover exercise
or any other method of exercise and payment of Liabilities permitted under the Plan.</I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Russia</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">Information contained in the Plan
Documents does not constitute an advertisement of any securities in Russia and must not be passed on to third parties or otherwise be
made publicly available in Russia. The Awards and the Stock to be granted under the Plan have not been and will not be registered in Russia
and are not intended for &lsquo;placement&rsquo; or &lsquo;circulation&rsquo; in Russia.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Singapore</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">You acknowledge that the Plan Documents
have not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the Plan Documents and any other document
or material in connection with the offer or sale, or invitation for subscription or purchase of the Stock may not be circulated or distributed,
nor may the Stock be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly,
to persons in Singapore other than pursuant to, and in accordance with the conditions of, an exemption under any provision (other than
Section 280) of Subdivision (4) of Division 1 of Part XIII of the Securities and Futures Act, Chapter 289 of Singapore.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">The Awards under the Plan are prescribed
capital markets products (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018) and Excluded Investment
Products (as defined in MAS Notices SFA 04-N12 and FAA-N16).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of South Africa</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">By accepting the Award, you agree
to immediately notify your employer of the amount of any income realized upon exercise or vesting of the Award. If you fail to advise
your employer of the income realized upon exercise or vesting of the Award, then you may be liable for a fine. You personally will be
responsible for paying the difference between the actual tax liability and the amount withheld by the Company or your employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 27pt; text-align: justify">The documents listed below are available
for your review on the Company&rsquo;s website at <U>https://investors.coca-colacompany.com/</U> and the Company&rsquo;s intranet:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">1.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company&rsquo;s most recent annual financial statements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company&rsquo;s most recent Plan prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">A copy of the above-listed documents will be sent to you free
of charge on written request to Global Equity, The Coca-Cola Company, at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA. You should
read these materials carefully before making a decision whether to participate in the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">22.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">If you are subject to the laws of Spain</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt 27pt; text-align: justify">By accepting the Award, you acknowledge
that you consent to participation in the Plan and have received a copy of the Plan Documents. Except as otherwise provided in the Plan
Documents, termination of your employment for any reason (including for the reasons listed below) will automatically result in the forfeiture
of any unvested Awards; in particular, you understand and agree that such Awards will be forfeited without entitlement to the underlying
Stock or to any amount as indemnification in the event of a termination of your employment prior to vesting by reason of, including, but
not limited to, resignation, disciplinary dismissal with or without cause, individual or collective layoff with or without cause, material
modification of employment under Article 41 of the Worker&rsquo;s Statute, relocation under Article 40 of the Worker&rsquo;s Statute,
Article 50 of the Worker&rsquo;s Statute, Article 10.3 of Royal Decree 1382/1985 and unilateral withdrawal by your employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27pt; text-align: justify">Furthermore, you understand that the
Company has unilaterally, gratuitously, and in its sole discretion decided to grant Awards under the Plan to individuals who may be employees
of the Company&rsquo;s group throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition
that any grant will not bind the Company or any Subsidiary (as defined in the Plan) or Affiliate, other than to the extent set forth in
the Plan Documents. Consequently, you understand that the Awards are offered on the assumption and condition that the Awards and any Stock
acquired under the Plan are not part of any employment contract (either with the Company or any Subsidiary or Affiliate), and shall not
be considered a mandatory benefit, salary for any purposes (including severance compensation), or any other right whatsoever. In addition,
you understand that this offer would not be made but for the assumptions and conditions referred to above; thus, you acknowledge and freely
accept that, should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant
of or right to the Award shall be null and void.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Sweden</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 11pt; text-align: justify; text-indent: 28.35pt">The following provision
supplements section 5 (Tax) of the Additional Terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><I>Without limiting the authority of
any Withholding Person to satisfy their withholding obligations for Tax as set forth in section 5 (Tax) of the Additional Terms, by accepting
the grant of the Award, you authorize any Withholding Person to withhold or to sell Stock otherwise deliverable to you to satisfy Tax,
regardless of whether the Withholding Person has an obligation to withhold such Tax.</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Switzerland</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">The offering of the Plan in Switzerland
is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial Services Act (<B>FinSA</B>) because such
offering by the Company is made exclusively to current or former members of the board of directors, members of the management board or
employees of the Company, the employer and its Affiliates. The Plan Documents do not constitute a prospectus pursuant to FinSA, and no
such prospectus has been or will be prepared for or in connection with the offering of the Plan.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of Turkey</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 11pt 27pt; text-align: justify">Under Turkish law, you are not permitted
to sell any Stock acquired under the Plan in Turkey. The shares are currently traded on the New York Stock Exchange, which is located
outside of Turkey, under the ticker symbol &ldquo;KO&rdquo; and the Stock may be sold through this exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">You acknowledge that any activity related to investments in
foreign securities (e.g. the sale of Stock) should be conducted through a bank or financial intermediary institution licensed by the Turkey
Capital Markets Board and should be reported to the Turkish Capital Markets Board. You are solely responsible for complying with this
requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-size: 10pt">26.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">If you are subject to the laws of the United Arab Emirates</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">The Awards are granted under the Plan
only to select employees of the Company&rsquo;s group and are in the nature of providing employee equity incentives in the United Arab Emirates.
The Plan Documents are intended for distribution only to such employees and must not be delivered to, or relied on by, any other person.
Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the
contents of the Plan Documents, you should consult an authorized financial adviser. The Emirates Securities and Commodities Authority
has no responsibility for reviewing or verifying any documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai
Department of Economic Development has approved the Plan Documents nor taken steps to verify the information set out herein, and has no
responsibility for such documents.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to the laws of the United Kingdom</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify">This offer is being made to selected
employees as part of an employee incentive program in order to provide an additional incentive and to encourage employee share ownership
and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company. The Stock which
is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company including
the stock price can be found at the following web address: <U>https://investors.coca-colacompany.com/</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">The obligation to publish a prospectus
does not apply because of Section 86(aa) of the Financial Services and Markets Act 2000 (as amended, supplemented or substituted by any
UK legislation enacted in connection with the UK&rsquo;s exit from the European Union). The total maximum number of Stock which is the
subject of this offer is [total number of stock awarded for this offer].</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Sans-Serif; font-size: 10pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If you are subject
to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or Vietnam</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt 27pt; text-align: justify">The Company reserves the right to restrict
you from acquiring Stock at exercise or vesting of your Award. Instead, the Company reserves the right to make a payment to you in cash
upon exercise or vesting of your Award. Any references to the issuance of shares or Stock in any documents related to the Award shall
not be applicable in these circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>Performance Criteria Appendix</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center"><B>[INTENTIONALLY LEFT BLANK]</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>




    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>



<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>e22073_ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Award
Notification &ndash; Stock Option</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Congratulations
[INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the <B>Company</B>) granted you an award (your <B>Award</B>)
under The Coca-Cola Company 2014 Equity Plan, as amended from time to time (the <B>Plan</B>). Your Award is a great opportunity
to share in the long-term success of the Company and contribute to its future growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
document provides details of the key terms of your Award. Your Award is subject to the formal rules of the Plan, plus the
additional terms and conditions (including country specific terms) as set out in a document called the &ldquo;Additional Terms&rdquo;.
The Additional Terms is available to review as part of the Award acceptance process. The Plan is available in the Documents section
of the Merrill Benefits OnLine&reg; website. This Award Notification (including the appendices), the Plan and the Additional Terms
together form your Award Agreement. You are being asked to confirm that you understand and agree to be bound by these documents
as part of the Award acceptance process, so we recommend you read them carefully.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: black; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt; color: White"><B>Details of Award</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.1in; text-align: justify; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 0.1in; width: 29%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Type
    of Award</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; width: 70%; text-align: justify; vertical-align: top"><FONT STYLE="font-size: 10pt"><B>Option</B>
    - This is a conditional right to purchase $0.25 par value common stock of the Company (Stock) in the future, at the exercise
    price specified below. For tax purposes, this is a nonqualified stock option.</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>BELGIUM
    ONLY - Option offer date</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT
                                         DATE]</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>BELGIUM ONLY</I></B><I>
        - If you accept your Award within 60 days of this date, the Award is taxable on the 60th day following the offer date.
        If you do not accept within the 60-day period, your Award is taxed at exercise.</I></FONT></P></TD>
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Number
    of shares of Stock subject to your Award</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><FONT STYLE="font-size: 10pt">[INSERT]</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Exercise
    price</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT]</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">This is the price you will
        pay per share of Stock.</FONT></P></TD>
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Continuing
    employment</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><FONT STYLE="font-size: 10pt">Your Award is
    subject to your continuing employment, as set out in the Employment Events Appendix to this document and the Plan.</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Dates
    your Award normally vests</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">25%
                                         per year over 4 years, as follows:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT DATE] - 25% of your
        Award vests</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT DATE] - a further
        25% of your Award vests</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT DATE] - a further
        25% of your Award vests</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT DATE] - the final
        25% of your Award vests</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">When your Award vests, you
        become entitled to exercise your Award.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Remember</B>:
        your Award will only vest if and to the extent that all of the terms and conditions of your Award are satisfied. To the
        extent that your Award does not vest, it will be forfeited.</FONT></P></TD>
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 99%; border-collapse: collapse; margin-bottom: 10pt">
<TR STYLE="vertical-align: bottom; background-color: black; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: center; vertical-align: top; padding-top: 6pt"><FONT STYLE="font-size: 10pt; color: White"><B>Details of Award</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 30%; padding-bottom: 6pt; padding-left: 0.1in; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; vertical-align: top; padding-top: 6pt"><FONT STYLE="font-size: 10pt"><B>Exercise
    of your Award</B></FONT></TD>
    <TD STYLE="width: 70%; padding: 6pt 0.1in; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify; vertical-align: top; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&lsquo;Exercising&rsquo;
                                         your Award simply means exercising your right to buy the vested Stock subject to your
                                         Award.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">In order to exercise
your Award, you must submit any required documentation, pay the exercise price (see above), arrange to pay any tax, fees and costs
(which may be withheld), and take any other steps that might be required from you. You will be informed of the acceptable form(s)
and method(s) of paying the exercise price when you exercise your Award.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; vertical-align: top; padding-top: 6pt"><FONT STYLE="font-size: 10pt"><B>Expiration
    date</B></FONT></TD>
    <TD STYLE="padding: 6pt 0.1in; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify; vertical-align: top; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT]</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">This is the date your Award
        will normally expire (unless it expires earlier under the Plan or the Award terms and conditions). When your Award expires,
        you lose your right to buy the Stock.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; vertical-align: top; padding-top: 6pt"><FONT STYLE="font-size: 10pt"><B>Prohibited
    Activities</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify; vertical-align: top; border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">If you engage
    in certain activities (called Prohibited Activities), your Award will be forfeited and you will be required to pay back any
    gain from your Award. Refer to the Prohibited Activities Appendix to this document.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Finally,
certain data privacy provisions apply to you in connection with your Award, as set out in the Data Privacy Appendix to this document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">In the
event of any conflict between this Award Notification (including the appendices), the Additional Terms and the Plan, the Plan
takes precedence.</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; background-color: Black">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; padding-top: 6pt; padding-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="font-size: 10pt; color: White"><B>Action
                                         required!</B></FONT></P>
        <P STYLE="padding-right: 6pt; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="font-size: 10pt; color: White"><B>If
        you wish to accept your Award, you must accept it using the Merrill Benefits OnLine&reg; website by [INSERT DATE/TIME].
        If you fail to do so by this deadline, then the Company may declare your Award grant null and void at any time. If this
        happens, your Award will be forfeited, and you will have no right to the underlying Stock.</B></FONT></P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Interpretation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>The
appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning given
in the Plan, unless otherwise specified. For the purposes of the Prohibited Activities Appendix, references to your employer include
your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current local
employing entity or former local employing entity and the Company (where applicable). References to the <B>Committee </B>mean
The Compensation Committee of the Board of Directors of the Company, unless otherwise specified.</I></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Employment
Events Appendix &ndash; Stock Option</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The table
below sets out the impact to your Award (if any) upon certain employment events. The terms of the table below apply to vested
and unvested portions of an Award equally, unless otherwise stated. Except as otherwise specified herein, all other terms and
conditions of your Award continue to apply.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-bottom: 10pt">
<TR STYLE="background-color: Black">
    <TD STYLE="width: 19%; border-top: black 1pt solid; border-right: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: justify; padding-top: 6pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: white"><B>Event</B></FONT></TD>
    <TD STYLE="width: 81%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: justify; padding-top: 6pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: white"><B>Impact
    to your Award</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Disability</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
    your employment with the Company or a Subsidiary terminates because of Disability, your Award immediately vests. Otherwise,
    if you remain employed, there is no impact to your Award.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Death</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Any
        Award that has not been accepted terminates immediately upon your death and may not be transferred to your heirs.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If
        you die while employed with the Company or a Subsidiary, your Award immediately vests, however, it expires on the earlier
        of (1) one year from your date of death, or (2) the expiration date in the Award Notification.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">If
        you die after your termination of employment (but before your Award has expired), your Award expires on the earlier of
        (1) one year from your date of death, or (2) the expiration date that applied to your Award at your date of death.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Leave
    of absences</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If
        you are on (1) US military leave, (2) a Company-paid leave of absence (meaning paid under Company payroll), or (3) an
        unpaid leave of absence (approved pursuant to a published Company policy available to all employees covered under the
        policy) of 12 months or less, there is no impact to your Award.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt">For
        all other leaves of absence not specified in the paragraph above, including all approved unpaid leaves that extend beyond
        12 months, your Award will be treated in accordance with the general termination provision at (C) below<SUP>1</SUP>,
        except thatif the Committee identifies a valid business interest in doing otherwise, it may specify what provisions it
        deems appropriate at its sole discretion (provided that the Committee shall have no obligation to consider any such matters).</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Transfer</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
    you transfer (1) between the Company and any Subsidiary or, (2) at the Committee&rsquo;s discretion, to an Affiliate that
    is not a Subsidiary, there is no impact to your Award.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-left: White 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: left; vertical-align: top; padding-top: 6pt"><B>Termination</B></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 0.1in; text-align: justify; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 0.25in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If your employment with the Company or a Subsidiary terminates after attaining age 60:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 24.3pt; text-indent: -4; text-align: justify"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards held less than 12 months are immediately forfeited, and</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.3pt; text-indent: -4; text-align: justify"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards held at least 12 months immediately vest.</FONT></P></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><SUP>1</SUP> If an approved unpaid
leave of absence extends beyond 12 months, the terms of the general termination provision (C) will &nbsp;&nbsp;&nbsp;apply at the end of the 12<SUP>th
</SUP>month.</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->






<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; background-color: black; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 20%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; color: white"><B>Event</B></FONT></TD>
    <TD STYLE="width: 80%; padding: 6pt 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; color: white"><B>Impact
    to your Award</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 6pt 6pt 6pt 24pt; text-align: justify; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: -18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">B.&nbsp;&nbsp;&nbsp;&nbsp;If
    your employment with the Company or a Subsidiary terminates involuntarily for any reason other than for cause within one year
    after a Change in Control, your Award will be treated as described in the Plan.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">C.&nbsp;&nbsp;&nbsp;&nbsp;If
        your employment (1) with the Company or a Subsidiary terminates for any other reason, or (2) with an Affiliate (that is
        not a Subsidiary) terminates for any reason<SUP>2</SUP>:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 24.3pt; text-align: justify; text-indent: -4"><FONT STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
        unvested portion of the Award is immediately forfeited, and</FONT></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 36.3pt; text-align: justify; text-indent: -20"><FONT STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
        vested portion of the Award will be forfeited upon the earlier of (1) six months from your termination date, or (2) the
        expiration date in the Award Notification. </FONT></FONT></P>
        <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Notwithstanding anything
        herein, if your employment with an Affiliate terminates and you immediately become employed by the Company or a Subsidiary,
        there is no impact on your Award.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 4.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">For the
purposes of your Award, you are deemed to have terminated employment on the date you are no longer actively providing services
to the relevant entity or entities, regardless of the reasons for termination and whether or not later found to be invalid or
in breach of your employment agreement, if any, or employment laws in the jurisdiction where you are employed. The Committee has
exclusive discretion to decide when you are considered to be no longer actively providing services for the purposes of your Award.
However, you will not be considered to be actively providing services during any contractual notice period or any period of &ldquo;garden
leave&rdquo; or similar period mandated under employment laws in the jurisdiction where you are employed or in your employment
agreement, if any, unless the Committee decides otherwise.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP></SUP></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>2
</SUP>This also would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your
Award. If your employer no longer meets the definition of &ldquo;Affiliate&rdquo;, you are deemed to have terminated employment
for the purposes of the Plan. </FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Prohibited
Activities Appendix</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 9pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Engaging
                                         in Prohibited Activity</B></FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Timing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Section
1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5 (Types of Prohibited Activity) below)
at any time during the term of your Award or within one year after the later of:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         termination of your employment with the Company, your employer or any Affiliate; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         last date of vesting or exercise of all or any portion of your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Implications</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">If
this section 1.2 applies:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.2.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">your
                                         Award will immediately terminate, be forfeited and (if relevant) cease to be exercisable;
                                         and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.2.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">within
                                         10 days after receiving written notice from the Company that this section applies, you
                                         must pay in cash to the Company:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         and all gains associated with any previous vesting or exercise of all or any portion
                                         of your Award; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">interest
                                         calculated from the time of the notice until the date of repayment to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Implications
                                         for settled Awards</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Calculation
                                         of gain</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">For
the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any portion of your Award will be calculated
as:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">where
                                         your Award is in the form of an Option, the closing price per share of Stock on the date
                                         of exercise as reported on the New York Stock Exchange Composite Transactions listing
                                         minus the exercise price per share of Stock, multiplied by the number of shares of Stock
                                         over which the Award was exercised;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">where
                                         your Award is in the form of Restricted Stock Units or Growth Share Units, the closing
                                         price per share of Stock on the date of vesting as reported on the New York Stock Exchange
                                         Composite Transactions listing, multiplied by the number of shares of Stock that vested;
                                         and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">where
                                         your Award is in the form of Performance Cash, the gross amount of the cash payment that
                                         vested. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Alternative
                                         payment</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Return
                                         of Stock</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">If
all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable for any reason by any court
with jurisdiction:</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">you
                                         will transfer to the Company all of the shares of Stock that you acquired on vesting
                                         or exercise of your Award that you still hold (and if your Award is an Option, the Company
                                         will pay to you the exercise price you paid for that Stock in exchange); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">where
                                         you have already sold, transferred or disposed of any shares of Stock you acquired on
                                         vesting or exercise of your Award, you must pay to the Company: </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         and all gains associated with each sale, transfer or disposal; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">interest
                                         calculated from the date of each sale, transfer or disposal until the date of repayment
                                         to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Calculation
                                         of gain</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">For
the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in each case be calculated as the
closing price per share of Stock on the date of the sale, transfer or disposal as reported on the New York Stock Exchange Composite
Transactions listing (minus, where your Award is an Option, the exercise price per share of Stock), multiplied by the number of
shares of Stock sold, transferred or disposed of.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Interest</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Any
interest payable under this Prohibited Activities Appendix will be calculated using the weighted prime rate at SunTrust Bank,
Atlanta.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Types
                                         of Prohibited Activity</B></FONT></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
term <B>Prohibited Activity</B> includes any and all of the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Disparagement
                                         </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Making
any statement, written or verbal, in any forum or media, or taking any action in disparagement of the Company, your employer and/or
any Affiliate, including but not limited to negative references to the Company or its products, services, corporate policies,
or current or former officers or employees, customers, suppliers, or business partners or associates.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Publicity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Publishing
any opinion, fact, or material, delivering any lecture or address, participating in the making of any film, radio broadcast or
television transmission, or communicating with any representative of the media relating to confidential matters regarding the
business or affairs of the Company, your employer and/or any Affiliate which you were involved with during your employment.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Disclosure
                                         of a Trade Secret </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Failure
to hold in confidence any and all Trade Secrets of the Company that came into your knowledge during your employment with the Company,
your employer and/or any Affiliate, or disclosing, publishing, or making use of, at any time, such Trade Secrets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">For
these purposes, <B>Trade Secret</B> means any technical or non-technical data, formula, pattern, compilation, program, device,
method, technique, drawing, process, financial data, financial plan, product plan, list of actual or potential customers or suppliers
or other information similar to any of the foregoing, which:</FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">derives
                                         economic value, actual or potential, from not being generally known to and not being
                                         readily ascertainable by proper means by other persons who can derive economic value
                                         from its disclosure or use; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">is
                                         the subject of efforts that are reasonable under the circumstances to maintain its secrecy.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Disclosure
                                         of Confidential Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Failure
to hold in confidence all Confidential Information of the Company, your employer and/or any Affiliate that came into your knowledge
during your employment with the Company, your employer or any Affiliate, or disclosing, publishing, or making use of such Confidential
Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">For
these purposes, <B>Confidential Information</B> means any data or information, other than Trade Secrets (as defined in section
5.3 (Disclosure of a Trade Secret)), that is valuable to the Company and not generally known to the public or to competitors of
the Company.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Failing
                                         to return materials</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Your
failure, in the event of your termination of employment for any reason, promptly to deliver to the Company all memoranda, notes,
records, manuals or other documents, including all copies of such materials and all documentation prepared or produced in connection
therewith, containing Trade Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential Information (as
defined in section 5.4 (Disclosure of Confidential Information)) regarding the Company&rsquo;s business, whether made or compiled
by you or furnished to you by virtue of your employment with the Company, your employer or any Affiliate, or failure promptly
to deliver to the Company all vehicles, computers, credit cards, telephones, handheld electronic devices, office equipment, and
other property furnished to you by virtue of your employment with the Company, your employer or any Affiliate.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Competing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Rendering
services for any organization which, or engaging directly or indirectly in any business which, in the sole judgment of the Committee
or the Chief Executive Officer of the Company or any senior officer designated by the Committee, is or becomes competitive with
the Company.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Solicitation</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting
or attempting to solicit for employment, for or on behalf of any corporation, partnership, or other business entity, any employee
of the Company, your employer or an Affiliate with whom you had professional interaction during the last twelve months of your
employment with the Company, your employer or the Affiliate.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.8</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Violation
                                         of Company policies</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Violating
any written policies of the Company or your employer applicable to you, including, without limitation, The Coca-Cola Company Global
Insider Trading Compliance Policy.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Release</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
may be released from the effects of this Prohibited Activities Appendix if the Committee determines in its sole discretion that
such action is in the best interest of the Company and its stockholders.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Other
                                         rights apply</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Nothing
in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or otherwise limiting the Company&rsquo;s
right under applicable state or local law or any prior agreement you have signed or made with the Company regarding trade secrets,
confidential information, or intellectual property.</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Data
Privacy Appendix</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>General</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Introduction</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
Data Privacy Appendix sets out certain data privacy provisions that apply to you in connection with your Award.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Meaning
                                         of Data</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">For
the purposes of this Data Privacy Appendix,<B> Data</B> means personal information that directly or indirectly identifies you,
including: your name, home address and telephone number, your date of birth, your government identification number, your salary
information, nationality, job title and employment location, any shares or directorships you hold or held in the Company or any
Affiliate, details of your Award and any equity or cash awards or any other entitlements to stock or cash granted (regardless
of whether or not exercised, vested or settled, and including any cancelled or forfeited awards), any information necessary to
process your Award or any other award (e.g. your mailing address for a check payment or bank account wire transfer information),
any other information necessary to process mandatory tax withholding and reporting and/or, where applicable, your employment or
service termination date and the reason for the termination.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>For
                                         Award recipients not located in the EEA or UK</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
section applies if you reside anywhere in the world except the European Economic Area (EEA) or the United Kingdom (UK). By accepting
your Award, you confirm the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Consent</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data by and between the Company,
your employer or any Affiliate for the purpose of implementing, administering, and managing your participation in the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Data
                                         collected</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that the Company and its Affiliates may hold Data for the exclusive purpose of implementing, administering, and managing
the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Purposes
                                         of collection </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that Data will be transferred to one or more stock or incentive plan service providers selected by the Company, which
may assist the Company with the implementation, administration, and/or management of the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Recipients
                                         of Data</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that the recipients of Data may be located in the United States or elsewhere. The Company also uses third party service
providers who may assist with the implementation, administration or management of the Plan. These service providers are bound
by contract to handle Data in a way that aligns with this Data Privacy Appendix and applicable law. If you have any questions
about the local entities or services providers who may access or handle your Data, please contact your local human resources representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
consenting at section 2.1 (Consent) above, you authorize the Company and any other possible recipients that do or may assist the
Company with implementing, administering or managing the Plan to receive, possess, use, retain and transfer the Data, in electronic
or other form, for the sole purpose of implementing, administering and/or managing your participation in the Plan.</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Data
                                         retention</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.
In some cases, your information will be retained for the Company or your employer to comply with a legal or tax obligation.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Your
                                         rights </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that if you reside in certain jurisdictions, to the extent required by applicable laws, you may, at any time and without
cost:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.6.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">request
                                         access to Data;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.6.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">request
                                         additional information about the storage and processing of Data;</FONT></TD></TR></TABLE>

                                         <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.6.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">require
                                         any necessary amendments to Data; or</FONT></TD></TR></TABLE>

                                         <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.6.4</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">refuse
                                         or withdraw the consents you give by accepting the Award,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">by
contacting your local human resources representative in writing. </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Implications
                                         of not consenting or withdrawing consent</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that you provide these consents on a purely voluntary basis. If you do not consent, or if you later withdraw your consent,
your employment or service contract with the Company or an Affiliate will not be adversely affected. Refusing or withdrawing your
consent will mean that the Company will not be able to grant new awards or administer or maintain any existing awards (including
this Award) under the Plan. You understand that refusing or withdrawing your consent may affect your ability to participate in
the Plan (including the right to retain an award, such as this Award). You understand that you may contact a local human resources
representative for more information on the consequences of refusal to consent or withdrawal of consent.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>For
                                         Award recipients located in the EEA and/or UK</B></FONT></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
section applies if you reside inside the United Kingdom (UK) and/or the European Economic Area (EEA). By accepting your Award,
you confirm the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Data
                                         collected </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that the your employer (acting as controller) and the Company may collect, to the extent permissible under applicable
law, Data for the exclusive purpose of implementing, administering, and managing the Plan. The Data is collected from you, the
employer, and the Company for the exclusive purpose of implementing, administering, and managing the Plan in accordance with the
terms of your Award.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Purposes
                                         of collection/processing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge the legal basis for Data processing is performance of the contract comprising your Award. The Data must be provided
in order for you to participate in the Plan and for the parties to your Award to perform their respective obligations as set out
in your Award documents. If you do not provide Data, you will not be able to participate in the Plan or continue to hold your
Award.</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Transfers
                                         and retention of Data </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that your employer will transfer Data to the Company for Plan administration purposes. The Company and your employer
may also transfer your Data to other service providers (such as accounting firms, payroll processing firms or tax firms), as may
be selected by the Company now or in the future, to assist the Company and your employer with the implementation, administration
and/or management of your Award. You understand that recipients of the Data may be located in a country that does not benefit
from an adequacy decision issued by the European Commission. When your information is transferred outside the EEA or the UK (as
applicable), it is done in accordance with data protection laws and regulations requiring adequate transfer mechanisms. For further
information as to the transfer of your Data, please contact <U>privacy@coca-cola.com</U>. Your Data will be held only as long
as is necessary to implement, administer and manage your rights and obligations under the terms of your Award documents, as well
as in compliance with other laws requiring a longer retention period.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Accuracy</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand the Company and your employer will take steps in accordance with applicable legislation to keep Data accurate, complete
and up to date.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Your
                                         rights</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">You
understand you are entitled to: </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.5.1</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">have any inadequate, incomplete or incorrect
    Data corrected;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.5.2</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">request access to your Data and additional
    information about the processing of that Data;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.5.3</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">object to the processing of Data or have
    your Data erased, under certain circumstances; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.5.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">subject to applicable law:</FONT></TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">restrict
                                         the processing of your Data so that it is stored but not actively processed (e.g. while
                                         the Company assesses whether you are entitled to have Data erased); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">receive
                                         a copy of the Data provided in connection with your Award or generated by you, in a common
                                         machine-readable format,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">and
you may exercise these rights by contacting a local human resources representative.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Other
                                         contacts</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand you have the right to contact, and may lodge a complaint with, the relevant data protection supervisory authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">You
may also contact the EU Data Protection Officer:</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Nicola Aliperti Coca-Cola Italia s.r.l.</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Viale Edison 110</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Building B</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">20099 Sesto San Giovanni (Milan)</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Italy</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal"><U>DPO-Europe@coca-cola.com</U></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Country
                                         specific provisions</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. By accepting
your Award, you confirm the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                         you are subject to the laws of Canada</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
authorize the Company, your employer, and your employer&rsquo;s representatives to discuss with and obtain all relevant information
from all personnel (professional or not) involved in the administration and operation of the Plan. You authorize your employer,
the Company, any Affiliates and any stock or incentive plan service provider that may be selected by the Company to assist with
the Plan to disclose and discuss the Plan with their respective advisors. You further authorize your employer, the Company and
any Affiliates to record this information and to keep it in your employee file.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                         you are subject to the laws of Russia </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that you have read, understood and agree to the terms regarding the collection, processing and transfer of data described
in section 2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. Upon request of the Company or
your employer, you agree to provide an executed data privacy consent form or any similar agreements or consents that the Company
or your employer may deem necessary to obtain under the data privacy laws in Russia, either now or in the future. You understand
that you will not be able to participate in the Plan if you fail to execute any such consent or agreement that may be requested.</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">2022
Awards made under</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt">The
Coca-Cola Company 2014 Equity Plan</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Additional
Terms</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting your Award you:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Plan
                                         Documents</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Agree
that you have been given all relevant information and materials regarding the terms and conditions of your Award, which are set
out in the rules of The Coca-Cola Company 2014 Equity Plan, as amended from time to time (the <B>Plan</B>), your Award Notification
(including any appendices attached to it) and these Additional Terms (including the Global Appendix set out below) (collectively,
the <B>Plan Documents</B>).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Employment</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the grant of your Award does not form part of and does not affect or change your
                                         employment contract or your employment relationship with your employer (which is entirely
                                         separate from the Plan). The grant of your Award and your participation in the Plan does
                                         not create a right to employment or continued service and will not be interpreted as
                                         forming an employment or service contract with The Coca-Cola Company (the <B>Company</B>),
                                         your employer or any Affiliate (as defined in the Plan). The Award does not impact the
                                         ability of the Company, your employer or any <B>Affiliate</B> to terminate that employment
                                         or service relationship. All benefits granted by your Award will constitute an occasional
                                         extraordinary payment and may not, in any way or for any purpose, be considered part
                                         of your normal remuneration or constitute consideration for any services you provide
                                         to the Company, your employer or any Affiliate, including when calculating any other
                                         benefits.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company&rsquo;s decision to grant your Award is voluntary and discretionary,
                                         and that you have no right to participate in the Plan. Acceptance of your Award and participation
                                         in the Plan does not create any right to, or expectation of, future employment or service,
                                         future participation in the Plan or the grant of future awards (on the same basis, or
                                         at all). The Company may at any time decide to cease offering awards under the Plan,
                                         or amend, modify, suspend, cancel or terminate the Plan and any benefits under it.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you are not entitled to the exercise of any discretion under the Plan in your favor,
                                         that decisions with respect to your Award and any future awards are at the sole discretion
                                         of the Company and are final, binding and conclusive, and that you do not have any claim
                                         or right of action in respect of any decision, omission, or discretion, which may in
                                         each case operate to your disadvantage.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree,
                                         in consideration for and as a condition of your Award, to waive all rights which might
                                         arise in connection with the Plan, including:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         right to institute any claim against the Company, your employer or any Affiliate; and
                                         </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         right to pursue any claim that is allowed by a court,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">other
than the right to acquire, as relevant, $0.25 par value shares of common stock of the Company (<B>Stock</B>) or cash (subject
to and in accordance with the Plan).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you do not have any right to compensation or damages for any loss (actual or potential)
                                         in relation to the Plan or your Award, including where it is forfeited on termination
                                         of employment or cessation of services for any reason, whether or not lawful or in breach
                                         of employment laws or the terms of your employment or service agreement, if any. </FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                         transfer</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Accept
that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your Award or any rights in respect of it,
whether voluntarily or involuntarily (other than to your personal representatives on death).</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Modifications
                                         and additional requirements</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may modify any of the terms of your Award to be consistent with any
                                         applicable law or applicable government agency regulation where, in the opinion of the
                                         Company, that term might otherwise conflict or be inconsistent.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may impose additional conditions, requirements and restrictions on your
                                         Award, your participation in the Plan and any Stock or cash you acquire on vesting or
                                         exercise of your Award, and that you will comply with them, including signing any additional
                                         agreements or undertakings.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         to any amendment made to the Plan or any term of your Award (including an amendment with
                                         retroactive effect) where the amendment is necessary or advisable to ensure the Plan
                                         or your Award complies with any future law relating to plans of this nature or their
                                         administration (including Section 409A of the U.S. Internal Revenue Code of 1986, as
                                         amended).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         to any amendment made to any of the terms of your Award (including rescinding your Award
                                         entirely) to correct any error that occurred in connection with the grant or documentation
                                         of your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that your Award may be adjusted to reflect a change in capital structure, in accordance
                                         with the terms of the Plan, and agree that, where your Award is over Stock and an adjustment
                                         results in a fractional share, the fractional share may be disregarded at the Company&rsquo;s
                                         discretion.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Tax</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that participating in the Plan will probably have tax consequences for you and that all
                                         payments made with respect to your Award (including payments in Stock or cash) may be
                                         subject to tax, social security and any similar charges in any country where you are
                                         employed, reside, or are otherwise subject to tax (<B>Tax</B>).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that you (or your personal representative) are ultimately responsible for and will bear
                                         any liability for any Tax in respect of your Award and your participation in the Plan,
                                         and understand that this liability may exceed any amounts withheld and paid on your behalf.
                                         </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company, your employer, an Affiliate, any trustee of any employee benefit trust
                                         and any third party service provider (each, a <B>Withholding Person</B>) is entitled
                                         to do any, all or a combination of the following methods (where relevant) to enable a
                                         Withholding Person to raise an amount it considers necessary or desirable to recover
                                         the Liabilities:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">sell
                                         or procure the sale on your behalf of a sufficient number of the Stock you acquire on
                                         vesting or exercise of your Award; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">reduce
                                         the number of Stock you acquire on vesting or exercise of your Award accordingly and
                                         settle the balance in cash; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">withhold
                                         amounts from:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">proceeds
                                         of sale under section 5.3.1;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         balance settled in cash under section 5.3.2; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 70.9pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         other cash payments of any kind owed to you.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">For
these purposes, <B>Liabilities </B>means any obligation on the Withholding Person to pay or account for Tax, any unpaid exercise
price, any associated costs (including under section 7 (Costs)) and any amount you owe to the Company, your employer or any Affiliate
due to any obligation of any nature whatsoever (including under a loan, the Company&rsquo;s tax equalization program or any travel
or expenses policy) to the extent that the Company, the employer or any Affiliate in its reasonable judgement determines you owe
them that amount.</FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that, for tax purposes, and where allowed by applicable law, you are deemed to have received
                                         the full number of Stock where the number of Stock you acquire is reduced under section
                                         5.3.2.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that, where permitted by the Company, you may elect to satisfy Tax and/or pay any exercise
                                         price by delivering (including by attestation) Stock to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if a Withholding Person&rsquo;s obligation to pay or account for Tax cannot or has
                                         not been fully satisfied by the above methods, you must pay to the Withholding Person
                                         an amount sufficient to enable them to discharge that obligation.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         to enter any tax elections for particular tax and/or social security treatment, execute
                                         any documents, give any directions and take any action as may be requested by the Company,
                                         your employer or any Affiliate in relation to any Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.8</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company, your employer and any Affiliate do not guarantee or warrant any particular
                                         Tax treatment in relation to your Award, the cash or Stock you acquire in connection
                                         with your Award (including any dividends on Stock), or your participation in the Plan
                                         and that they are not under any obligation to structure the Award in a Tax favorable
                                         way or avoid adverse Tax treatment in any jurisdiction. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.9</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that neither the Company, your employer nor any Affiliate will be liable for any Tax,
                                         interest, penalties or other amounts owed by any taxpayer as a consequence of the Plan
                                         or an Award and that any Tax information provided is for guidance purposes only. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.10</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that the cash or Stock subject to your Award may only vest or be exercised (as applicable)
                                         if satisfactory arrangements are in place to enable all Withholding Persons to obtain
                                         the funds needed to satisfy any Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.11</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the vested (and, if applicable, exercised) Stock or cash subject to your Award may
                                         not be delivered or paid to you unless you have complied with your obligation to pay
                                         the Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Internationally
                                         mobile employees</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that if you are a mobile employee, meaning that you are based in different jurisdictions
                                         during the course of your employment or service that you are or may be subject to Tax
                                         in more than one country, you are strongly encouraged to inform the Company and your
                                         employer, and to speak with your personal tax adviser regarding the tax treatment of
                                         your participation in the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that, if you are a mobile employee, the Company or your employer may be required to withhold
                                         for Tax in more than one jurisdiction.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that if you are a &ldquo;Global Mobility Associate&rdquo; as defined in the Company&rsquo;s
                                         Global Mobility Policy (or the equivalent under any applicable international service
                                         policy from time to time), you remain responsible for all Tax except where expressly
                                         stated otherwise in that policy and/or the Company&rsquo;s tax equalization program.
                                         A copy of the Company&rsquo;s Global Mobility Policy is available on the Company&rsquo;s
                                         intranet.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Costs</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Agree
that you are responsible for the payment of any fees, dealing, commission or currency conversion costs or any other costs associated
with your Award, including costs associated with the payment of any cash and the sale of any Stock.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Notices</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that any notice or other communication required in relation to your Award will be given
                                         in writing, which may include electronic means.</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that any notice or other communication to be given to you in connection with your Award
                                         may be delivered by electronic means (including by email, or through the Company or your
                                         employer&rsquo;s intranet or a share plan portal), personally delivered, or sent by ordinary
                                         post to the principal address on file for you from time to time with the Company, your
                                         employer, an Affiliate or the Company&rsquo;s agents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that any notice or other communication to be given to the Company or its agents in connection
                                         with your Award may be delivered or sent to its registered office or to such other place
                                         and by such means as communicated to you by or on behalf of the Company from time to
                                         time.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that notices or other communications:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">8.4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">sent
                                         electronically will be deemed to have been received immediately (if sent during usual
                                         business hours) or at the opening of business on the next business day (if sent outside
                                         usual business hours);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">8.4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">that
                                         are personally delivered will be deemed to have been received when left at the relevant
                                         address (if left during usual business hours) or at the opening of business on the next
                                         business day (if left outside usual business hours); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">8.4.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">sent
                                         by post will be deemed to have been received 24 hours after posting to a U.S. address
                                         or 3 days after posting to an address outside the U.S.,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">unless
there is evidence to the contrary.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that all notices or communications to be given to you are given and sent at your risk
                                         and that neither the Company, your employer nor any Affiliate has any liability in respect
                                         of any notice or communication given or sent, nor need they be concerned to see that
                                         you actually receive it.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Insider
                                            trading and market abuse</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>9.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that rules on insider trading, dealing notification requirements, and market abuse laws
                                         may apply in relation to any actions or decisions taken relating to your Award, including
                                         in relation to the acceptance, vesting, exercise or settlement of your Award, the delivery
                                         or payment of any Stock or cash, and the sale of any Stock. These rules, requirements
                                         and laws:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">9.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">are
                                         separate from and in addition to the requirements that apply to you under The Coca-Cola
                                         Company Global Insider Trading Compliance Policy; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">9.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">may
                                         prohibit or delay your actions or decisions. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>9.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that it is your responsibility to comply with the rules, requirements and laws referred
                                         to in section 9.1. You should consult with your personal legal adviser on these matters.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Currency
                                         risk</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>10.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that if any Stock relating to your Award is traded in a currency that is not the currency
                                         in your jurisdiction, the value of the Stock may also be affected by movements in the
                                         exchange rate.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>10.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that neither the Company, your employer nor any Affiliate is liable for any loss due
                                         to movements in the exchange rate nor any charges imposed in relation to the conversion
                                         or transfer of money.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                            advice</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Confirm
                                         you are accepting your Award and participating in the Plan voluntarily and understand
                                         that the Company is not making any recommendations regarding your Award or any Stock
                                         or cash relating to your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that neither the Company, your employer, any Affiliate nor any person or entity acting
                                         on their behalf has provided you with any legal, investment, tax (including reporting)
                                         or financial advice with respect to your participation in the Plan, your Award or any
                                         Stock or cash acquired upon vesting or exercise of your Award. You should consult with
                                         your own suitably qualified advisers before taking any action under the Plan. </FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the information and materials provided do not take into account your objectives,
                                         financial situation or needs and that if you do not understand the contents of the Plan
                                         Documents, or you are in any doubt, you should consult an independent authorized financial
                                         adviser.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         you will have no remedies for any statement, representation, assurance or warranty that
                                         is not set out in your Plan Documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                            guarantee</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>12.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that neither the Company, your employer nor any Affiliate guarantees a specified level
                                         of return in respect of your Award or any Stock.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>12.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that there is a risk that any Stock relating to your Award may fall as well as rise in
                                         value, that the future value of Stock cannot be predicted with certainty and that market
                                         forces will impact the price of any Stock relating to your Award and, in the worst case,
                                         the market value of the Stock may become zero. More information in relation to the Company,
                                         including its share price, can be found at <U>https://www.coca-colacompany.com/</U>. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                            public offer</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that your Award is being offered to you in your capacity as an employee of the Company&rsquo;s
                                         group and that the offer is not intended for the general public and may not be used for
                                         any public offer.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company is not required to deliver any Stock or cash on settlement of your Award
                                         before it completes, on terms to its satisfaction, any registration, listing, exemption
                                         or qualification or other legal requirements or obtains any clearance or approval that
                                         the Company considers is necessary or desirable, and you agree to provide any information,
                                         make any agreements and give any representations that the Company requests as part of
                                         this process.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse
                                         to deliver any Stock or cash where the Company considers the delivery of Stock or cash
                                         may conflict or be inconsistent with applicable law or applicable government agency regulation.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that neither the Company, your employer nor any Affiliate is under any obligation to
                                         register, exempt or qualify, or seek clearance or approval for, your Award or any Stock
                                         or cash that you may acquire in connection with your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that your Award may not have been authorized or approved by any applicable securities
                                         authorities and may have been offered pursuant to an exemption from registration in your
                                         local jurisdiction. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the regulatory bodies in your jurisdiction accept no responsibility for the accuracy
                                         and completeness of the statements and information contained in the Plan Documents and
                                         take no liability whatsoever for any loss arising from reliance upon the whole or any
                                         part of the contents of those documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that a prospectus or similar offering or registration document may not have been prepared,
                                         authorized or approved by any applicable authority in any jurisdiction outside the United
                                         States.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Exchange
                                            controls and any reporting requirements</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that exchange control regulations and/or foreign asset reporting requirements may apply
                                         to you in respect of your Award and/or any Stock or cash acquired in connection with
                                         your Award, and that you are solely responsible for complying with those regulations
                                         and requirements. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that neither the Company, your employer nor any Affiliate are responsible for obtaining
                                         exchange control approval or making any reports on your behalf, nor for monitoring compliance
                                         with those regulations and requirements and that if you fail to obtain any required exchange
                                         control approval or make the necessary reports, neither the Company, your employer nor
                                         any Affiliate will be liable in any way for any resulting fines or penalties. You should
                                         seek independent professional advice if you are unsure about the obligations that apply
                                         to you as a result of your participation in the Plan.</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that you are solely responsible for complying with any filing, notification or reporting
                                         requirements in respect of: </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">14.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">your
                                         participation in the Plan and/or </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">14.3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">benefits
                                         received under the Plan, </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">as
required by the local law in any jurisdiction. The Company accepts no responsibility for your failure or delay in complying with
such requirements. If you are in any doubt as to what actions you should take, you should consult a duly authorized independent
adviser.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>General</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Consent
                                         to the use of electronic communications in connection with the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Confirm
                                         that references to &ldquo;employer&rdquo; throughout these Additional Terms include your
                                         former employer, where applicable.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that all determinations and decisions on questions of interpretation in respect of your
                                         Award and the Plan Documents will be made by the Company (or any committee on its behalf)
                                         in its sole and absolute discretion. Those determinations and decisions will be final,
                                         binding and conclusive. Any references to determinations or decisions made, or actions
                                         taken, by the &ldquo;Company&rdquo; as referred to in these Additional Terms include
                                         any committee acting on its behalf.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable
                                         for any reason by any court in any jurisdiction then, for the purposes of that jurisdiction
                                         only:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">15.4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">such
                                         provision will be deleted; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">15.4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         remaining provisions will continue in full force and effect.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if the Company waives a breach of one or more provisions in the Plan Documents,
                                         this does not constitute a waiver of any other provision of the Plan Documents, or a
                                         waiver of any subsequent breach of the Plan Documents (by you or anyone else).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">15.6.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         federal laws of the United States of America and the state laws of the State of Delaware,
                                         United States of America, govern your Plan Documents and your Award without regard to
                                         the conflict of law provisions; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">15.6.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         courts of the United States District Court for the District of Delaware or the Delaware
                                         Superior Court, New Castle County have exclusive jurisdiction in respect of disputes
                                         arising under or in connection with the Plan or your Award,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">and
you waive any current or future objection you may have to this choice of law and jurisdiction.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>English
                                            language (<I>this applies if you have received an English language version only of any Plan
                                            Document</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that you fully understand the contents of the English language version of the Plan Documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you do not need a translation of the Plan Documents and that you are fluent and
                                         regularly conduct business in the English language as part of your duties and responsibilities
                                         to your employer.</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>17.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Translations
                                            (<I>this applies if you have received a Plan Document in a language other than English</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>17.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if there is any conflict between the terms of the English language version of the
                                         Plan Documents and a version in any other language, the English language version will
                                         prevail.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>18.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Options
                                            (<I>this applies if your Award Notification specifies that your Award is an Option</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>18.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Understand
                                         that, in order to exercise your Award, you will need to pay the exercise price. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>18.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you will be informed of the acceptable forms and methods of paying the exercise
                                         price when you come to exercise your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>19.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Restricted
                                            resale (<I>this applies if your Award is over Stock</I>)</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Acknowledge
that any Stock you may acquire upon settlement of your Award may be subject to restrictions on transfer and resale in your local
jurisdiction and you agree that you will comply with those restrictions, including that you will not offer, sell, advertise or
otherwise market the Stock (or cause any of these to occur) in circumstances which constitute any type of public offering of securities,
unless an exemption applies.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>20.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Performance
                                            conditions (<I>this applies if your Award Notification specifies that your Award is subject
                                            to performance conditions</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>20.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that the vesting of your Award is conditional on the satisfaction of one or more performance
                                         conditions as set out in the Performance Criteria Appendix to your Award Notification
                                         (the <B>Performance Criteria</B>) and, to the extent the Performance Criteria are not
                                         satisfied, your Award may be forfeited.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>20.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that the Performance Criteria may be altered in the circumstances specified in Section
                                         10.2 of the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>21.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Malus
                                            and clawback (<I>this applies if your Award Notification specifies that your Award is subject
                                            to &ldquo;Malus and clawback&rdquo;</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>21.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Agree
                                         that any benefits you may receive with respect to your Award will be subject to reduction,
                                         cancellation, repayment, forfeiture or recoupment if there is a determination that the
                                         vesting of, or amount realized from, your Award was based on:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">21.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">materially
                                         inaccurate financial statements; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 42.55pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">21.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         other materially inaccurate performance metric criteria,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">and
you acknowledge that this applies regardless of whether you caused or contributed to the material inaccuracy.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>21.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may also seek to recover your Award where required by the provisions
                                         of the Dodd-Frank Wall Street Reform and Consumer Protection Act or any other &ldquo;clawback&rdquo;
                                         provision required by applicable law, regulation or listing standards, including the
                                         listing standards of the New York Stock Exchange, and you authorize such recovery.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Stock
                                            ownership guidelines (this only applies if you are subject to the Company&rsquo;s stock ownership
                                            guidelines)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that if you have not met the Company&rsquo;s stock ownership guidelines <U>before</U>
                                         the applicable compliance deadline but you are a &ldquo;Section 16 officer&rdquo; under
                                         the U.S. Securities Exchange Act of 1934, you are prohibited from selling 50% of any
                                         Stock you obtain upon vesting or exercise of your Award until you meet the relevant guidelines,
                                         except for any Stock that is sold or cash settled to cover Tax and any exercise price.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that if you have not met the guidelines by the applicable compliance deadline, you are
                                         prohibited at all times <U>after</U> that compliance deadline from selling any Stock
                                         you obtain on vesting or exercise of your Award, except for any Stock that is sold or
                                         cash settled to cover Tax, commissions and fees and any exercise price. Once you meet
                                         the guidelines, you can sell Stock in excess of the guidelines.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Global
Appendix &ndash; Equity Awards<B><SUP>3</SUP></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-indent: -28.35pt"><FONT STYLE="font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If you are subject to the laws of the European Union</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive
and to encourage employee share ownership and to increase your interest in the success of the Company. The company offering these
rights is The Coca-Cola Company. The Stock which is the subject of these rights is new or existing par value common stock in the
Company. More information in relation to the Company including the stock price can be found at the following web address: <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU Prospectus Regulation. The total maximum
number of Stock which is the subject of this offer is [total number of stock awarded for this offer].</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-indent: -28.35pt"><FONT STYLE="font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you are subject to the laws of Argentina</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Neither
the Award nor the underlying Stock are publicly offered or listed on any stock exchange in Argentina.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
provision applies if your Award Notification specifies that your Award is an Option:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Depending
upon the method of exercise chosen for the Option, you may be subject to restrictions with respect to the purchase and/or remittance
of U.S. dollars pursuant to Argentine currency exchange regulations. The Company reserves the right to restrict the methods of
exercise if required or advisable to comply with Argentine laws. </I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Australia</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
grant of Awards under the Plan is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49
and ASIC Class Order CO 14/1000. Additional details are set forth in the Australia Offer Document, which is<I> </I>available on
the Merrill Benefits OnLine&reg; website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
offer is intended to receive tax deferred treatment under Subdivision 83A-C of the Income Tax Assessment Act 1997(Cth). The conditions
to receive such treatment are contained in the Award Agreement.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Belgium</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">If
your Award Notification specifies that your Award is an Option, you confirm you have read and understood the information regarding
the Belgian taxation of Options which has been separately made available to you by email and/or on the Merrill Benefits OnLine&reg;
website. You should review this information thoroughly before accepting your Option grant.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Brazil</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you agree that you are (i) making an investment decision, and (ii) the value of the underlying Stock is not
fixed and may increase or decrease in value over the vesting or exercise period without compensation to you.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><SUP>3</SUP> If you are subject
to the laws of any of the following countries, there are no country-specific provisions for your country in this appendix: Bangladesh,
Costa Rica, Dominican Republic, Ecuador, Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico, Serbia, Sri Lanka, Swaziland,
Taiwan, Thailand and Ukraine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Canada</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">For
purposes of your Award, your employment will be considered terminated and your right (if any) to vest in any Award or exercise
any Option after such termination (regardless of the reason for such termination and whether or not later found to be invalid,
unlawful or in breach of the employment laws in the jurisdiction where you are employed or the terms of your employment agreement,
if any) will be measured as of the earlier of: (a) the date your employment with the Company or one of its Subsidiaries (as defined
in the Plan) or Affiliates is terminated, (b) the date you receive written notice of termination from the Company or a Subsidiary
or Affiliate, regardless of any notice period or period of pay in lieu of such notice mandated under the employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any, or (c) the date you are no longer employed
by the Company or any of its Subsidiaries or Affiliates. You will not be entitled to a pro-rata portion of the Award for any time
before the date on which your right to vest terminates, nor will you be entitled to any compensation for lost vesting. In the
event the date on which you are no longer actively providing services cannot be reasonably determined under the terms of your
Award, the Company, in its sole discretion, shall determine when you are no longer employed for purposes of the Award (including
whether you may still be considered employed or actively providing services while on a leave of absence).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">Notwithstanding
the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory
notice period, your right to vest in the Award under the Plan, if any, will terminate effective as of the last day of your minimum
statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of
your statutory notice period, nor will you be entitled to any compensation for lost vesting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">In
addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired pursuant to the Plan will be subject
to certain restrictions on resale imposed by Canadian provincial securities laws (in general, you may not resell your Stock to
Canadian purchasers). Accordingly, you are encouraged to seek legal advice prior to any resale of the Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Furthermore,
notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards granted to Canadian residents shall only be
settled in Stock and shall not be settled in cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">The
following terms and conditions apply if you are resident in Quebec:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>You
agree that you wish the Plan Documents to be drawn up in English.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Vous
confirmez que vous souhaitiez que les Documents du Plan soient r&eacute;dig&eacute;s en anglais</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Chile</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Neither
the Company, the Plan nor the Stock have been registered in the <I>Registro de Valores</I> (Securities Registry) or in the <I>Registro
de Valores Extranjeros</I> (Foreign Securities Registry) of the <I>Comisi&oacute;n para el Mercado Financiero de Chile</I> (Chilean
Commission for the Financial market or CMF) and they are not subject to the control of the CMF. The Plan is governed by General
Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to deliver public information
regarding the Stock in Chile. Shares of Stock cannot be publicly offered in Chile unless they are registered with the CMF.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Ni
The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de Valores o en el Registro de Valores Extranjeros
que lleva la Comisi&oacute;n para el Mercado Financiero de Chile (CMF) y ninguno de ellos est&aacute; sujeto a la fiscalizaci&oacute;n
de la CMF. Esta oferta de Acciones se acoge a la Norma de Car&aacute;cter General 336. Por tratarse de valores no inscritos, el
emisor de las Acciones no tiene obligaci&oacute;n bajo la ley chilena de entregar en Chile informaci&oacute;n p&uacute;blica acerca
de las Acciones. Las Acciones no pueden ser ofrecidas p&uacute;blicamente en Chile en tanto &eacute;stas no se inscriban en el
Registro de Valores correspondiente.</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to exchange control restrictions imposed by the China State Administration
                                            of Foreign Exchange (SAFE), as determined by the Company in its sole discretion</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Notwithstanding
any other provision in the Plan Documents, the following provisions apply in the event of the termination of your employment (as
interpreted in accordance with the Employment Events Appendix) with the Company or a Subsidiary (as defined in the Plan)</FONT><FONT STYLE="font-size: 10pt">
<FONT STYLE="font-weight: normal">(1) because of your Disability, or (2) after attaining age 55:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Awards
that are Options and Awards held at least 12 months will immediately vest and will be settled in cash. The cash amount will be
determined based on the closing price of the Stock on the date of your termination of employment (or, if a non-trading day, the
next trading day) or the exercise of your Option (if applicable) within the post-termination exercise period stated below. Awards
that are not Options and that are held less than 12 months from the date of grant are forfeited.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>If
your Award is an Option, the period over which you may exercise your Option expires upon earlier of (1) six months from your termination
of employment or (2) the Option expiration date provided in the Plan Documents.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
Company has the discretion to arrange for the sale of any Stock issued upon settlement of your Award, either immediately upon
settlement or at any time thereafter. In any event, if you terminate employment, you will be required to sell all Stock acquired
upon settlement of the Award within such time period as required by the Company in accordance with SAFE requirements. Any Stock
remaining in your brokerage account at the end of this period shall be sold by the broker (on your behalf pursuant to this authorization
and without further consent). In addition, any Award that has not vested by the end of this period will then immediately be forfeited.
The Company shall have the exclusive discretion to determine when your employment has been terminated for the purposes of the
Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
agree to sign any additional agreements, forms and/or consents that reasonably may be requested by the Company (or the Company&rsquo;s
designated broker) to effectuate the sale of the Stock (including, without limitation, as to the transfer of the sale proceeds
and other exchange control matters noted below) and shall otherwise cooperate with the Company with respect to such matters. You
acknowledge that neither the Company nor the designated broker is under any obligation to arrange for the sale of Stock at any
particular price (it being understood that the sale will occur in the market) and that broker&rsquo;s fees and similar expenses
may be incurred in any such sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for applicable
taxes, any broker&rsquo;s fees or commissions, and any similar expenses of the sale will be remitted to you in accordance with
applicable exchange control laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you acknowledge that you understand and agree that you are not permitted to transfer any Stock acquired under
the Plan out of your account established with the Company&rsquo;s designated broker until the Stock is sold. The limitation applies
to all Stock issued to you under the Plan, whether or not you remained employed with the Company or a Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand and agree that you will be required to immediately repatriate to China the proceeds from the sale of any Stock acquired
under the Plan and any such dividends paid on such shares. You further understand that such repatriation proceeds may need to
be effected through a special bank account established by the Company (or a Subsidiary or Affiliate in China), and you hereby
consent and agree that any sale proceeds and cash dividends may be transferred to such special account by the Company (or a Subsidiary
or Affiliate in China) on your behalf prior to being delivered to you and that no interest shall be paid with respect to funds
held in such account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify">&nbsp;</P>




<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 31.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
proceeds may be paid to you in U.S. dollars or local currency at the Company&rsquo;s discretion. If the proceeds are paid to you
in U.S. dollars, you understand that a U.S. dollar bank account in China must be established and maintained so that the proceeds
may be deposited into such account. If the proceeds are paid to you in local currency, you acknowledge that the Company (and its
Subsidiaries and Affiliates) are under no obligation to secure any particular exchange conversion rate and that the Company (and
its Subsidiaries and Affiliates) may face delays in converting the proceeds to local currency due to exchange control restrictions.
You agree to bear any currency fluctuation risk between the time the Stock is sold and the net proceeds are converted into local
currency and distributed to you. You further agree to comply with any other requirements that may be imposed by the Company in
the future in order to facilitate compliance with exchange control requirements in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 31.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">In
addition to the vesting schedule for your Award, settlement of the Award is also conditioned on the continued effectiveness of
the Company&rsquo;s registration of the Plan with SAFE (the <B>SAFE Registration Requirement</B>). If or to the extent the Company
is unable to maintain the registration, no Stock for which a registration cannot be maintained shall be issued. In this case,
the Company retains the discretion to settle any Award for which the vesting schedule, but not the SAFE Registration Requirement,
has been met in cash paid through local payroll in an amount equal to the market value of the Stock subject to the Award less
any withholding for applicable taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 31.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost interest or dividends or other losses
that you may incur or suffer resulting from the enforcement of the foregoing terms or otherwise from the Company&rsquo;s operation
and enforcement of the Plan, the Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and
requirements.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Colombia</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component
of &ldquo;salary&rdquo; for any legal purpose.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of France</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you confirm that you have read and understood the Plan Documents, which were provided in English. You accept
the terms of those Plan Documents and confirm that you have a good knowledge of the English language.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>En
acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs &agrave; ce plan d&rsquo;incitation &agrave;
long terme (qui vous ont &eacute;t&eacute; fournis en anglais) et que vous acceptez les termes de ce plan.&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Hong Kong</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>WARNING:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
contents of the Plan Documents have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution
in relation to the offer. If you are in any doubt about any of the contents of the Plan Documents, you should obtain independent
professional advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
offer to receive an Award under the Plan (the <B>Offer</B>) is strictly private and only available to eligible employees of [name
of Hong Kong company]. The Offer has also not been approved by the Securities and Futures Commission in Hong Kong and it should
not be made in whole or in part to the public or any third-party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">No
Awards granted under the Plan may be transferred or assigned, except as expressly permitted by the Company in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>




<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Sale
of Stock.</U> Any Stock received at vesting is accepted as a personal investment. In the event that any portion of this Award
vests within six months of the grant date, you agree that you will not offer to the public or otherwise dispose of the Stock acquired
prior to the six-month anniversary of the grant date.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of India</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
must repatriate to India all funds resulting from the sale of Stock acquired in relation to your Award within 90 days, and all
proceeds from the receipt of any dividends within 180 days. You should receive a foreign inward remittance certificate (<B>FIRC</B>)
from your bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in
the event that the Reserve Bank of India or your employer requests proof of repatriation.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Indonesia</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">A
translation of the documents relating to this grant into Bahasa Indonesia can be provided to you upon request to your local human
resources representative. By accepting the grant of the Award, you (i) confirm having read and understood the documents relating
to this grant which were provided in the English language, (ii) accept the terms of those documents accordingly, and (iii) agree
not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag, Language, Coat of Arms and National
Anthem or the implementing Presidential Regulation (when issued).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Terjemahan
dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat disediakan bagi anda berdasarkan permintaan kepada
perwakilan sumber daya manusia lokal anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah membaca
dan mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan dalam Bahasa Inggris, (ii) menerima syarat-syarat
dari dokumen-dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-Undang
No. 24 Tahun 2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu Kebangsaan atau Peraturan Presiden pelaksananya (ketika
diterbitkan).</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Italy</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the grant of the Award, you acknowledge that you have received a copy of the Plan Documents, you have reviewed the Plan
Documents in their entirety and you fully understand and accept all provisions of the Plan Documents. You further acknowledge
that you have read and expressly approve the following sections of the Additional Terms: section 2 (Employment); section 4 (Modifications
and additional requirements); section 5 (Tax); and section 15 (General).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Mexico</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed the Plan in its entirety and fully
understand and accept all provisions of the Plan. You further acknowledge that you have read and expressly approve the terms and
conditions set forth in section 2 (Employment) of the Additional Terms, in which the following is clearly described and established:
(i) your participation in the Plan does not constitute an acquired right; (ii) the Plan and your participation in the Plan are
offered by the Company on a wholly discretionary basis; (iii) your participation in the Plan is voluntary; and (iv) the Company
and its Subsidiaries (as defined in the Plan) are not responsible for any decrease in the value of the underlying Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>




<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
participating in the Plan, you expressly recognize that The Coca Cola Company, with registered offices at One Coca-Cola Plaza,
Atlanta, Georgia 30313, USA, is solely responsible for the administration of the Plan and that your participation in the Plan
and acquisition of Stock does not constitute an employment relationship between you and the Company since you are participating
in the Plan on a wholly commercial basis. Based on the foregoing, you expressly recognize that the Plan and the benefits that
you may derive from participation in the Plan do not establish any rights between you and the Company and do not form part of
the employment conditions and/or benefits provided by the Company and any modification of the Plan or its termination shall not
constitute a change or impairment of the terms and conditions of your employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company;
therefore, the Company reserves the absolute right to amend and/or discontinue your participation at any time without any liability
to you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">Finally,
you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or
damages regarding any provision of the Plan or the benefits derived under the Plan, and you therefore grant a full and broad release
to the Company, its Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal representatives
with respect to any claim that may arise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Al
participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el Plan en su totalidad, y que entiende
y acepta en su totalidad, todas y cada una de las disposiciones del Plan. Asimismo reconoce que ha le&iacute;do y aprueba expresamente
los t&eacute;rminos y condiciones se&ntilde;alados en el p&aacute;rrafo titulado Naturaleza de la Oferta en el Convenio, en lo
que claramente se describe y establece lo siguiente: (i) su participaci&oacute;n en el Plan no constituye un derecho adquirido;
(ii) el Plan y su participaci&oacute;n en el Plan son ofrecidos por la Compa&ntilde;&iacute;a sobre una base completamente discrecional;
(iii) su participaci&oacute;n en el Plan es voluntaria; y (iv) la Compa&ntilde;&iacute;a y sus Afiliadas no son responsables de
ninguna por la disminuci&oacute;n en el valor de las Acciones subyacentes.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Al
participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con oficinas registradas en One Coca-Cola Plaza,
Atlanta, Georgia 30313, Estados Unidos de Am&eacute;rica, es la &uacute;nica responsable por la administraci&oacute;n del Plan,
y que su participaci&oacute;n en el Plan, as&iacute; como la adquisici&oacute;n de las Acciones, no constituye una relaci&oacute;n
laboral entre usted y la Compa&ntilde;&iacute;a, debido a que usted participa en el plan sobre una base completamente mercantil.
Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que pudiera obtener por su participaci&oacute;n
en el Plan, no establecen derecho alguno entre usted y la Compa&ntilde;&iacute;a, y no forman parte de las condiciones y/o prestaciones
laborales que la Compa&ntilde;&iacute;a ofrece, y que las modificaciones al Plan o su terminaci&oacute;n, no constituir&aacute;n
un cambio ni afectar&aacute;n los t&eacute;rminos y condiciones de su relaci&oacute;n laboral.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Asimismo
usted entiende que su participaci&oacute;n en el Plan es el resultado de una decisi&oacute;n unilateral y discrecional de la Compa&ntilde;&iacute;a;
por lo tanto, la Compa&ntilde;&iacute;a se reserva el derecho absoluto de modificar y/o suspender su participaci&oacute;n en cualquier
momento, sin que usted incurra en responsabilidad alguna.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Finalmente,
usted declara que no se reserva acci&oacute;n o derecho alguno para interponer reclamaci&oacute;n alguna en contra de la Compa&ntilde;&iacute;a,
por concepto de compensaci&oacute;n o da&ntilde;os relacionados con cualquier disposici&oacute;n del Plan o de los beneficios
derivados del Plan, y por lo tanto, usted libera total y ampliamente de toda responsabilidad a la Compa&ntilde;&iacute;a, a sus
Afiliadas, sucursales, oficinas de representaci&oacute;n, sus accionistas, funcionarios, agentes o representantes legales, con
respecto a cualquier reclamaci&oacute;n que pudiera surgir.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
Stock underlying your Award has not been registered with the National Register of Securities maintained by the Mexican Banking
and Securities Commission and may not be offered or sold publicly in Mexico. The Plan Documents may not be publicly distributed
in Mexico. These materials are addressed to you only because of your existing relationship with the Company and its Subsidiaries
and may not be reproduced or copied in any form. The offer contained in these materials is addressed solely to the present employees
of the Company and its Subsidiaries in Mexico and any rights under the Plan may not be assigned or transferred. The Stock underlying
your Award will be offered pursuant to a private placement exception under the Mexican Securities Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of New Zealand</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with the terms of the Plan Documents.
The Stock, if issued, will give you a stake in the ownership of the Company. You may receive a return if dividends are paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">If
the Company runs into financial difficulties and is wound up, you will be paid only after all creditors and holders of preference
shares (if any) have been paid. You may lose some or all of your investment, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">New
Zealand law normally requires people who offer financial products to give information to investors before they invest. This information
is designed to help investors to make an informed decision. The usual rules do not apply to this offer because it is made under
an employee share scheme. As a result, you may not be given all the information usually required. You will also have fewer other
legal protections for this investment. You are advised to ask questions, read all documents carefully, and seek independent financial
advice before committing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under the Plan, you may be able to sell the
Stock on the New York Stock Exchange if there are interested buyers. You may get less than you invested. The price will depend
on the demand for the Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">For
information on risk factors impacting the Company&rsquo;s business that may affect the value of the Stock, you should refer to
the risk factors discussion on the Company&rsquo;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed
with the U.S. Securities and Exchange Commission and are available online at <U>www.sec.gov</U>, as well as on the Company&rsquo;s
&ldquo;Investor Relations&rdquo; website at <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>17.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Peru</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
grant of the Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information
concerning the offer, please refer to the Plan Documents and any other materials or documentation made available by the Company.
For more information regarding the Company, please refer to the Company&rsquo;s Annual Report on Form 10-K and Quarterly Reports
on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available at <U>www.sec.gov</U>, as well
as the Company&rsquo;s &ldquo;Investor Relations&rdquo; website at <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you acknowledge that the Award is being granted <I>ex gratia</I> with the purpose of rewarding you.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>18.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Philippines</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>The
following wording is hereby made a part of the Plan Documents: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
securities being offered or sold under the Plan have not been registered with the Philippine Securities and Exchange Commission
under the Philippine Securities Regulation Code. Any future offer or sale of the securities in the Philippines is subject to registration
requirements under the Securities Regulation Code unless such offer or sale qualifies as an exempt transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
applies if your Award Notification specifies that your Award is an Option:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Notwithstanding
any terms or conditions of the Plan Documents, you acknowledge and agree that you will be restricted to the cashless sell-all
method of exercise. To complete a cashless sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued
upon exercise of the Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and brokerage fees or
commissions; and (iii) remit the balance in cash to you. You will not be permitted to hold the Stock after exercise. Depending
on the development of local laws, the Company reserves the right to modify the methods of exercising the Option and, in its sole
discretion, to permit cash exercise, cashless sell-to cover exercise or any other method of exercise and payment of Liabilities
permitted under the Plan.</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>19.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Russia</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">Information
contained in the Plan Documents does not constitute an advertisement of any securities in Russia and must not be passed on to
third parties or otherwise be made publicly available in Russia. The Awards and the Stock to be granted under the Plan have not
been and will not be registered in Russia and are not intended for 'placement' or 'circulation' in Russia.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>20.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Singapore</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that the Plan Documents have not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly,
the Plan Documents and any other document or material in connection with the offer or sale, or invitation for subscription or
purchase of the Stock may not be circulated or distributed, nor may the Stock be offered or sold, or be made the subject of an
invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than pursuant to, and in
accordance with the conditions of, an exemption under any provision (other than Section 280) of Subdivision (4) of Division 1
of Part XIII of the Securities and Futures Act, Chapter 289 of Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
Awards under the Plan are prescribed capital markets products (as defined in the Securities and Futures (Capital Markets Products)
Regulations 2018) and Excluded Investment Products (as defined in MAS Notices SFA 04-N12 and FAA-N16).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>21.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of South Africa</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you agree to immediately notify your employer of the amount of any income realized upon exercise or vesting
of the Award. If you fail to advise your employer of the income realized upon exercise or vesting of the Award, then you may be
liable for a fine. You personally will be responsible for paying the difference between the actual tax liability and the amount
withheld by the Company or your employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
documents listed below are available for your review on the Company&rsquo;s website at <U>https://investors.coca-colacompany.com/</U> and the Company&rsquo;s intranet:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt; font-weight: normal">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company&rsquo;s most recent annual financial statements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt; font-weight: normal">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company&rsquo;s most recent Plan prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">A
copy of the above-listed documents will be sent to you free of charge on written request to Global Equity, The Coca-Cola Company,
at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA. You should read these materials carefully before making a decision whether
to participate in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Spain</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you acknowledge that you consent to participation in the Plan and have received a copy of the Plan Documents.
Except as otherwise provided in the Plan Documents, termination of your employment for any reason (including for the reasons listed
below) will automatically result in the forfeiture of any unvested Awards; in particular, you understand and agree that such Awards
will be forfeited without entitlement to the underlying Stock or to any amount as indemnification in the event of a termination
of your employment prior to vesting by reason of, including, but not limited to, resignation, disciplinary dismissal with or without
cause, individual or collective layoff with or without cause, material modification of employment under Article 41 of the Worker&rsquo;s
Statute, relocation under Article 40 of the Worker&rsquo;s Statute, Article 50 of the Worker&rsquo;s Statute, Article 10.3 of
Royal Decree 1382/1985 and unilateral withdrawal by your employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">Furthermore,
you understand that the Company has unilaterally, gratuitously, and in its sole discretion decided to grant Awards under the Plan
to individuals who may be employees of the Company's group throughout the world. The decision is a limited decision that is entered
into upon the express assumption and condition that any grant will not bind the Company or any Subsidiary (as defined in the Plan)
or Affiliate, other than to the extent set forth in the Plan Documents. Consequently, you understand that the Awards are offered
on the assumption and condition that the Awards and any Stock acquired under the Plan are not part of any employment contract
(either with the Company or any Subsidiary or Affiliate), and shall not be considered a mandatory benefit, salary for any purposes
(including severance compensation), or any other right whatsoever. In addition, you understand that this offer would not be made
but for the assumptions and conditions referred to above; thus, you acknowledge and freely accept that, should any or all of the
assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of or right to the Award shall
be null and void.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>23.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Sweden</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-size: 10pt">The
following provision supplements section 5 (Tax) of the Additional Terms:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 45pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Without
limiting the authority of any Withholding Person to satisfy their withholding obligations for Tax as set forth in section 5 (Tax)
of the Additional Terms, by accepting the grant of the Award, you authorize any Withholding Person to withhold or to sell Stock
otherwise deliverable to you to satisfy Tax, regardless of whether the Withholding Person has an obligation to withhold such Tax.</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>24.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Switzerland</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial
Services Act (<B>FinSA</B>) because such offering by the Company is made exclusively to current or former members of the board
of directors, members of the management board or employees of the Company, the employer and its Affiliates. The Plan Documents
do not constitute a prospectus pursuant to FinSA, and no such prospectus has been or will be prepared for or in connection with
the offering of the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>25.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Turkey</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">Under
Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The shares are currently traded on the
New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &ldquo;KO&rdquo; and the Stock may be sold
through this exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that any activity related to investments in foreign securities (e.g. the sale of Stock) should be conducted through
a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish
Capital Markets Board. You are solely responsible for complying with this requirement and should consult with a personal legal
advisor for further information regarding any obligations in this respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>26.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of the United Arab Emirates</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
Awards are granted under the Plan only to select employees of the Company's group and are in the nature of providing employee
equity incentives in the United Arab Emirates. The Plan Documents are intended for distribution only to such employees and must
not be delivered to, or relied on by, any other person. Prospective purchasers of the securities offered should conduct their
own due diligence on the securities. If you do not understand the contents of the Plan Documents, you should consult an authorized
financial adviser. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents
in connection with the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic Development has approved the
Plan Documents nor taken steps to verify the information set out herein, and has no responsibility for such documents.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>27.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of the United Kingdom</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive
and to encourage employee share ownership and to increase your interest in the success of the Company. The company offering these
rights is The Coca-Cola Company. The Stock which is the subject of these rights is new or existing par value common stock in the
Company. More information in relation to the Company including the stock price can be found at the following web address: <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial Services and Markets Act 2000 (as
amended, supplemented or substituted by any UK legislation enacted in connection with the UK&rsquo;s exit from the European Union).
The total maximum number of Stock which is the subject of this offer is [total number of stock awarded for this offer].</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 28.35pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>28.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or Vietnam</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 10pt 27pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your Award. Instead, the Company reserves
the right to make a payment to you in cash upon exercise or vesting of your Award. Any references to the issuance of shares or
Stock in any documents related to the Award shall not be applicable in these circumstances.</FONT></P>





    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>e22073_ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 15pt; text-align: center"><FONT STYLE="font-size: 10pt">Award
Notification &ndash; Restricted Stock Unit</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-size: 10pt">Congratulations
[INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the <B>Company</B>) granted you an award (your <B>Award</B>)
under The Coca-Cola Company 2014 Equity Plan, as amended from time to time (the <B>Plan</B>). Your Award is a great opportunity
to share in the long-term success of the Company and contribute to its future growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-size: 10pt">This
document provides details of the key terms of your Award. Your Award is subject to the formal rules of the Plan, plus the additional
terms and conditions (including country specific terms) as set out in a document called the &ldquo;Additional Terms&rdquo;. The
Additional Terms is available to review as part of the Award acceptance process. The Plan is available in the Documents section
of the Merrill Benefits OnLine&reg; website. This Award Notification (including the appendices), the Plan and the Additional Terms
together form your Award Agreement. You are being asked to confirm that you understand and agree to be bound by these documents
as part of the Award acceptance process, so we recommend you read them carefully.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: black; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.1in; text-align: justify; padding-top: 6pt"><FONT STYLE="font-size: 10pt; color: white"><B>Details
    of Award</B></FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0.05in 0.5in 6pt 0.1in; width: 19%; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; border-right: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Type
    of Award</B></FONT></td>
    <TD STYLE="width: 81%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; border-right: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Restricted
    Stock Units </B>- This is a conditional right to receive $0.25 par value common stock of the Company (<B>Stock</B>) in the
    future. You will not receive the Stock (or have any shareholder rights) unless your Award vests.</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0.05in 0.5in 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Number
    of shares of Stock subject to your Award</B></FONT></td>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT]
    </FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0.05in 0.5in 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Continuing
    employment</B></FONT></td>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">Your
    Award is subject to your continuing employment, as set out in the Employment Events Appendix to this document and the Plan.</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0.05in 0.5in 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Date
    your Award normally vests</B></FONT></td>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">[INSERT
                                         DATE]</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">When
        your Award vests, you become entitled to the Stock subject to your Award. You do not need to purchase that Stock - it
        is delivered automatically to you.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">The
        number of shares of Stock that vest will normally be delivered to you as soon as administratively possible following vesting,
        unless a different timing for delivering the Stock applies under the Employment Events Appendix.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">Your
        Award will generally be settled in Shares, except where the Employment Events Appendix applies and specifies otherwise.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">You
        are liable for any tax, fees and costs due on vesting, which may be withheld.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Remember</B>:
        your Award will only vest if and to the extent that all of the terms and conditions of your Award are satisfied. To the
        extent that your Award does not vest, it will be forfeited.</FONT></P></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0.05in 0.5in 6pt 0.1in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: white 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Prohibited
    Activities</B></FONT></td>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.05in 0.1in 6pt; text-align: justify"><FONT STYLE="font-size: 10pt">If
    you engage in certain activities (called Prohibited Activities), your Award will be forfeited and you will be required to
    pay back any gain from your Award. Refer to the Prohibited Activities Appendix to this document.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #E00015"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">Finally,
certain data privacy provisions apply to you in connection with your Award, as set out in the Data Privacy Appendix to this document.</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">In the
event of any conflict between this Award Notification (including the appendices), the Additional Terms and the Plan, the Plan
takes precedence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: Black">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 4.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; color: white"><FONT STYLE="font-size: 10pt; color: White"><B>Action
                                         required!</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; color: white"><FONT STYLE="font-size: 10pt; color: White">If
        you wish to accept your Award, you must accept it using the Merrill Benefits OnLine&reg; website by [<B>INSERT DATE/TIME</B>].
        If you fail to do so by this deadline, then the Company may declare your Award grant null and void at any time. If this
        happens, your Award will be forfeited, and you will have no right to the underlying Stock.</FONT></P></td></tr>
</table>
<P STYLE="margin: 0; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Interpretation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>The
appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning given
in the Plan, unless otherwise specified. For the purposes of the Prohibited Activities Appendix, references to your employer include
your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current local
employing entity or former local employing entity and the Company (where applicable). References to the <B>Committee</B> mean
The Compensation Committee of the Board of Directors of the Company, unless otherwise specified.</I></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">Employment
Events Appendix &ndash; Restricted Stock Unit</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The table
below sets out the impact to your Award (if any) upon certain employment events. The terms of the table below apply to vested
and unvested portions of an Award equally, unless otherwise stated. Except as otherwise specified herein, all other terms and
conditions of your Award continue to apply.</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-bottom: 10pt">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: Black">
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt; color: White"><B>Event</B></FONT></TD>
    <TD STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt 6pt 0.1in"><FONT STYLE="font-size: 10pt; color: White"><B>Impact
    to your Award</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt; border-bottom: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Disability</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt 6pt 0.1in; border-bottom: Black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">If
    your employment with the Company or a Subsidiary terminates because of Disability, your Award immediately vests, and shares
    of Stock will be released within 90 days after your termination date. Otherwise, if you remain employed, there is no impact
    to your Award.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt; border-bottom: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Death</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt 6pt 0.1in; border-bottom: Black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Any
                                         Award that has not been accepted terminates immediately upon your death and may not be
                                         transferred to your heirs.</FONT></P>
        <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">If you die while employed
        with the Company or a Subsidiary, your Award immediately vests, and your estate will be paid, within 90 days after your
        death, a cash amount equal to the value of the shares of Stock subject to the Award. The value shall be determined based
        on the closing price of the Stock on the date of death (or in the case of a non-trading day, the next trading day).</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt; border-bottom: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Leave of absences</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt 6pt 0.1in; border-bottom: Black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify"><FONT STYLE="font-size: 10pt">If
                                         you are on (1) US military leave, (2) a Company-paid leave of absence (meaning paid under
                                         Company payroll), or (3) an unpaid leave of absence (approved pursuant to a published
                                         Company policy available to all employees covered under the policy) of 12 months or less,
                                         there is no impact to your Award.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">For
        all other leaves of absence not specified in the paragraph above, including all approved unpaid leaves that extend beyond
        12 months:</FONT></P>
        <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 24pt; text-indent: -14.2pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any portion of your Award that is unvested is immediately forfeited<SUP>1</SUP>; or </FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-indent: -14.2pt"><FONT STYLE="font-size: 10pt"></FONT></P>
        <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-indent: -14.2pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if the Committee identifies a valid business interest in doing otherwise, it may specify what provisions it deems appropriate
        at its sole discretion (provided that the Committee shall have no obligation to consider any such matters).</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt; border-bottom: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt"><B>Transfer</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt 6pt 0.1in; border-bottom: Black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">If
    you transfer (1) between the Company and any Subsidiary or, (2) at the Committee&rsquo;s discretion, to an Affiliate that
    is not a Subsidiary, there is no impact to your Award.</FONT></TD></TR>
</TABLE>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"><SUP>1 </SUP>If an approved unpaid leave of absence extends beyond 12 months, the portion of
                                         your Award that is unvested as of the end of the 12<SUP>th</SUP> month is forfeited.</FONT></P>



<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: Black">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; padding-left: 4.5pt; padding-top: 6pt; padding-bottom: 6pt"><FONT STYLE="font-size: 10pt; color: White"><B>Event</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt; width: 80%"><FONT STYLE="font-size: 10pt; color: White"><B>Impact
    to your Award</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 6pt; padding-left: 4.5pt"><B>Termination<SUP>2</SUP></B><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 6pt 4.5pt; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0 0 0 18pt; text-indent: -18pt">A.&nbsp;&nbsp;&nbsp;&nbsp;If your employment with the Company or a Subsidiary terminates after attaining age 60:</P>
        <P STYLE="padding-bottom: 4.5pt; font: 10pt Times New Roman, Times, Serif; margin: 4.5pt 0 0 24pt; text-indent: -14.2pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards
held less than 12 months are immediately forfeited, and&nbsp;</FONT></P>
        <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-indent: -14.2pt"><FONT STYLE="font: 10pt Symbol">&#183;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards held at least 12 months immediately vest and shares of Stock will be released within 90 days after your termination
        date.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0 0 0 18pt; text-indent: -18pt">B.&nbsp;&nbsp;&nbsp;&nbsp;If
your employment with the Company or a Subsidiary terminates involuntarily for any reason other than for cause
within one year after a Change in Control, your Award will be treated as described in the Plan.</P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 6pt 4.5pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt"><FONT STYLE="font-size: 10pt">C.&nbsp;&nbsp;&nbsp;&nbsp;If
your employment (1) with the Company or a Subsidiary terminates for any other reason, or (2) with an Affiliate (that is not a Subsidiary)
terminates for any reason<SUP>3</SUP>, your Award is immediately forfeited.&nbsp;</FONT></P>
        <P STYLE="text-align: justify; padding-top: 5.4pt; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><FONT STYLE="font-size: 10pt">Notwithstanding anything
        herein, if your employment with an Affiliate terminates and you immediately become employed by the Company or a Subsidiary,
        there is no impact on your Award.</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 4.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 4.5pt; padding-left: 4.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">For the
purposes of your Award, you are deemed to have terminated employment on the date you are no longer actively providing services
to the relevant entity or entities, regardless of the reasons for termination and whether or not later found to be invalid or
in breach of your employment agreement, if any, or employment laws in the jurisdiction where you are employed. The Committee has
exclusive discretion to decide when you are considered to be no longer actively providing services for the purposes of your Award.
However, you will not be considered to be actively providing services during any contractual notice period or any period of &ldquo;garden
leave&rdquo; or similar period mandated under employment laws in the jurisdiction where you are employed or in your employment
agreement, if any, unless the Committee decides otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP></SUP></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"><SUP>2</SUP> If required by Section
409A of the Code, the payment may not be made (if applicable) until at least six months following the termination date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>3</SUP>
This also would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award.
If your employer no longer meets the definition of &ldquo;Affiliate&rdquo;, you are deemed to have terminated employment for the
purposes of the Plan.</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">Prohibited
Activities Appendix</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Engaging
                                            in Prohibited Activity</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Timing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Section
1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5 (Types of Prohibited Activity) below)
at any time during the term of your Award or within one year after the later of:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         termination of your employment with the Company, your employer or any Affiliate; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         last date of vesting or exercise of all or any portion of your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Implications</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">If
this section 1.2 applies:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.2.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">your
                                         Award will immediately terminate, be forfeited and (if relevant) cease to be exercisable;
                                         and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">1.2.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">within
                                         10 days after receiving written notice from the Company that this section applies, you
                                         must pay in cash to the Company:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         and all gains associated with any previous vesting or exercise of all or any portion
                                         of your Award; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">interest
                                         calculated from the time of the notice until the date of repayment to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Implications
                                            for settled Awards</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Calculation
                                            of gain</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">For
the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any portion of your Award will be calculated
as:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">where
                                         your Award is in the form of an Option, the closing price per share of Stock on the date
                                         of exercise as reported on the New York Stock Exchange Composite Transactions listing
                                         minus the exercise price per share of Stock, multiplied by the number of shares of Stock
                                         over which the Award was exercised;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">where
                                         your Award is in the form of Restricted Stock Units or Growth Share Units, the closing
                                         price per share of Stock on the date of vesting as reported on the New York Stock Exchange
                                         Composite Transactions listing, multiplied by the number of shares of Stock that vested;
                                         and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.1.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">where
                                         your Award is in the form of Performance Cash, the gross amount of the cash payment that
                                         vested. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Alternative
                                            payment</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Return
                                            of Stock</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">If
all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable for any reason by any court
with jurisdiction:</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">you
                                         will transfer to the Company all of the shares of Stock that you acquired on vesting
                                         or exercise of your Award that you still hold (and if your Award is an Option, the Company
                                         will pay to you the exercise price you paid for that Stock in exchange); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3.1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">where
                                         you have already sold, transferred or disposed of any shares of Stock you acquired on
                                         vesting or exercise of your Award, you must pay to the Company: </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         and all gains associated with each sale, transfer or disposal; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">interest
                                         calculated from the date of each sale, transfer or disposal until the date of repayment
                                         to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Calculation
                                            of gain</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">For
the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in each case be calculated as the
closing price per share of Stock on the date of the sale, transfer or disposal as reported on the New York Stock Exchange Composite
Transactions listing (minus, where your Award is an Option, the exercise price per share of Stock), multiplied by the number of
shares of Stock sold, transferred or disposed of.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Interest</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Any
interest payable under this Prohibited Activities Appendix will be calculated using the weighted prime rate at SunTrust Bank,
Atlanta.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Types
                                            of Prohibited Activity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
term <B>Prohibited Activity</B> includes any and all of the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Disparagement
                                            </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Making
any statement, written or verbal, in any forum or media, or taking any action in disparagement of the Company, your employer and/or
any Affiliate, including but not limited to negative references to the Company or its products, services, corporate policies,
or current or former officers or employees, customers, suppliers, or business partners or associates.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Publicity</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Publishing
any opinion, fact, or material, delivering any lecture or address, participating in the making of any film, radio broadcast or
television transmission, or communicating with any representative of the media relating to confidential matters regarding the
business or affairs of the Company, your employer and/or any Affiliate which you were involved with during your employment.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Disclosure
                                            of a Trade Secret </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Failure
to hold in confidence any and all Trade Secrets of the Company that came into your knowledge during your employment with the Company,
your employer and/or any Affiliate, or disclosing, publishing, or making use of, at any time, such Trade Secrets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">For
these purposes, <B>Trade Secret</B> means any technical or non-technical data, formula, pattern, compilation, program, device,
method, technique, drawing, process, financial data, financial plan, product plan, list of actual or potential customers or suppliers
or other information similar to any of the foregoing, which:</FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">derives
                                         economic value, actual or potential, from not being generally known to and not being
                                         readily ascertainable by proper means by other persons who can derive economic value
                                         from its disclosure or use; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">is
                                         the subject of efforts that are reasonable under the circumstances to maintain its secrecy.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Disclosure
                                            of Confidential Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Failure
to hold in confidence all Confidential Information of the Company, your employer and/or any Affiliate that came into your knowledge
during your employment with the Company, your employer or any Affiliate, or disclosing, publishing, or making use of such Confidential
Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">For
these purposes, <B>Confidential Information</B> means any data or information, other than Trade Secrets (as defined in section
5.3 (Disclosure of a Trade Secret)), that is valuable to the Company and not generally known to the public or to competitors of
the Company.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Failing
                                            to return materials</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Your
failure, in the event of your termination of employment for any reason, promptly to deliver to the Company all memoranda, notes,
records, manuals or other documents, including all copies of such materials and all documentation prepared or produced in connection
therewith, containing Trade Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential Information (as
defined in section 5.4 (Disclosure of Confidential Information)) regarding the Company&rsquo;s business, whether made or compiled
by you or furnished to you by virtue of your employment with the Company, your employer or any Affiliate, or failure promptly
to deliver to the Company all vehicles, computers, credit cards, telephones, handheld electronic devices, office equipment, and
other property furnished to you by virtue of your employment with the Company, your employer or any Affiliate.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Competing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Rendering
services for any organization which, or engaging directly or indirectly in any business which, in the sole judgment of the Committee
or the Chief Executive Officer of the Company or any senior officer designated by the Committee, is or becomes competitive with
the Company.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Solicitation</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting
or attempting to solicit for employment, for or on behalf of any corporation, partnership, or other business entity, any employee
of the Company, your employer or an Affiliate with whom you had professional interaction during the last twelve months of your
employment with the Company, your employer or the Affiliate.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.8</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Violation
                                            of Company policies</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Violating
any written policies of the Company or your employer applicable to you, including, without limitation, The Coca-Cola Company Global
Insider Trading Compliance Policy.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Release</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
may be released from the effects of this Prohibited Activities Appendix if the Committee determines in its sole discretion that
such action is in the best interest of the Company and its stockholders.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Other
                                            rights apply</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Nothing
in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or otherwise limiting the Company&rsquo;s
right under applicable state or local law or any prior agreement you have signed or made with the Company regarding trade secrets,
confidential information, or intellectual property.</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><FONT STYLE="font-size: 10pt">Data
Privacy Appendix</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>General</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Introduction</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
Data Privacy Appendix sets out certain data privacy provisions that apply to you in connection with your Award.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Meaning
                                            of Data</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">For
the purposes of this Data Privacy Appendix,<B> Data</B> means personal information that directly or indirectly identifies you,
including: your name, home address and telephone number, your date of birth, your government identification number, your salary
information, nationality, job title and employment location, any shares or directorships you hold or held in the Company or any
Affiliate, details of your Award and any equity or cash awards or any other entitlements to stock or cash granted (regardless
of whether or not exercised, vested or settled, and including any cancelled or forfeited awards), any information necessary to
process your Award or any other award (e.g. your mailing address for a check payment or bank account wire transfer information),
any other information necessary to process mandatory tax withholding and reporting and/or, where applicable, your employment or
service termination date and the reason for the termination.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>For
                                            Award recipients not located in the EEA or UK</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
section applies if you reside anywhere in the world except the European Economic Area (EEA) or the United Kingdom (UK). By accepting
your Award, you confirm the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Consent</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data by and between the Company,
your employer or any Affiliate for the purpose of implementing, administering, and managing your participation in the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Data
                                            collected</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that the Company and its Affiliates may hold Data for the exclusive purpose of implementing, administering, and managing
the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Purposes
                                            of collection </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that Data will be transferred to one or more stock or incentive plan service providers selected by the Company, which
may assist the Company with the implementation, administration, and/or management of the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Recipients
                                            of Data</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that the recipients of Data may be located in the United States or elsewhere. The Company also uses third party service
providers who may assist with the implementation, administration or management of the Plan. These service providers are bound
by contract to handle Data in a way that aligns with this Data Privacy Appendix and applicable law. If you have any questions
about the local entities or services providers who may access or handle your Data, please contact your local human resources representative.</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
consenting at section 2.1 (Consent) above, you authorize the Company and any other possible recipients that do or may assist the
Company with implementing, administering or managing the Plan to receive, possess, use, retain and transfer the Data, in electronic
or other form, for the sole purpose of implementing, administering and/or managing your participation in the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Data
                                            retention</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.
In some cases, your information will be retained for the Company or your employer to comply with a legal or tax obligation.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Your
                                            rights </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that if you reside in certain jurisdictions, to the extent required by applicable laws, you may, at any time and without
cost:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">2.6.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">request
access to Data;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">2.6.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">request
additional information about the storage and processing of Data;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">2.6.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">require
any necessary amendments to Data; or</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">2.6.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">refuse
or withdraw the consents you give by accepting the Award,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">by
contacting your local human resources representative in writing. </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Implications
                                            of not consenting or withdrawing consent</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that you provide these consents on a purely voluntary basis. If you do not consent, or if you later withdraw your consent,
your employment or service contract with the Company or an Affiliate will not be adversely affected. Refusing or withdrawing your
consent will mean that the Company will not be able to grant new awards or administer or maintain any existing awards (including
this Award) under the Plan. You understand that refusing or withdrawing your consent may affect your ability to participate in
the Plan (including the right to retain an award, such as this Award). You understand that you may contact a local human resources
representative for more information on the consequences of refusal to consent or withdrawal of consent.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>For
                                            Award recipients located in the EEA and/or UK</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
section applies if you reside inside the United Kingdom (UK) and/or the European Economic Area (EEA). By accepting your Award,
you confirm the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Data
                                            collected </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that the your employer (acting as controller) and the Company may collect, to the extent permissible under applicable
law, Data for the exclusive purpose of implementing, administering, and managing the Plan. The Data is collected from you, the
employer, and the Company for the exclusive purpose of implementing, administering, and managing the Plan in accordance with the
terms of your Award.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Purposes
                                            of collection/processing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge the legal basis for Data processing is performance of the contract comprising your Award. The Data must be provided
in order for you to participate in the Plan and for the parties to your Award to perform their respective obligations as set out
in your Award documents. If you do not provide Data, you will not be able to participate in the Plan or continue to hold your
Award.</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Transfers
                                            and retention of Data </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand that your employer will transfer Data to the Company for Plan administration purposes. The Company and your employer
may also transfer your Data to other service providers (such as accounting firms, payroll processing firms or tax firms), as may
be selected by the Company now or in the future, to assist the Company and your employer with the implementation, administration
and/or management of your Award. You understand that recipients of the Data may be located in a country that does not benefit
from an adequacy decision issued by the European Commission. When your information is transferred outside the EEA or the UK (as
applicable), it is done in accordance with data protection laws and regulations requiring adequate transfer mechanisms. For further
information as to the transfer of your Data, please contact <U>privacy@coca-cola.com</U>. Your Data will be held only as long
as is necessary to implement, administer and manage your rights and obligations under the terms of your Award documents, as well
as in compliance with other laws requiring a longer retention period.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Accuracy</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand the Company and your employer will take steps in accordance with applicable legislation to keep Data accurate, complete
and up to date.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Your
                                            rights</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">You
understand you are entitled to: </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">3.5.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">have
any inadequate, incomplete or incorrect Data corrected;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">3.5.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">request
access to your Data and additional information about the processing of that Data;</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">3.5.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">object
to the processing of Data or have your Data erased, under certain circumstances; and</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">3.5.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">subject
to applicable law:</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">restrict
                                         the processing of your Data so that it is stored but not actively processed (e.g. while
                                         the Company assesses whether you are entitled to have Data erased); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">receive
                                         a copy of the Data provided in connection with your Award or generated by you, in a common
                                         machine-readable format,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">and
you may exercise these rights by contacting a local human resources representative.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Other
                                            contacts</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand you have the right to contact, and may lodge a complaint with, the relevant data protection supervisory authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">You
may also contact the EU Data Protection Officer:</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Nicola Aliperti Coca-Cola Italia s.r.l.</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Viale Edison 110</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Building B</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">20099 Sesto San Giovanni (Milan)</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal">Italy</FONT><BR>
<FONT STYLE="font-size: 10pt; font-weight: normal"><U>DPO-Europe@coca-cola.com</U></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Country
                                            specific provisions</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. By accepting
your Award, you confirm the following:</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><B>If
                                            you are subject to the laws of Canada</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify">You authorize the Company,
your employer, and your employer&rsquo;s representatives to discuss with and obtain all relevant information from all personnel
(professional or not) involved in the administration and operation of the Plan. You authorize your employer, the Company, any
Affiliates and any stock or incentive plan service provider that may be selected by the Company to assist with the Plan to disclose
and discuss the Plan with their respective advisors. You further authorize your employer, the Company and any Affiliates to record
this information and to keep it in your employee file.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Russia </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that you have read, understood and agree to the terms regarding the collection, processing and transfer of data described
in section 2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. Upon request of the Company or
your employer, you agree to provide an executed data privacy consent form or any similar agreements or consents that the Company
or your employer may deem necessary to obtain under the data privacy laws in Russia, either now or in the future. You understand
that you will not be able to participate in the Plan if you fail to execute any such consent or agreement that may be requested.</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><FONT STYLE="font-size: 10pt">2022
Awards made under</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><FONT STYLE="font-size: 10pt">The
Coca-Cola Company 2014 Equity Plan</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">Additional
Terms</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">By accepting
your Award you:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Plan
                                            Documents</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Agree
that you have been given all relevant information and materials regarding the terms and conditions of your Award, which are set
out in the rules of The Coca-Cola Company 2014 Equity Plan, as amended from time to time (the <B>Plan</B>), your Award Notification
(including any appendices attached to it) and these Additional Terms (including the Global Appendix set out below) (collectively,
the <B>Plan Documents</B>).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Employment</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the grant of your Award does not form part of and does not affect or change your
                                         employment contract or your employment relationship with your employer (which is entirely
                                         separate from the Plan). The grant of your Award and your participation in the Plan does
                                         not create a right to employment or continued service and will not be interpreted as
                                         forming an employment or service contract with The Coca-Cola Company (the <B>Company</B>),
                                         your employer or any <B>Affiliate</B> (as defined in the Plan). The Award does not impact
                                         the ability of the Company, your employer or any Affiliate to terminate that employment
                                         or service relationship. All benefits granted by your Award will constitute an occasional
                                         extraordinary payment and may not, in any way or for any purpose, be considered part
                                         of your normal remuneration or constitute consideration for any services you provide
                                         to the Company, your employer or any Affiliate, including when calculating any other
                                         benefits. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company&rsquo;s decision to grant your Award is voluntary and discretionary,
                                         and that you have no right to participate in the Plan. Acceptance of your Award and participation
                                         in the Plan does not create any right to, or expectation of, future employment or service,
                                         future participation in the Plan or the grant of future awards (on the same basis, or
                                         at all). The Company may at any time decide to cease offering awards under the Plan,
                                         or amend, modify, suspend, cancel or terminate the Plan and any benefits under it.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you are not entitled to the exercise of any discretion under the Plan in your favor,
                                         that decisions with respect to your Award and any future awards are at the sole discretion
                                         of the Company and are final, binding and conclusive, and that you do not have any claim
                                         or right of action in respect of any decision, omission, or discretion, which may in
                                         each case operate to your disadvantage.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree,
                                         in consideration for and as a condition of your Award, to waive all rights which might
                                         arise in connection with the Plan, including:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         right to institute any claim against the Company, your employer or any Affiliate; and
                                         </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">2.4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         right to pursue any claim that is allowed by a court,</FONT></TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">other
than the right to acquire, as relevant, $0.25 par value shares of common stock of the Company (<B>Stock</B>) or cash (subject
to and in accordance with the Plan).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you do not have any right to compensation or damages for any loss (actual or potential)
                                         in relation to the Plan or your Award, including where it is forfeited on termination
                                         of employment or cessation of services for any reason, whether or not lawful or in breach
                                         of employment laws or the terms of your employment or service agreement, if any. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                            transfer</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Accept
that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your Award or any rights in respect of it,
whether voluntarily or involuntarily (other than to your personal representatives on death).</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Modifications
                                            and additional requirements</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may modify any of the terms of your Award to be consistent with any
                                         applicable law or applicable government agency regulation where, in the opinion of the
                                         Company, that term might otherwise conflict or be inconsistent.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may impose additional conditions, requirements and restrictions on your
                                         Award, your participation in the Plan and any Stock or cash you acquire on vesting or
                                         exercise of your Award, and that you will comply with them, including signing any additional
                                         agreements or undertakings.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         to any amendment made to the Plan or any term of your Award (including an amendment with
                                         retroactive effect) where the amendment is necessary or advisable to ensure the Plan
                                         or your Award complies with any future law relating to plans of this nature or their
                                         administration (including Section 409A of the U.S. Internal Revenue Code of 1986, as
                                         amended).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         to any amendment made to any of the terms of your Award (including rescinding your Award
                                         entirely) to correct any error that occurred in connection with the grant or documentation
                                         of your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that your Award may be adjusted to reflect a change in capital structure, in accordance
                                         with the terms of the Plan, and agree that, where your Award is over Stock and an adjustment
                                         results in a fractional share, the fractional share may be disregarded at the Company&rsquo;s
                                         discretion.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Tax</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that participating in the Plan will probably have tax consequences for you and that all
                                         payments made with respect to your Award (including payments in Stock or cash) may be
                                         subject to tax, social security and any similar charges in any country where you are
                                         employed, reside, or are otherwise subject to tax (<B>Tax</B>).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that you (or your personal representative) are ultimately responsible for and will bear
                                         any liability for any Tax in respect of your Award and your participation in the Plan,
                                         and understand that this liability may exceed any amounts withheld and paid on your behalf.
                                         </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company, your employer, an Affiliate, any trustee of any employee benefit trust
                                         and any third party service provider (each, a <B>Withholding Person</B>) is entitled
                                         to do any, all or a combination of the following methods (where relevant) to enable a
                                         Withholding Person to raise an amount it considers necessary or desirable to recover
                                         the Liabilities:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">sell
                                         or procure the sale on your behalf of a sufficient number of the Stock you acquire on
                                         vesting or exercise of your Award; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">reduce
                                         the number of Stock you acquire on vesting or exercise of your Award accordingly and
                                         settle the balance in cash; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">5.3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">withhold
                                         amounts from:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">proceeds
                                         of sale under section 5.3.1;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         balance settled in cash under section 5.3.2; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 1in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         other cash payments of any kind owed to you.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">For
these purposes, <B>Liabilities </B>means any obligation on the Withholding Person to pay or account for Tax, any unpaid exercise
price, any associated costs (including under section 7 (Costs)) and any amount you owe to the Company, your employer or any Affiliate
due to any obligation of any nature whatsoever (including under a loan, the Company&rsquo;s tax equalization program or any travel
or expenses policy) to the extent that the Company, the employer or any Affiliate in its reasonable judgement determines you owe
them that amount.</FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that, for tax purposes, and where allowed by applicable law, you are deemed to have received
                                         the full number of Stock where the number of Stock you acquire is reduced under section
                                         5.3.2.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that, where permitted by the Company, you may elect to satisfy Tax and/or pay any exercise
                                         price by delivering (including by attestation) Stock to the Company.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if a Withholding Person&rsquo;s obligation to pay or account for Tax cannot or has
                                         not been fully satisfied by the above methods, you must pay to the Withholding Person
                                         an amount sufficient to enable them to discharge that obligation.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         to enter any tax elections for particular tax and/or social security treatment, execute
                                         any documents, give any directions and take any action as may be requested by the Company,
                                         your employer or any Affiliate in relation to any Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.8</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company, your employer and any Affiliate do not guarantee or warrant any particular
                                         Tax treatment in relation to your Award, the cash or Stock you acquire in connection
                                         with your Award (including any dividends on Stock), or your participation in the Plan
                                         and that they are not under any obligation to structure the Award in a Tax favorable
                                         way or avoid adverse Tax treatment in any jurisdiction. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.9</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that neither the Company, your employer nor any Affiliate will be liable for any Tax,
                                         interest, penalties or other amounts owed by any taxpayer as a consequence of the Plan
                                         or an Award and that any Tax information provided is for guidance purposes only. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.10</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that the cash or Stock subject to your Award may only vest or be exercised (as applicable)
                                         if satisfactory arrangements are in place to enable all Withholding Persons to obtain
                                         the funds needed to satisfy any Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>5.11</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the vested (and, if applicable, exercised) Stock or cash subject to your Award may
                                         not be delivered or paid to you unless you have complied with your obligation to pay
                                         the Liabilities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Internationally
                                            mobile employees</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that if you are a mobile employee, meaning that you are based in different jurisdictions
                                         during the course of your employment or service that you are or may be subject to Tax
                                         in more than one country, you are strongly encouraged to inform the Company and your
                                         employer, and to speak with your personal tax adviser regarding the tax treatment of
                                         your participation in the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that, if you are a mobile employee, the Company or your employer may be required to withhold
                                         for Tax in more than one jurisdiction.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>6.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that if you are a &ldquo;Global Mobility Associate&rdquo; as defined in the Company&rsquo;s
                                         Global Mobility Policy (or the equivalent under any applicable international service
                                         policy from time to time), you remain responsible for all Tax except where expressly
                                         stated otherwise in that policy and/or the Company&rsquo;s tax equalization program.
                                         A copy of the Company&rsquo;s Global Mobility Policy is available on the Company&rsquo;s
                                         intranet.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Costs</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Agree
that you are responsible for the payment of any fees, dealing, commission or currency conversion costs or any other costs associated
with your Award, including costs associated with the payment of any cash and the sale of any Stock.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Notices</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that any notice or other communication required in relation to your Award will be given
                                         in writing, which may include electronic means.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that any notice or other communication to be given to you in connection with your Award
                                         may be delivered by electronic means (including by email, or through the Company or your
                                         employer&rsquo;s intranet or a share plan portal), personally delivered, or sent by ordinary
                                         post to the principal address on file for you from time to time with the Company, your
                                         employer, an Affiliate or the Company&rsquo;s agents.</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that any notice or other communication to be given to the Company or its agents in connection
                                         with your Award may be delivered or sent to its registered office or to such other place
                                         and by such means as communicated to you by or on behalf of the Company from time to
                                         time.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that notices or other communications:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">8.4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">sent
                                         electronically will be deemed to have been received immediately (if sent during usual
                                         business hours) or at the opening of business on the next business day (if sent outside
                                         usual business hours);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">8.4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">that
                                         are personally delivered will be deemed to have been received when left at the relevant
                                         address (if left during usual business hours) or at the opening of business on the next
                                         business day (if left outside usual business hours); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">8.4.3</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">sent
                                         by post will be deemed to have been received 24 hours after posting to a U.S. address
                                         or 3 days after posting to an address outside the U.S.,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">unless
there is evidence to the contrary.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that all notices or communications to be given to you are given and sent at your risk
                                         and that neither the Company, your employer nor any Affiliate has any liability in respect
                                         of any notice or communication given or sent, nor need they be concerned to see that
                                         you actually receive it.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Insider
                                            trading and market abuse</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>9.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that rules on insider trading, dealing notification requirements, and market abuse laws
                                         may apply in relation to any actions or decisions taken relating to your Award, including
                                         in relation to the acceptance, vesting, exercise or settlement of your Award, the delivery
                                         or payment of any Stock or cash, and the sale of any Stock. These rules, requirements
                                         and laws:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">9.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">are
                                         separate from and in addition to the requirements that apply to you under The Coca-Cola
                                         Company Global Insider Trading Compliance Policy; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">9.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">may
                                         prohibit or delay your actions or decisions. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>9.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that it is your responsibility to comply with the rules, requirements and laws referred
                                         to in section 9.1. You should consult with your personal legal adviser on these matters.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Currency
                                            risk</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>10.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that if any Stock relating to your Award is traded in a currency that is not the currency
                                         in your jurisdiction, the value of the Stock may also be affected by movements in the
                                         exchange rate.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>10.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that neither the Company, your employer nor any Affiliate is liable for any loss due
                                         to movements in the exchange rate nor any charges imposed in relation to the conversion
                                         or transfer of money.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                            advice</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Confirm
                                         you are accepting your Award and participating in the Plan voluntarily and understand
                                         that the Company is not making any recommendations regarding your Award or any Stock
                                         or cash relating to your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that neither the Company, your employer, any Affiliate nor any person or entity acting
                                         on their behalf has provided you with any legal, investment, tax (including reporting)
                                         or financial advice with respect to your participation in the Plan, your Award or any
                                         Stock or cash acquired upon vesting or exercise of your Award. You should consult with
                                         your own suitably qualified advisers before taking any action under the Plan. </FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the information and materials provided do not take into account your objectives,
                                         financial situation or needs and that if you do not understand the contents of the Plan
                                         Documents, or you are in any doubt, you should consult an independent authorized financial
                                         adviser.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>11.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         you will have no remedies for any statement, representation, assurance or warranty that
                                         is not set out in your Plan Documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                            guarantee</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>12.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that neither the Company, your employer nor any Affiliate guarantees a specified level
                                         of return in respect of your Award or any Stock.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>12.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                            that there is a risk that any Stock relating to your Award may fall as well as rise in value,
                                            that the future value of Stock cannot be predicted with certainty and that market forces
                                            will impact the price of any Stock relating to your Award and, in the worst case, the market
                                            value of the Stock may become zero. More information in relation to the Company, including
                                            its share price, can be found at <U>https://www.coca-colacompany.com/</U>. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>No
                                            public offer</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that your Award is being offered to you in your capacity as an employee of the Company&rsquo;s
                                         group and that the offer is not intended for the general public and may not be used for
                                         any public offer.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the Company is not required to deliver any Stock or cash on settlement of your Award
                                         before it completes, on terms to its satisfaction, any registration, listing, exemption
                                         or qualification or other legal requirements or obtains any clearance or approval that
                                         the Company considers is necessary or desirable, and you agree to provide any information,
                                         make any agreements and give any representations that the Company requests as part of
                                         this process.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse
                                         to deliver any Stock or cash where the Company considers the delivery of Stock or cash
                                         may conflict or be inconsistent with applicable law or applicable government agency regulation.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that neither the Company, your employer nor any Affiliate is under any obligation to
                                         register, exempt or qualify, or seek clearance or approval for, your Award or any Stock
                                         or cash that you may acquire in connection with your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that your Award may not have been authorized or approved by any applicable securities
                                         authorities and may have been offered pursuant to an exemption from registration in your
                                         local jurisdiction. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that the regulatory bodies in your jurisdiction accept no responsibility for the accuracy
                                         and completeness of the statements and information contained in the Plan Documents and
                                         take no liability whatsoever for any loss arising from reliance upon the whole or any
                                         part of the contents of those documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>13.7</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that a prospectus or similar offering or registration document may not have been prepared,
                                         authorized or approved by any applicable authority in any jurisdiction outside the United
                                         States.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Exchange
                                            controls and any reporting requirements</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that exchange control regulations and/or foreign asset reporting requirements may apply
                                         to you in respect of your Award and/or any Stock or cash acquired in connection with
                                         your Award, and that you are solely responsible for complying with those regulations
                                         and requirements. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that neither the Company, your employer nor any Affiliate are responsible for obtaining
                                         exchange control approval or making any reports on your behalf, nor for monitoring compliance
                                         with those regulations and requirements and that if you fail to obtain any required exchange
                                         control approval or make the necessary reports, neither the Company, your employer nor
                                         any Affiliate will be liable in any way for any resulting fines or penalties. You should
                                         seek independent professional advice if you are unsure about the obligations that apply
                                         to you as a result of your participation in the Plan.</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>14.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that you are solely responsible for complying with any filing, notification or reporting
                                         requirements in respect of: </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">14.3.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">your
                                         participation in the Plan and/or </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">14.3.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">benefits
                                         received under the Plan, </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">as
required by the local law in any jurisdiction. The Company accepts no responsibility for your failure or delay in complying with
such requirements. If you are in any doubt as to what actions you should take, you should consult a duly authorized independent
adviser.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>General</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Consent
                                         to the use of electronic communications in connection with the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Confirm
                                         that references to &ldquo;employer&rdquo; throughout these Additional Terms include your
                                         former employer, where applicable.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.3</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that all determinations and decisions on questions of interpretation in respect of your
                                         Award and the Plan Documents will be made by the Company (or any committee on its behalf)
                                         in its sole and absolute discretion. Those determinations and decisions will be final,
                                         binding and conclusive. Any references to determinations or decisions made, or actions
                                         taken, by the &ldquo;Company&rdquo; as referred to in these Additional Terms include
                                         any committee acting on its behalf.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.4</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable
                                         for any reason by any court in any jurisdiction then, for the purposes of that jurisdiction
                                         only:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">15.4.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">such
                                         provision will be deleted; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal">15.4.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         remaining provisions will continue in full force and effect.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.5</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if the Company waives a breach of one or more provisions in the Plan Documents,
                                         this does not constitute a waiver of any other provision of the Plan Documents, or a
                                         waiver of any subsequent breach of the Plan Documents (by you or anyone else).</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>15.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">15.6.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         federal laws of the United States of America and the state laws of the State of Delaware,
                                         United States of America, govern your Plan Documents and your Award without regard to
                                         the conflict of law provisions; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">15.6.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">the
                                         courts of the United States District Court for the District of Delaware or the Delaware
                                         Superior Court, New Castle County have exclusive jurisdiction in respect of disputes
                                         arising under or in connection with the Plan or your Award,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">and
you waive any current or future objection you may have to this choice of law and jurisdiction.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>English
                                            language (<I>this applies if you have received an English language version only of any Plan
                                            Document</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that you fully understand the contents of the English language version of the Plan Documents.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you do not need a translation of the Plan Documents and that you are fluent and
                                         regularly conduct business in the English language as part of your duties and responsibilities
                                         to your employer.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>17.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Translations
                                            (<I>this applies if you have received a Plan Document in a language other than English</I>)</B></FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>17.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that if there is any conflict between the terms of the English language version of the
                                         Plan Documents and a version in any other language, the English language version will
                                         prevail.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>18.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Options
                                            (<I>this applies if your Award Notification specifies that your Award is an Option</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>18.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Understand
                                         that, in order to exercise your Award, you will need to pay the exercise price. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>18.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Acknowledge
                                         that you will be informed of the acceptable forms and methods of paying the exercise
                                         price when you come to exercise your Award.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>19.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Restricted
                                            resale (<I>this applies if your Award is over Stock</I>)</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Acknowledge
that any Stock you may acquire upon settlement of your Award may be subject to restrictions on transfer and resale in your local
jurisdiction and you agree that you will comply with those restrictions, including that you will not offer, sell, advertise or
otherwise market the Stock (or cause any of these to occur) in circumstances which constitute any type of public offering of securities,
unless an exemption applies.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>20.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Performance
                                            conditions (<I>this applies if your Award Notification specifies that your Award is subject
                                            to performance conditions</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>20.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that the vesting of your Award is conditional on the satisfaction of one or more performance
                                         conditions as set out in the Performance Criteria Appendix to your Award Notification
                                         (the <B>Performance Criteria</B>) and, to the extent the Performance Criteria are not
                                         satisfied, your Award may be forfeited.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>20.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that the Performance Criteria may be altered in the circumstances specified in Section
                                         10.2 of the Plan.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>21.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Malus
                                            and clawback (<I>this applies if your Award Notification specifies that your Award is subject
                                            to &ldquo;Malus and clawback&rdquo;</I>)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>21.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Agree
                                         that any benefits you may receive with respect to your Award will be subject to reduction,
                                         cancellation, repayment, forfeiture or recoupment if there is a determination that the
                                         vesting of, or amount realized from, your Award was based on:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">21.1.1</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">materially
                                         inaccurate financial statements; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">21.1.2</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">any
                                         other materially inaccurate performance metric criteria,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">and
you acknowledge that this applies regardless of whether you caused or contributed to the material inaccuracy.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>21.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Agree
                                         that the Company may also seek to recover your Award where required by the provisions
                                         of the Dodd-Frank Wall Street Reform and Consumer Protection Act or any other &ldquo;clawback&rdquo;
                                         provision required by applicable law, regulation or listing standards, including the
                                         listing standards of the New York Stock Exchange, and you authorize such recovery.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Stock
                                            ownership guidelines (this only applies if you are subject to the Company&rsquo;s stock ownership
                                            guidelines)</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.1</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that if you have not met the Company&rsquo;s stock ownership guidelines <U>before</U>
                                         the applicable compliance deadline but you are a &ldquo;Section 16 officer&rdquo; under
                                         the U.S. Securities Exchange Act of 1934, you are prohibited from selling 50% of any
                                         Stock you obtain upon vesting or exercise of your Award until you meet the relevant guidelines,
                                         except for any Stock that is sold or cash settled to cover Tax and any exercise price.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.2</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Accept
                                         that if you have not met the guidelines by the applicable compliance deadline, you are
                                         prohibited at all times <U>after</U> that compliance deadline from selling any Stock
                                         you obtain on vesting or exercise of your Award, except for any Stock that is sold or
                                         cash settled to cover Tax, commissions and fees and any exercise price. Once you meet
                                         the guidelines, you can sell Stock in excess of the guidelines.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Global Appendix &ndash; Equity
Awards<B><SUP>4</SUP></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of the European Union</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive
and to encourage employee share ownership and to increase your interest in the success of the Company. The company offering these
rights is The Coca-Cola Company. The Stock which is the subject of these rights is new or existing par value common stock in the
Company. More information in relation to the Company including the stock price can be found at the following web address: <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU Prospectus Regulation. The total maximum
number of Stock which is the subject of this offer is [total number of stock awarded for this offer].</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Argentina</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Neither
the Award nor the underlying Stock are publicly offered or listed on any stock exchange in Argentina.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
provision applies if your Award Notification specifies that your Award is an Option:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Depending
upon the method of exercise chosen for the Option, you may be subject to restrictions with respect to the purchase and/or remittance
of U.S. dollars pursuant to Argentine currency exchange regulations. The Company reserves the right to restrict the methods of
exercise if required or advisable to comply with Argentine laws. </I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>If
                                            you are subject to the laws of Australia</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
grant of Awards under the Plan is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49
and ASIC Class Order CO 14/1000. Additional details are set forth in the Australia Offer Document, which is<I> </I>available on
the Merrill Benefits OnLine&reg; website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify">The offer is intended to receive
tax deferred treatment under Subdivision 83A-C of the Income Tax Assessment Act 1997(Cth). The conditions to receive such treatment
are contained in the Award Agreement.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Belgium</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">If
your Award Notification specifies that your Award is an Option, you confirm you have read and understood the information regarding
the Belgian taxation of Options which has been separately made available to you by email and/or on the Merrill Benefits OnLine&reg;
website. You should review this information thoroughly before accepting your Option grant.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Brazil</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you agree that you are (i) making an investment decision, and (ii) the value of the underlying Stock is not
fixed and may increase or decrease in value over the vesting or exercise period without compensation to you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP></SUP></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><SUP>4</SUP>
If you are subject to the laws of any of the following countries, there are no country-specific provisions for your country in
this appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador, Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico,
Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Canada</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">For
purposes of your Award, your employment will be considered terminated and your right (if any) to vest in any Award or exercise
any Option after such termination (regardless of the reason for such termination and whether or not later found to be invalid,
unlawful or in breach of the employment laws in the jurisdiction where you are employed or the terms of your employment agreement,
if any) will be measured as of the earlier of: (a) the date your employment with the Company or one of its Subsidiaries (as defined
in the Plan) or Affiliates is terminated, (b) the date you receive written notice of termination from the Company or a Subsidiary
or Affiliate, regardless of any notice period or period of pay in lieu of such notice mandated under the employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any, or (c) the date you are no longer employed
by the Company or any of its Subsidiaries or Affiliates. You will not be entitled to a pro-rata portion of the Award for any time
before the date on which your right to vest terminates, nor will you be entitled to any compensation for lost vesting. In the
event the date on which you are no longer actively providing services cannot be reasonably determined under the terms of your
Award, the Company, in its sole discretion, shall determine when you are no longer employed for purposes of the Award (including
whether you may still be considered employed or actively providing services while on a leave of absence).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Notwithstanding
the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory
notice period, your right to vest in the Award under the Plan, if any, will terminate effective as of the last day of your minimum
statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of
your statutory notice period, nor will you be entitled to any compensation for lost vesting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">In
addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired pursuant to the Plan will be subject
to certain restrictions on resale imposed by Canadian provincial securities laws (in general, you may not resell your Stock to
Canadian purchasers). Accordingly, you are encouraged to seek legal advice prior to any resale of the Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Furthermore,
notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards granted to Canadian residents shall only be
settled in Stock and shall not be settled in cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">The
following terms and conditions apply if you are resident in Quebec:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>You
agree that you wish the Plan Documents to be drawn up in English.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Vous
confirmez que vous souhaitiez que les Documents du Plan soient r&eacute;dig&eacute;s en anglais</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>If
                                            you are subject to the laws of Chile</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Neither
the Company, the Plan nor the Stock have been registered in the <I>Registro de Valores</I> (Securities Registry) or in the <I>Registro
de Valores Extranjeros</I> (Foreign Securities Registry) of the <I>Comisi&oacute;n para el Mercado Financiero de Chile</I> (Chilean
Commission for the Financial market or CMF) and they are not subject to the control of the CMF. The Plan is governed by General
Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to deliver public information
regarding the Stock in Chile. Shares of Stock cannot be publicly offered in Chile unless they are registered with the CMF.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Ni
The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de Valores o en el Registro de Valores Extranjeros
que lleva la Comisi&oacute;n para el Mercado Financiero de Chile (CMF) y ninguno de ellos est&aacute; sujeto a la fiscalizaci&oacute;n
de la CMF. Esta oferta de Acciones se acoge a la Norma de Car&aacute;cter General 336. Por tratarse de valores no inscritos, el
emisor de las Acciones no tiene obligaci&oacute;n bajo la ley chilena de entregar en Chile informaci&oacute;n p&uacute;blica acerca
de las Acciones. Las Acciones no pueden ser ofrecidas p&uacute;blicamente en Chile en tanto &eacute;stas no se inscriban en el
Registro de Valores correspondiente.</I></FONT></P>




<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to exchange control restrictions imposed by the China State Administration
                                            of Foreign Exchange (SAFE), as determined by the Company in its sole discretion</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; font-weight: normal">Notwithstanding
any other provision in the Plan Documents, the following provisions apply in the event of the termination of your employment (as
interpreted in accordance with the Employment Events Appendix) with the Company or a Subsidiary (as defined in the Plan)</FONT><FONT STYLE="font-size: 10pt">
<FONT STYLE="font-weight: normal">(1) because of your Disability, or (2) after attaining age 55:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Awards
that are Options and Awards held at least 12 months will immediately vest and will be settled in cash. The cash amount will be
determined based on the closing price of the Stock on the date of your termination of employment (or, if a non-trading day, the
next trading day) or the exercise of your Option (if applicable) within the post-termination exercise period stated below. Awards
that are not Options and that are held less than 12 months from the date of grant are forfeited.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Where
Performance Criteria apply, the Performance Criteria will be measured over a shortened performance period, ending at the end of
the year prior to your termination of employment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>If
your Award is an Option, the period over which you may exercise your Option expires upon earlier of (1) six months from your termination
of employment or (2) the Option expiration date provided in the Plan Documents.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
Company has the discretion to arrange for the sale of any Stock issued upon settlement of your Award, either immediately upon
settlement or at any time thereafter. In any event, if you terminate employment, you will be required to sell all Stock acquired
upon settlement of the Award within such time period as required by the Company in accordance with SAFE requirements. Any Stock
remaining in your brokerage account at the end of this period shall be sold by the broker (on your behalf pursuant to this authorization
and without further consent). In addition, any Award that has not vested by the end of this period will then immediately be forfeited.
The Company shall have the exclusive discretion to determine when your employment has been terminated for the purposes of the
Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
agree to sign any additional agreements, forms and/or consents that reasonably may be requested by the Company (or the Company&rsquo;s
designated broker) to effectuate the sale of the Stock (including, without limitation, as to the transfer of the sale proceeds
and other exchange control matters noted below) and shall otherwise cooperate with the Company with respect to such matters. You
acknowledge that neither the Company nor the designated broker is under any obligation to arrange for the sale of Stock at any
particular price (it being understood that the sale will occur in the market) and that broker&rsquo;s fees and similar expenses
may be incurred in any such sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for applicable
taxes, any broker&rsquo;s fees or commissions, and any similar expenses of the sale will be remitted to you in accordance with
applicable exchange control laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you acknowledge that you understand and agree that you are not permitted to transfer any Stock acquired under
the Plan out of your account established with the Company&rsquo;s designated broker until the Stock is sold. The limitation applies
to all Stock issued to you under the Plan, whether or not you remained employed with the Company or a Subsidiary.</FONT></P>




<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
understand and agree that you will be required to immediately repatriate to China the proceeds from the sale of any Stock acquired
under the Plan and any such dividends paid on such shares. You further understand that such repatriation proceeds may need to
be effected through a special bank account established by the Company (or a Subsidiary or Affiliate in China), and you hereby
consent and agree that any sale proceeds and cash dividends may be transferred to such special account by the Company (or a Subsidiary
or Affiliate in China) on your behalf prior to being delivered to you and that no interest shall be paid with respect to funds
held in such account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
proceeds may be paid to you in U.S. dollars or local currency at the Company&rsquo;s discretion. If the proceeds are paid to you
in U.S. dollars, you understand that a U.S. dollar bank account in China must be established and maintained so that the proceeds
may be deposited into such account. If the proceeds are paid to you in local currency, you acknowledge that the Company (and its
Subsidiaries and Affiliates) are under no obligation to secure any particular exchange conversion rate and that the Company (and
its Subsidiaries and Affiliates) may face delays in converting the proceeds to local currency due to exchange control restrictions.
You agree to bear any currency fluctuation risk between the time the Stock is sold and the net proceeds are converted into local
currency and distributed to you. You further agree to comply with any other requirements that may be imposed by the Company in
the future in order to facilitate compliance with exchange control requirements in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">In
addition to the vesting schedule for your Award, settlement of the Award is also conditioned on the continued effectiveness of
the Company&rsquo;s registration of the Plan with SAFE (the <B>SAFE Registration Requirement</B>). If or to the extent the Company
is unable to maintain the registration, no Stock for which a registration cannot be maintained shall be issued. In this case,
the Company retains the discretion to settle any Award for which the vesting schedule, but not the SAFE Registration Requirement,
has been met in cash paid through local payroll in an amount equal to the market value of the Stock subject to the Award less
any withholding for applicable taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost interest or dividends or other losses
that you may incur or suffer resulting from the enforcement of the foregoing terms or otherwise from the Company&rsquo;s operation
and enforcement of the Plan, the Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and
requirements.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>If
                                            you are subject to the laws of Colombia</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component
of &ldquo;salary&rdquo; for any legal purpose.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>If
                                            you are subject to the laws of France</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you confirm that you have read and understood the Plan Documents, which were provided in English. You accept
the terms of those Plan Documents and confirm that you have a good knowledge of the English language.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>En
acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs &agrave; ce plan d&rsquo;incitation &agrave;
long terme (qui vous ont &eacute;t&eacute; fournis en anglais) et que vous acceptez les termes de ce plan.&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Hong Kong</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt"><B>WARNING:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
contents of the Plan Documents have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution
in relation to the offer. If you are in any doubt about any of the contents of the Plan Documents, you should obtain independent
professional advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
offer to receive an Award under the Plan (the <B>Offer</B>) is strictly private and only available to eligible employees of [name
of Hong Kong company]. The Offer has also not been approved by the Securities and Futures Commission in Hong Kong and it should
not be made in whole or in part to the public or any third-party.</FONT></P>



<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">No
Awards granted under the Plan may be transferred or assigned, except as expressly permitted by the Company in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Sale
of Stock.</U> Any Stock received at vesting is accepted as a personal investment. In the event that any portion of this Award
vests within six months of the grant date, you agree that you will not offer to the public or otherwise dispose of the Stock acquired
prior to the six-month anniversary of the grant date.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>If
                                            you are subject to the laws of India</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
must repatriate to India all funds resulting from the sale of Stock acquired in relation to your Award within 90 days, and all
proceeds from the receipt of any dividends within 180 days. You should receive a foreign inward remittance certificate (<B>FIRC</B>)
from your bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in
the event that the Reserve Bank of India or your employer requests proof of repatriation.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">13.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If you are subject to the
laws of Indonesia</FONT></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">A
translation of the documents relating to this grant into Bahasa Indonesia can be provided to you upon request to your local human
resources representative. By accepting the grant of the Award, you (i) confirm having read and understood the documents relating
to this grant which were provided in the English language, (ii) accept the terms of those documents accordingly, and (iii) agree
not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag, Language, Coat of Arms and National
Anthem or the implementing Presidential Regulation (when issued).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Terjemahan
dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat disediakan bagi anda berdasarkan permintaan kepada
perwakilan sumber daya manusia lokal anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah membaca
dan mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan dalam Bahasa Inggris, (ii) menerima syarat-syarat
dari dokumen-dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-Undang
No. 24 Tahun 2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu Kebangsaan atau Peraturan Presiden pelaksananya (ketika
diterbitkan).</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Italy</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the grant of the Award, you acknowledge that you have received a copy of the Plan Documents, you have reviewed the Plan
Documents in their entirety and you fully understand and accept all provisions of the Plan Documents. You further acknowledge
that you have read and expressly approve the following sections of the Additional Terms: section 2 (Employment); section 4 (Modifications
and additional requirements); section 5 (Tax); and section 15 (General).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Mexico</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed the Plan in its entirety and fully
understand and accept all provisions of the Plan. You further acknowledge that you have read and expressly approve the terms and
conditions set forth in section 2 (Employment) of the Additional Terms, in which the following is clearly described and established:
(i) your participation in the Plan does not constitute an acquired right; (ii) the Plan and your participation in the Plan are
offered by the Company on a wholly discretionary basis; (iii) your participation in the Plan is voluntary; and (iv) the Company
and its Subsidiaries (as defined in the Plan) are not responsible for any decrease in the value of the underlying Stock.</FONT></P>




<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
participating in the Plan, you expressly recognize that The Coca Cola Company, with registered offices at One Coca-Cola Plaza,
Atlanta, Georgia 30313, USA, is solely responsible for the administration of the Plan and that your participation in the Plan
and acquisition of Stock does not constitute an employment relationship between you and the Company since you are participating
in the Plan on a wholly commercial basis. Based on the foregoing, you expressly recognize that the Plan and the benefits that
you may derive from participation in the Plan do not establish any rights between you and the Company and do not form part of
the employment conditions and/or benefits provided by the Company and any modification of the Plan or its termination shall not
constitute a change or impairment of the terms and conditions of your employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company;
therefore, the Company reserves the absolute right to amend and/or discontinue your participation at any time without any liability
to you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Finally,
you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or
damages regarding any provision of the Plan or the benefits derived under the Plan, and you therefore grant a full and broad release
to the Company, its Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal representatives
with respect to any claim that may arise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Al
participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el Plan en su totalidad, y que entiende
y acepta en su totalidad, todas y cada una de las disposiciones del Plan. Asimismo reconoce que ha le&iacute;do y aprueba expresamente
los t&eacute;rminos y condiciones se&ntilde;alados en el p&aacute;rrafo titulado Naturaleza de la Oferta en el Convenio, en lo
que claramente se describe y establece lo siguiente: (i) su participaci&oacute;n en el Plan no constituye un derecho adquirido;
(ii) el Plan y su participaci&oacute;n en el Plan son ofrecidos por la Compa&ntilde;&iacute;a sobre una base completamente discrecional;
(iii) su participaci&oacute;n en el Plan es voluntaria; y (iv) la Compa&ntilde;&iacute;a y sus Afiliadas no son responsables de
ninguna por la disminuci&oacute;n en el valor de las Acciones subyacentes.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Al
participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con oficinas registradas en One Coca-Cola Plaza,
Atlanta, Georgia 30313, Estados Unidos de Am&eacute;rica, es la &uacute;nica responsable por la administraci&oacute;n del Plan,
y que su participaci&oacute;n en el Plan, as&iacute; como la adquisici&oacute;n de las Acciones, no constituye una relaci&oacute;n
laboral entre usted y la Compa&ntilde;&iacute;a, debido a que usted participa en el plan sobre una base completamente mercantil.
Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que pudiera obtener por su participaci&oacute;n
en el Plan, no establecen derecho alguno entre usted y la Compa&ntilde;&iacute;a, y no forman parte de las condiciones y/o prestaciones
laborales que la Compa&ntilde;&iacute;a ofrece, y que las modificaciones al Plan o su terminaci&oacute;n, no constituir&aacute;n
un cambio ni afectar&aacute;n los t&eacute;rminos y condiciones de su relaci&oacute;n laboral.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Asimismo
usted entiende que su participaci&oacute;n en el Plan es el resultado de una decisi&oacute;n unilateral y discrecional de la Compa&ntilde;&iacute;a;
por lo tanto, la Compa&ntilde;&iacute;a se reserva el derecho absoluto de modificar y/o suspender su participaci&oacute;n en cualquier
momento, sin que usted incurra en responsabilidad alguna.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Finalmente,
usted declara que no se reserva acci&oacute;n o derecho alguno para interponer reclamaci&oacute;n alguna en contra de la Compa&ntilde;&iacute;a,
por concepto de compensaci&oacute;n o da&ntilde;os relacionados con cualquier disposici&oacute;n del Plan o de los beneficios
derivados del Plan, y por lo tanto, usted libera total y ampliamente de toda responsabilidad a la Compa&ntilde;&iacute;a, a sus
Afiliadas, sucursales, oficinas de representaci&oacute;n, sus accionistas, funcionarios, agentes o representantes legales, con
respecto a cualquier reclamaci&oacute;n que pudiera surgir.</I></FONT></P>




<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify">The Stock underlying your
Award has not been registered with the National Register of Securities maintained by the Mexican Banking and Securities Commission
and may not be offered or sold publicly in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials
are addressed to you only because of your existing relationship with the Company and its Subsidiaries and may not be reproduced
or copied in any form. The offer contained in these materials is addressed solely to the present employees of the Company and
its Subsidiaries in Mexico and any rights under the Plan may not be assigned or transferred. The Stock underlying your Award will
be offered pursuant to a private placement exception under the Mexican Securities Law.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>16.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of New Zealand</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with the terms of the Plan Documents.
The Stock, if issued, will give you a stake in the ownership of the Company. You may receive a return if dividends are paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">If
the Company runs into financial difficulties and is wound up, you will be paid only after all creditors and holders of preference
shares (if any) have been paid. You may lose some or all of your investment, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">New
Zealand law normally requires people who offer financial products to give information to investors before they invest. This information
is designed to help investors to make an informed decision. The usual rules do not apply to this offer because it is made under
an employee share scheme. As a result, you may not be given all the information usually required. You will also have fewer other
legal protections for this investment. You are advised to ask questions, read all documents carefully, and seek independent financial
advice before committing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under the Plan, you may be able to sell the
Stock on the New York Stock Exchange if there are interested buyers. You may get less than you invested. The price will depend
on the demand for the Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">For information
on risk factors impacting the Company&rsquo;s business that may affect the value of the Stock, you should refer to the risk factors discussion
on the Company&rsquo;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange
Commission and are available online at <U>www.sec.gov</U>, as well as on the Company&rsquo;s &ldquo;Investor Relations&rdquo; website
at <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>17.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Peru</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The grant
of the Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning
the offer, please refer to the Plan Documents and any other materials or documentation made available by the Company. For more information
regarding the Company, please refer to the Company&rsquo;s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed
with the U.S. Securities and Exchange Commission and are available at <U>www.sec.gov</U>, as well as the Company&rsquo;s &ldquo;Investor
Relations&rdquo; website at <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you acknowledge that the Award is being granted <I>ex gratia</I> with the purpose of rewarding you.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>18.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Philippines</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt"><B>The
following wording is hereby made a part of the Plan Documents: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt">The
securities being offered or sold under the Plan have not been registered with the Philippine Securities and Exchange Commission
under the Philippine Securities Regulation Code. Any future offer or sale of the securities in the Philippines is subject to registration
requirements under the Securities Regulation Code unless such offer or sale qualifies as an exempt transaction.</FONT></P>




<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
applies if your Award Notification specifies that your Award is an Option:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Notwithstanding
any terms or conditions of the Plan Documents, you acknowledge and agree that you will be restricted to the cashless sell-all
method of exercise. To complete a cashless sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued
upon exercise of the Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and brokerage fees or
commissions; and (iii) remit the balance in cash to you. You will not be permitted to hold the Stock after exercise. Depending
on the development of local laws, the Company reserves the right to modify the methods of exercising the Option and, in its sole
discretion, to permit cash exercise, cashless sell-to cover exercise or any other method of exercise and payment of Liabilities
permitted under the Plan.</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>19.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Russia</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Information
contained in the Plan Documents does not constitute an advertisement of any securities in Russia and must not be passed on to
third parties or otherwise be made publicly available in Russia. The Awards and the Stock to be granted under the Plan have not
been and will not be registered in Russia and are not intended for 'placement' or 'circulation' in Russia.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>20.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Singapore</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that the Plan Documents have not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly,
the Plan Documents and any other document or material in connection with the offer or sale, or invitation for subscription or
purchase of the Stock may not be circulated or distributed, nor may the Stock be offered or sold, or be made the subject of an
invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than pursuant to, and in
accordance with the conditions of, an exemption under any provision (other than Section 280) of Subdivision (4) of Division 1
of Part XIII of the Securities and Futures Act, Chapter 289 of Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
Awards under the Plan are prescribed capital markets products (as defined in the Securities and Futures (Capital Markets Products)
Regulations 2018) and Excluded Investment Products (as defined in MAS Notices SFA 04-N12 and FAA-N16).</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>21.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of South Africa</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you agree to immediately notify your employer of the amount of any income realized upon exercise or vesting
of the Award. If you fail to advise your employer of the income realized upon exercise or vesting of the Award, then you may be
liable for a fine. You personally will be responsible for paying the difference between the actual tax liability and the amount
withheld by the Company or your employer.</FONT></P>




<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The documents
listed below are available for your review on the Company&rsquo;s website at <U>https://investors.coca-colacompany.com/</U> and the Company&rsquo;s
intranet:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">The
Company&rsquo;s most recent annual financial statements; and</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">The
Company&rsquo;s most recent Plan prospectus.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">A
copy of the above-listed documents will be sent to you free of charge on written request to Global Equity, The Coca-Cola Company,
at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA. You should read these materials carefully before making a decision whether
to participate in the Plan.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>22.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Spain</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">By
accepting the Award, you acknowledge that you consent to participation in the Plan and have received a copy of the Plan Documents.
Except as otherwise provided in the Plan Documents, termination of your employment for any reason (including for the reasons listed
below) will automatically result in the forfeiture of any unvested Awards; in particular, you understand and agree that such Awards
will be forfeited without entitlement to the underlying Stock or to any amount as indemnification in the event of a termination
of your employment prior to vesting by reason of, including, but not limited to, resignation, disciplinary dismissal with or without
cause, individual or collective layoff with or without cause, material modification of employment under Article 41 of the Worker&rsquo;s
Statute, relocation under Article 40 of the Worker&rsquo;s Statute, Article 50 of the Worker&rsquo;s Statute, Article 10.3 of
Royal Decree 1382/1985 and unilateral withdrawal by your employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Furthermore,
you understand that the Company has unilaterally, gratuitously, and in its sole discretion decided to grant Awards under the Plan
to individuals who may be employees of the Company's group throughout the world. The decision is a limited decision that is entered
into upon the express assumption and condition that any grant will not bind the Company or any Subsidiary (as defined in the Plan)
or Affiliate, other than to the extent set forth in the Plan Documents. Consequently, you understand that the Awards are offered
on the assumption and condition that the Awards and any Stock acquired under the Plan are not part of any employment contract
(either with the Company or any Subsidiary or Affiliate), and shall not be considered a mandatory benefit, salary for any purposes
(including severance compensation), or any other right whatsoever. In addition, you understand that this offer would not be made
but for the assumptions and conditions referred to above; thus, you acknowledge and freely accept that, should any or all of the
assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of or right to the Award shall
be null and void.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>23.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Sweden</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-size: 10pt">The
following provision supplements section 5 (Tax) of the Additional Terms:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.75in; text-align: justify"><FONT STYLE="font-size: 10pt"><I>Without
limiting the authority of any Withholding Person to satisfy their withholding obligations for Tax as set forth in section 5 (Tax)
of the Additional Terms, by accepting the grant of the Award, you authorize any Withholding Person to withhold or to sell Stock
otherwise deliverable to you to satisfy Tax, regardless of whether the Withholding Person has an obligation to withhold such Tax.</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>24.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Switzerland</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial
Services Act (<B>FinSA</B>) because such offering by the Company is made exclusively to current or former members of the board
of directors, members of the management board or employees of the Company, the employer and its Affiliates. The Plan Documents
do not constitute a prospectus pursuant to FinSA, and no such prospectus has been or will be prepared for or in connection with
the offering of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>




<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>25.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Turkey</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">Under
Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The shares are currently traded on the
New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &ldquo;KO&rdquo; and the Stock may be sold
through this exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">You
acknowledge that any activity related to investments in foreign securities (e.g. the sale of Stock) should be conducted through
a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish
Capital Markets Board. You are solely responsible for complying with this requirement and should consult with a personal legal
advisor for further information regarding any obligations in this respect.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>26.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of the United Arab Emirates</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
Awards are granted under the Plan only to select employees of the Company's group and are in the nature of providing employee
equity incentives in the United Arab Emirates. The Plan Documents are intended for distribution only to such employees and must
not be delivered to, or relied on by, any other person. Prospective purchasers of the securities offered should conduct their
own due diligence on the securities. If you do not understand the contents of the Plan Documents, you should consult an authorized
financial adviser. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents
in connection with the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic Development has approved the
Plan Documents nor taken steps to verify the information set out herein, and has no responsibility for such documents.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>27.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of the United Kingdom </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">This
offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive
and to encourage employee share ownership and to increase your interest in the success of the Company. The company offering these
rights is The Coca-Cola Company. The Stock which is the subject of these rights is new or existing par value common stock in the
Company. More information in relation to the Company including the stock price can be found at the following web address: <U>https://investors.coca-colacompany.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial Services and Markets Act 2000 (as
amended, supplemented or substituted by any UK legislation enacted in connection with the UK&rsquo;s exit from the European Union).
The total maximum number of Stock which is the subject of this offer is [total number of stock awarded for this offer].</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt; font-style: normal; font-variant: normal"><B>28.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>If
                                            you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or Vietnam </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">The
Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your Award. Instead, the Company reserves
the right to make a payment to you in cash upon exercise or vesting of your Award. Any references to the issuance of shares or
Stock in any documents related to the Award shall not be applicable in these circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 11pt 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 8pt 28.35pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ko_bw-logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ko_bw-logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M,/B!%8O\3/%&V.2*"02KI5MC*ID$C>3U^M 'ZBI]VEI%/R#Z4Q[A$^\P'XT
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MV_K?@V;3_@VTFN>#-1_M'1+:]O#-;O=XVQ.T:??*'D ]Z]D_96_X)Z_M;?\
M!<3QK9^+OVD_%7B#PG\)5E$R:,$^RM?QCG8D"D;1@C#-Q0!^EG[.?[>NO?\
M!2?]H:]MOA4MQ9?!?P?/LU/Q/<02(?$5QD?N+0_\\U[MWK[@MX_+ ^9CN X/
M;BN)^ OP"\+_ +-'PUTGP;X*T6UT'PWHT0BM;2WCVJ@[LQ_B9NYKNT.4']*
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MAAN6VDM*<(#@#MWXK]D-9\*Z?K#;[ZPL[QH^4>X@20Q>R[@WZ5_.K_P= _\
M!79?'OC2;]GKX8WD=MX7\+OCQ#<6!$4=S<G@VX"8&U>E 'S+_P %R_\ @MGX
ME_X*@_%EO#?AMKW2/A?H=T8M-TU&/G:FX./M$H[L> %/J*_1W_@V=_X(._\
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MK18+=4554*NQ0#P!Z8_"E@ES\I5MW7<5P#4IEVXX;Z^E $PZ44#I10 4444
M(>M? ?\ P<7?MSS?L4?\$Y_$T^DWD=KXH\8'^QM,*OMD3?G?*/\ <&/SK[]K
M^=K_ (/4OC8VH?&3X7_#^*\5O[*TV35IK53\P^T,\:,?8^2P_"@#\6?A9\/;
M_P"-7Q4T/PWIZ376I>(KZ.SC !+EG?D^^!7]JO\ P3Y_9'TC]B/]D;P3\.]&
MM857P_I\8N7C&/M-RRYED/K\WZU_-7_P:R?LPQ_M!_\ !4?0]6O;7[1IW@.S
MEUIG*Y3SU*(BGUSDGVZ]J_K"$$<9#+GJ,?GQ0!^*?_!W?_P4;OO@]\']#^!O
MAC4)K?4_&<37NM-$V#]B0D>6<="S8)SV%?,7_!H?_P $^+#XQ_'#Q%\:_$=G
M'<Z7X%86.E+(NY/MSX.?^ KR/>OFS_@Z!\3ZOK__  5U\>6^J3S20Z7;6EO9
M*X*J(S"&.WMC)P?K7HG_  1&_P""X'B+]A3]G7Q%\(O!/PRN/'7C;Q-J_P!J
MT.2#<R^=(OECS549XSR>F!0!^V'_  62_;DOO@IX#TOX0_#<V^M?&3XK2?V1
MH^EH!+)912X1[J1>RH&!R17XY_\ !>:YT+_@G;^S)X!_9;\)QV[>(]0MU\2^
M.]4$:BXO[ER"H,G7&[/ Q7Z[_P#!*?\ X)>:[\,O&%[\>/CO?KXL^.WBR(/(
M]S^\B\,1-\WV:W[+CH<=Z_!/_@YL356_X*[_ !%_M/[447ROL7GL2IAVC&SV
MZG ^M 'VI_P: ?\ !/:U\5>*/$7Q_P#$5IYJZ&SZ5X?$L9.)3_KI 3W7Y0/]
MXU^]_P 4/B9HOP7\!:MXF\3:G:Z3HFBPO<W%S<2!%B4#USC<>@ ]:_#?_@@=
M_P %U/@#^Q%_P3EL? WCK7[K3_%.F:G<W'V".W+O=A]I7:0,'./Q)%6O^"GG
MQ8^,'_!4K]A7XB?&#6M-UCX7_ 7P;8_:M!T65C!?>*YFD"++,.JH,YP>#B@#
M\Z_^"VW_  5@U_\ X*N?M41VNCK<)X%T.Z^P>'M-1SBY8OCS67^)FQC\:_;K
M_@EQ^S9X(_X(4?\ !*BZ^(GCIK/3_$VI:>-:URX<;9))67,-H,\\;E&T=Z_F
M;_91^+&E?!#]HSP?XNU[1QKVEZ#J$5X]@I^:81D,H'/7=M^O-?:'_!=3_@KQ
M\4_V_O$^@V.I:!J_@#X8R6WVG1='F!C.HH#@SNIZ\@8ST&* .5\ ^'/'W_!P
M'_P5=,UXMU-#XBU/S[PJ?W>DZ6C9  ['8.!ZBOW<^//[2.I?"#QU\/OV/_V6
M[>PM_$FG6L46L:NT?G6OAFQ0[3N["5_F.#ZBOQ=_X(8?M:_$#X4Z#XM^'_P-
M^&P\0?&CXA70M(?$THW6_A^Q*H'9L#@@[B/:OZ'_ /@F3_P3OL?V$_A%(NK7
MK>)/B9XI/V[Q3XDF3==:A<E>5WMR(P>%4<#% 'F7_!<?_@HVO_!-3_@G[<WE
MOJ/VKQ]XDMO[)T1\;9&N2!NN"O4!2.O8FOY6_P!FWX&^*?VXOVF_#_@[2YIK
M[Q)XVU18VG.78%\EY'/T!Z^M?<7_  =0?MJS?M,_\%$]2\)V5UYF@_#*+^RD
MC$FZ/[2<F1Q]?E'X5]&?\&='[&%OXM^)?CCXV:W HM_#=NNDZ5(R_+YC8>25
M3V91'C/;<?6@#]8#XP^$'_!"/_@G?HMKK5U!INB^%; )%!%A;K6KLKD[5!RS
M;@<]@":_+'PC_P %COVV/^"R/QJU'2?V=='M/!WA?1WW-/C*0C^$338/S$'.
MWVKY%_X.)?\ @H1K'[?'[?FJ^$]%FFN/"O@>];1-'LX'RES<!@&E 'WBS9 S
M7] 7_!&/]B[0O^"=G_!.CPS8W$<-C?WVG#7O$-TT:A]SIYA#GT5>.?2@#SW_
M ((@_ME_&KXC>(?B9\'?V@+:SD^(WPONXO/U"USMNHI55E!X'/S @XQC-?37
M[>/_  4&^'?_  3N^".H>,_'^J6]M#'&196*M_I&H2]D1>IR?XAP*_/W]A#]
MJ_0OA'HO[5G[8_C:Z6ST3Q#K\EEHZKPNJ0VD2P((AQDEXL<9QDFOQ[^+/Q/^
M-W_!Q!^WZFGZ3N,UWYHTG3FE9K'1+-0>IZ L.?\ :S[4 ?HU\(?^"A'[;G_!
M;?XF:A?_  )_L_X4?#+1Y&A6^NEPTN%R!OQEV^GK7VY_P0M_;*^*GQR\*?$_
MP+\9KNVU/QA\(]:?2KS584"Q7P^8AL^RKDUX!_P1>_;Q\ _\$_?V)?%'P>^*
MDT/@3XE?"<7MQ>Z9J(-NVJJNXI+"3Q(&&/NG(KQ[6_\ @H98?L(?\$GOB)\2
M+?6M'C^+G[16NW6J6.GV=VDDEC;W+,L<SQJ=RX53D=MXH ^0_P#@Y8_X*>7G
M[='[8I^'/A>:>X\%> ;LZ=!#"^Y-2O\ <%=E'?YOE'UQ7V9_P30_LO\ X(X_
ML?:1X3\(Z'#X\_:N^-0CF@T"V DDTF*0 Q-<Y_U4:J064D9(-?D[_P $N?\
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M_5W^Q[_P6&^ /[9?@/3]9\-_$#0=/NKF,>;IVIW:6=S#(< IL=@3@],=1@T
M<1_P4M_X(7?!G_@I?XML_$GBZWU+2?$UJBPG4M,.&EC7A59.C, ,9)Z"NF_X
M)_\ _!&SX'?\$[+,S>!/"R3:XZX;5]087%VW4Y#-G;GGA>E?0WB?X[^"?!VE
M+=ZQXL\.Z99R$!9KO4HX4?/3!8@'\*\'^-'_  65_9K^ S2+KGQ6\.S7,+A#
M;Z7.;^4D^B1,Q/UH ^HHPJ1YV_+G"\<CZU\=?\%+_P#@B=\&_P#@I\;;4/&5
MG<:3XKLX/L]OK6GG;<*B\JK \,!GH37E_C'_ (+V7/C0R6?P;^ 7Q6^(DTC8
MAU&73)+#3\G@,3( 2/?I7EOC+X__ /!3O]H#4KBU\-?"/P?\*]-\L^1=SW\=
MQ*V1P2&)7/T'% 'I'[$/_!L3^SI^R+XDLO$&H:?>_$#7+%MT-QK2;8%P<@F
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M]\&OQL_9/\>>'_AE^TMX)\2>*[634/#NBZO;WNH0#YF:)'#'COSSB@#^F/\
MX(M_L=^$?^"-/_!,?4/BC\0)+?3?$FO:>==UVYEQN@C9=T%JA]U*C']YC7X6
M_'SXF?$+_@NU_P %3%CTNWO)I?%FI+I^E6RC<FE:>& $A'15"_.Q],U]!?\
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MP3XHU(M)/J&AE8O/D(/+H<J0>]?'EA_P9=Z)HVH_:+#XQZ]9?/D-#$$D5<\
M$ 8(K]T:* /RY^&W_!K%\&]"%HWC#QO\3_'JPHH>UU369/LNX$98*K#&1D9R
M>":^NO@!_P $I_@!^S79+'X5^%WAFT>,[EDNH/MLN[^]OEW'/>OHRB@#/TSP
MY8Z);+%9V-G;1H-H6&%8U 'H .*N)'A/>I*,\T 0F-@<[E''ITKYK_X*-?\
M!,+X<_\ !1[X+:AX9\5:+I\6K-&QT[6$MP+NRFQA9 XY(_V2<8KZ8+9I"N*
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M[FZA37[#6^W?QG=CIZ5-L7</E'?M1"-J?C0 X'(HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ko-20220216.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qg5o7xRiXgOn8uEb3ZMSaiH6aP9wpJ5OelBtWx6fYnqbyUqeSh9HidnW4+G8cIP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ko="http://ko/20220216" elementFormDefault="qualified" targetNamespace="http://ko/20220216">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://ko/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ko-20220216_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ko-20220216_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ko-20220216_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="ko_CommonStock0.25ParValueMember" name="CommonStock0.25ParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.500NotesDue2024Member" name="Sec0.500NotesDue2024Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec1.875NotesDue2026Member" name="Sec1.875NotesDue2026Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.750NotesDue2026Member" name="Sec0.750NotesDue2026Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec1.125NotesDue2027Member" name="Sec1.125NotesDue2027Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.125NotesDue2029Member" name="Sec0.125NotesDue2029Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.125NotesDue20291Member" name="Sec0.125NotesDue20291Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.400NotesDue2030Member" name="Sec0.400NotesDue2030Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec1.250NotesDue2031Member" name="Sec1.250NotesDue2031Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.375NotesDue2033Member" name="Sec0.375NotesDue2033Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.500NotesDue2033Member" name="Sec0.500NotesDue2033Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec1.625NotesDue2035Member" name="Sec1.625NotesDue2035Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec1.100NotesDue2036Member" name="Sec1.100NotesDue2036Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.950NotesDue2036Member" name="Sec0.950NotesDue2036Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec0.800NotesDue2040Member" name="Sec0.800NotesDue2040Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ko_Sec1.000NotesDue2041Member" name="Sec1.000NotesDue2041Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ko-20220216_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ko/role/Cover" xlink:href="ko-20220216.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://ko/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_CommonStock0.25ParValueMember" xlink:label="loc_koCommonStock0.25ParValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koCommonStock0.25ParValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.500NotesDue2024Member" xlink:label="loc_koSec0.500NotesDue2024Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.500NotesDue2024Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.875NotesDue2026Member" xlink:label="loc_koSec1.875NotesDue2026Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.875NotesDue2026Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.750NotesDue2026Member" xlink:label="loc_koSec0.750NotesDue2026Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.750NotesDue2026Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.125NotesDue2027Member" xlink:label="loc_koSec1.125NotesDue2027Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.125NotesDue2027Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.125NotesDue2029Member" xlink:label="loc_koSec0.125NotesDue2029Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.125NotesDue2029Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.125NotesDue20291Member" xlink:label="loc_koSec0.125NotesDue20291Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.125NotesDue20291Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.400NotesDue2030Member" xlink:label="loc_koSec0.400NotesDue2030Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.400NotesDue2030Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.250NotesDue2031Member" xlink:label="loc_koSec1.250NotesDue2031Member_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.250NotesDue2031Member_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.375NotesDue2033Member" xlink:label="loc_koSec0.375NotesDue2033Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.375NotesDue2033Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.500NotesDue2033Member" xlink:label="loc_koSec0.500NotesDue2033Member_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.500NotesDue2033Member_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.625NotesDue2035Member" xlink:label="loc_koSec1.625NotesDue2035Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.625NotesDue2035Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.100NotesDue2036Member" xlink:label="loc_koSec1.100NotesDue2036Member_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.100NotesDue2036Member_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.950NotesDue2036Member" xlink:label="loc_koSec0.950NotesDue2036Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.950NotesDue2036Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.800NotesDue2040Member" xlink:label="loc_koSec0.800NotesDue2040Member_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.800NotesDue2040Member_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.000NotesDue2041Member" xlink:label="loc_koSec1.000NotesDue2041Member_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.000NotesDue2041Member_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_180" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_180" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_180" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_180" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_180" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_180" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_180" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_180" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_180" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_180" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_180" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_180" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_180" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_180" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_180" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_180" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_180" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_180" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_180" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_180" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_180" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_180" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_180" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_180" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_180" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_180" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_180" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_180" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_180" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_180" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_180" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_180" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_180" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_180" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_180" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_180" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_180" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_180" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_180" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_180" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_180" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_180" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_180" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_180" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_180" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_180" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_180" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_180" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_180" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_180" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_180" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ko-20220216_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_CommonStock0.25ParValueMember" xlink:label="ko_CommonStock0.25ParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_CommonStock0.25ParValueMember" xlink:to="ko_CommonStock0.25ParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_CommonStock0.25ParValueMember_lbl" xml:lang="en-US">Common Stock, $0.25 Par Value</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.500NotesDue2024Member" xlink:label="ko_Sec0.500NotesDue2024Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.500NotesDue2024Member" xlink:to="ko_Sec0.500NotesDue2024Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.500NotesDue2024Member_lbl" xml:lang="en-US">0.500% Notes Due 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.875NotesDue2026Member" xlink:label="ko_Sec1.875NotesDue2026Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec1.875NotesDue2026Member" xlink:to="ko_Sec1.875NotesDue2026Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec1.875NotesDue2026Member_lbl" xml:lang="en-US">1.875% Notes Due 2026</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.750NotesDue2026Member" xlink:label="ko_Sec0.750NotesDue2026Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.750NotesDue2026Member" xlink:to="ko_Sec0.750NotesDue2026Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.750NotesDue2026Member_lbl" xml:lang="en-US">0.750% Notes Due 2026</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.125NotesDue2027Member" xlink:label="ko_Sec1.125NotesDue2027Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec1.125NotesDue2027Member" xlink:to="ko_Sec1.125NotesDue2027Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec1.125NotesDue2027Member_lbl" xml:lang="en-US">1.125% Notes Due 2027</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.125NotesDue2029Member" xlink:label="ko_Sec0.125NotesDue2029Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.125NotesDue2029Member" xlink:to="ko_Sec0.125NotesDue2029Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.125NotesDue2029Member_lbl" xml:lang="en-US">0.125% Notes Due 2029</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.125NotesDue20291Member" xlink:label="ko_Sec0.125NotesDue20291Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.125NotesDue20291Member" xlink:to="ko_Sec0.125NotesDue20291Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.125NotesDue20291Member_lbl" xml:lang="en-US">Sec 0. 125 Notes Due 20291 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.400NotesDue2030Member" xlink:label="ko_Sec0.400NotesDue2030Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.400NotesDue2030Member" xlink:to="ko_Sec0.400NotesDue2030Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.400NotesDue2030Member_lbl" xml:lang="en-US">Sec 0. 400 Notes Due 2030 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.250NotesDue2031Member" xlink:label="ko_Sec1.250NotesDue2031Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec1.250NotesDue2031Member" xlink:to="ko_Sec1.250NotesDue2031Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec1.250NotesDue2031Member_lbl" xml:lang="en-US">1.250% Notes Due 2031</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.375NotesDue2033Member" xlink:label="ko_Sec0.375NotesDue2033Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.375NotesDue2033Member" xlink:to="ko_Sec0.375NotesDue2033Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.375NotesDue2033Member_lbl" xml:lang="en-US">0.375% Notes Due 2033</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.500NotesDue2033Member" xlink:label="ko_Sec0.500NotesDue2033Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.500NotesDue2033Member" xlink:to="ko_Sec0.500NotesDue2033Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.500NotesDue2033Member_lbl" xml:lang="en-US">0.500% Notes Due 2033</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.625NotesDue2035Member" xlink:label="ko_Sec1.625NotesDue2035Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec1.625NotesDue2035Member" xlink:to="ko_Sec1.625NotesDue2035Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec1.625NotesDue2035Member_lbl" xml:lang="en-US">1.625% Notes Due 2035</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.100NotesDue2036Member" xlink:label="ko_Sec1.100NotesDue2036Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec1.100NotesDue2036Member" xlink:to="ko_Sec1.100NotesDue2036Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec1.100NotesDue2036Member_lbl" xml:lang="en-US">1.100% Notes Due 2036</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.950NotesDue2036Member" xlink:label="ko_Sec0.950NotesDue2036Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.950NotesDue2036Member" xlink:to="ko_Sec0.950NotesDue2036Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.950NotesDue2036Member_lbl" xml:lang="en-US">Sec 0. 950 Notes Due 2036 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.800NotesDue2040Member" xlink:label="ko_Sec0.800NotesDue2040Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec0.800NotesDue2040Member" xlink:to="ko_Sec0.800NotesDue2040Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec0.800NotesDue2040Member_lbl" xml:lang="en-US">0.800% Notes Due 2040</link:label>
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.000NotesDue2041Member" xlink:label="ko_Sec1.000NotesDue2041Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ko_Sec1.000NotesDue2041Member" xlink:to="ko_Sec1.000NotesDue2041Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ko_Sec1.000NotesDue2041Member_lbl" xml:lang="en-US">1.000% Notes Due 2041</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ko-20220216_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ko/role/Cover" xlink:href="ko-20220216.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ko/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_CommonStock0.25ParValueMember" xlink:label="loc_koCommonStock0.25ParValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koCommonStock0.25ParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.500NotesDue2024Member" xlink:label="loc_koSec0.500NotesDue2024Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.500NotesDue2024Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.875NotesDue2026Member" xlink:label="loc_koSec1.875NotesDue2026Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.875NotesDue2026Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.750NotesDue2026Member" xlink:label="loc_koSec0.750NotesDue2026Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.750NotesDue2026Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.125NotesDue2027Member" xlink:label="loc_koSec1.125NotesDue2027Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.125NotesDue2027Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.125NotesDue2029Member" xlink:label="loc_koSec0.125NotesDue2029Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.125NotesDue2029Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.125NotesDue20291Member" xlink:label="loc_koSec0.125NotesDue20291Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.125NotesDue20291Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.400NotesDue2030Member" xlink:label="loc_koSec0.400NotesDue2030Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.400NotesDue2030Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.250NotesDue2031Member" xlink:label="loc_koSec1.250NotesDue2031Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.250NotesDue2031Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.375NotesDue2033Member" xlink:label="loc_koSec0.375NotesDue2033Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.375NotesDue2033Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.500NotesDue2033Member" xlink:label="loc_koSec0.500NotesDue2033Member" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.500NotesDue2033Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.625NotesDue2035Member" xlink:label="loc_koSec1.625NotesDue2035Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.625NotesDue2035Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.100NotesDue2036Member" xlink:label="loc_koSec1.100NotesDue2036Member" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.100NotesDue2036Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.950NotesDue2036Member" xlink:label="loc_koSec0.950NotesDue2036Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.950NotesDue2036Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec0.800NotesDue2040Member" xlink:label="loc_koSec0.800NotesDue2040Member" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec0.800NotesDue2040Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ko-20220216.xsd#ko_Sec1.000NotesDue2041Member" xlink:label="loc_koSec1.000NotesDue2041Member" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_koSec1.000NotesDue2041Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140084132563272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 16,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-02217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COCA COLA CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000021344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">58-0628465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Coca-Cola Plaza<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Atlanta<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">676-2121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_CommonStock0.25ParValueMember', window );">Common Stock, $0.25 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.25 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.500NotesDue2024Member', window );">0.500% Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.500% Notes Due 2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.875NotesDue2026Member', window );">1.875% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.875% Notes Due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.750NotesDue2026Member', window );">0.750% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750% Notes Due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO26C<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.125NotesDue2027Member', window );">1.125% Notes Due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.125% Notes Due 2027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.125NotesDue2029Member', window );">0.125% Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.125% Notes Due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO29A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.125NotesDue20291Member', window );">Sec 0. 125 Notes Due 20291 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.125% Notes Due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO29B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.400NotesDue2030Member', window );">Sec 0. 400 Notes Due 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.400% Notes Due 2030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO30B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.250NotesDue2031Member', window );">1.250% Notes Due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.250% Notes Due 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.375NotesDue2033Member', window );">0.375% Notes Due 2033</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.375% Notes Due 2033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.500NotesDue2033Member', window );">0.500% Notes Due 2033</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.500% Notes Due 2033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO33A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.625NotesDue2035Member', window );">1.625% Notes Due 2035</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes Due 2035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.100NotesDue2036Member', window );">1.100% Notes Due 2036</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.100% Notes Due 2036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.950NotesDue2036Member', window );">Sec 0. 950 Notes Due 2036 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.950% Notes Due 2036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO36A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.800NotesDue2040Member', window );">0.800% Notes Due 2040</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.800% Notes Due 2040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO40B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.000NotesDue2041Member', window );">1.000% Notes Due 2041</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes Due 2041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KO41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_CommonStock0.25ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_CommonStock0.25ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.500NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.500NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.875NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec1.875NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.750NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.750NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.125NotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec1.125NotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.125NotesDue20291Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.125NotesDue20291Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.400NotesDue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.400NotesDue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.250NotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec1.250NotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.375NotesDue2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.375NotesDue2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.500NotesDue2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.500NotesDue2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.625NotesDue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec1.625NotesDue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.100NotesDue2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec1.100NotesDue2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.950NotesDue2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.950NotesDue2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec0.800NotesDue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec0.800NotesDue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ko_Sec1.000NotesDue2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ko_Sec1.000NotesDue2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>e22073_ko-8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:ko="http://ko/20220216"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ko-20220216.xsd" xlink:type="simple"/>
    <context id="From2022-02-16to2022-02-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:CommonStock0.25ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.500NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.875NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.750NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.125NotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.125NotesDue20291Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.400NotesDue2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.250NotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.375NotesDue2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.500NotesDue2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.625NotesDue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.100NotesDue2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.950NotesDue2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec0.800NotesDue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <context id="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ko:Sec1.000NotesDue2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-16</startDate>
            <endDate>2022-02-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-02-16to2022-02-16">0000021344</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-02-16to2022-02-16">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-02-16to2022-02-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-02-16to2022-02-16">2022-02-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-02-16to2022-02-16">COCA COLA CO</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-02-16to2022-02-16">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-02-16to2022-02-16">001-02217</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-02-16to2022-02-16">58-0628465</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-02-16to2022-02-16">One Coca-Cola Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode contextRef="From2022-02-16to2022-02-16">30313</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="From2022-02-16to2022-02-16">Atlanta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-02-16to2022-02-16">GA</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode contextRef="From2022-02-16to2022-02-16">(404)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-02-16to2022-02-16">676-2121</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-02-16to2022-02-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-02-16to2022-02-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-02-16to2022-02-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-02-16to2022-02-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember">Common Stock, $0.25 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember">KO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_CommonStock0.25ParValueMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member">0.500% Notes Due 2024</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member">KO24</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2024Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member">1.875% Notes Due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member">KO26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec1.875NotesDue2026Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member">0.750% Notes Due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member">KO26C</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.750NotesDue2026Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member">1.125% Notes Due 2027</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member">KO27</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec1.125NotesDue2027Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member">0.125% Notes Due 2029</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member">KO29A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue2029Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member">0.125% Notes Due 2029</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member">KO29B</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.125NotesDue20291Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member">0.400% Notes Due 2030</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member">KO30B</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.400NotesDue2030Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member">1.250% Notes Due 2031</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member">KO31</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec1.250NotesDue2031Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member">0.375% Notes Due 2033</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member">KO33</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.375NotesDue2033Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member">0.500% Notes Due 2033</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member">KO33A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.500NotesDue2033Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member">1.625% Notes Due 2035</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member">KO35</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec1.625NotesDue2035Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member">1.100% Notes Due 2036</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member">KO36</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec1.100NotesDue2036Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member">0.950% Notes Due 2036</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member">KO36A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.950NotesDue2036Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member">0.800% Notes Due 2040</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member">KO40B</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec0.800NotesDue2040Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member">1.000% Notes Due 2041</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member">KO41</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-162022-02-16_custom_Sec1.000NotesDue2041Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-02-16to2022-02-16">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MT/^?2+T>RR?FAO#5_?RG_P%02P,$%     @ 0G905.#T.HFJ @  , P   T
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $)V4%3Y>($.[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $)V
M4%297)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ 0G905*W2+K\9!P  VR\  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $)V
M4%3@]#J)J@(  # ,   -              "  5P/  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ 0G905)>*NQS     $P(   L              ( !,1(
M %]R96QS+RYR96QS4$L! A0#%     @ 0G905*K$(A8S 0  (@(   \
M         ( !&A,  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $)V4%0D
M'INBK0   /@!   :              "  7H4  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( $)V4%1ED'F2&0$  ,\#   3
M      "  5\5  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
' *D6      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>17</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>16</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="e22073_ko-8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ko/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="e22073_ko-8k.htm">e22073_ko-8k.htm</File>
    <File>e22073_ex10-1.htm</File>
    <File>e22073_ex10-2.htm</File>
    <File>e22073_ex10-3.htm</File>
    <File>ko-20220216.xsd</File>
    <File>ko-20220216_def.xml</File>
    <File>ko-20220216_lab.xml</File>
    <File>ko-20220216_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ko_bw-logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="67">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "e22073_ko-8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 17,
   "dts": {
    "definitionLink": {
     "local": [
      "ko-20220216_def.xml"
     ]
    },
    "inline": {
     "local": [
      "e22073_ko-8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ko-20220216_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ko-20220216_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ko-20220216.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 79,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 16,
   "memberStandard": 0,
   "nsprefix": "ko",
   "nsuri": "http://ko/20220216",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "e22073_ko-8k.htm",
      "contextRef": "From2022-02-16to2022-02-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://ko/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "e22073_ko-8k.htm",
      "contextRef": "From2022-02-16to2022-02-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 16,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ko_CommonStock0.25ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, $0.25 Par Value"
       }
      }
     },
     "localname": "CommonStock0.25ParValueMember",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.125NotesDue20291Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sec 0. 125 Notes Due 20291 [Member]"
       }
      }
     },
     "localname": "Sec0.125NotesDue20291Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.125% Notes Due 2029"
       }
      }
     },
     "localname": "Sec0.125NotesDue2029Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.375NotesDue2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.375% Notes Due 2033"
       }
      }
     },
     "localname": "Sec0.375NotesDue2033Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.400NotesDue2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sec 0. 400 Notes Due 2030 [Member]"
       }
      }
     },
     "localname": "Sec0.400NotesDue2030Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.500NotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.500% Notes Due 2024"
       }
      }
     },
     "localname": "Sec0.500NotesDue2024Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.500NotesDue2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.500% Notes Due 2033"
       }
      }
     },
     "localname": "Sec0.500NotesDue2033Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.750NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.750% Notes Due 2026"
       }
      }
     },
     "localname": "Sec0.750NotesDue2026Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.800NotesDue2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "0.800% Notes Due 2040"
       }
      }
     },
     "localname": "Sec0.800NotesDue2040Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec0.950NotesDue2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sec 0. 950 Notes Due 2036 [Member]"
       }
      }
     },
     "localname": "Sec0.950NotesDue2036Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec1.000NotesDue2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.000% Notes Due 2041"
       }
      }
     },
     "localname": "Sec1.000NotesDue2041Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec1.100NotesDue2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.100% Notes Due 2036"
       }
      }
     },
     "localname": "Sec1.100NotesDue2036Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec1.125NotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.125% Notes Due 2027"
       }
      }
     },
     "localname": "Sec1.125NotesDue2027Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec1.250NotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.250% Notes Due 2031"
       }
      }
     },
     "localname": "Sec1.250NotesDue2031Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec1.625NotesDue2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.625% Notes Due 2035"
       }
      }
     },
     "localname": "Sec1.625NotesDue2035Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ko_Sec1.875NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.875% Notes Due 2026"
       }
      }
     },
     "localname": "Sec1.875NotesDue2026Member",
     "nsuri": "http://ko/20220216",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://ko/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001552781-22-000167-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001552781-22-000167-xbrl.zip
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M%0F@*'H*]\C]-CNT$:&WICJ]@_)^WRV$KL[-D,Z\K-?:.<>T'[3LQP.L3HV
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M9'##A1O*M$<AN\:618-Z<-!J;W?(K:$IU#H(50J $^TB^$9532P*//G  %-
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M,(N&IDQ*'QJ.\_#MI71%OD%+B&#O\S[PERW!>;FH]CPQ1S1?8DQ.L7!%DJE
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M17#I[ESU@J7#T[MOI3H V,H?\',@6'@R-$/%S$$,;:F'9F;'224V-J\@J6*
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M \Z*5<1$Y9F+.4[[G%C\==7>ZI<=4EE9)ST^!5XZ".[F'<!C.;9;ILP0_1]
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MDA<'-)[;]"2I)YO7<Z^O6V_C33,-K6N#@8#5P0C+N[+'Y+FPQX3NN0!H'+*
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MZ3,=]!8;+N2_ P#2ZPKUC7A&OZ2M^<)D)KZ]6--AZ(3]M'!G_HKVT$$;G1!
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M$7O+SF.\Q !LXS0FYBD-FGW&E"1EP2#P6F5TS&70L7+)2P,Y.#.88BXSD(8
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MX;.<*_5FPXNV=5:/4ET>O^VQ5\^5"HUTMUFURX9L."9'8:PX)21W!H7:O/?
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M"AN!=C8+=JE[^=B7@V^*.%F*ZTA*2M20Q&(]5+EX#=&9%(!O_MU!-8R2;N<
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MU?/[V\OP;9NE].'@,U;2HW^=O'_W\O]02P,$%     @ 0G905'B^)QZFB0
M!SD$ !$   !E,C(P-S-?97@Q,"TR+FAT;>R]:W/;QI8V^EU5^@^8G'>GI"I:
MMF3GXLNXCGQ)QN].'!]?9E=J:CXT@:;8$0@P:$ R]Z\_Z]:-!@A*@FXD$V1J
MMFT2!!K=O5:OR[.>]>*_/O_ZR\O=G1?_]?;X#?P9X7\O/K_[_,O;ER\>\I_P
M[4/Y^L6KW][\'GWZ_/LO;__SFTF>E<^BPT?S,OIL9MI&[_5Y]#&?J6S$'XRB
M3[HPDV_@A_A_+S[T_>7S:*:*$Y,]B_!2_'_\S?.HU%_+!RHU)_!-84ZFY3<O
M7_STV_O/X?T?6/-OS0^!;U^]?/MU:L:FW-TY?'1P].+A*W@]_ G\\>%EU^C&
M>9KT&.*#,I_3,/T'X[PL\]FSCB''.BMU<=F8C\]5D>SNO,]+,S&Q*DV>1=]F
MB;+3Y]&G,H]/H]_F^.$E[]%[ECL&_$=E81"+RT;\.L]."E56*0W6[N[\S[OW
MG]Y^_!S]].677Z+WQ[^^_=__B'[+(O?QSQ^/X6YOCC^__5\8T51'K_-8/7B=
MIPK^-INK;!'ME? QK)[\&]=M/X*'P 0FT2*O(I5%"B<JVH-_%7@IS1M=N+M3
M98DN5MSZZ-'AD^CMGY4I%]&'%"=%V4C--/PDB29%/HM*F*2HS/E/-Q*\E.Y^
M$/V.3Z3'109^"N/2JHSR^3PORBJ#^^[NP*_M5!4Z,EF$-TAABA[ XL\B6\6Q
MMC;*)_2%&Y7*DBB&B2W,N"KIZ::TT:0J*[C)29&?E].#S5GQSU,#RYSD<07S
M5D;S(C\S"3PWT:4RJ7^Y4[V(\*7I@X6?M?8,VFK\AXY+FG+XU20O9BJ-BBK5
M_DZ\4/.TLOC/W1V5) 8W&US'#Y#YXT]MM&>R.*T2DYW IQ5,ZR*R<QVC1/$/
M]G'5K89EJTI<)!7YMXE5FL)6P,=^FR9_5OGSX_IIG_''WQ;T\<'N#FZQ]K>T
M*<Y@'M0XI94L])F!!8$'SE51NE?BUU>P&^:ERF*-LX@[XX#V+;YP\T:RD][(
M,''T,3YV=T=N^*LN"I.FT2N=Z0GNGM^R7TRFORWTR?/H7(^M*37>'.[*SVZH
MF&#&\&9J/@>),#"@_9%? 9KELN.5<<.?:/BFH-4+UCHZ!NG0.&!:]0AE8JSQ
M*<J>XBSGN&P3 S\JIR!%*-LDO;;$A]'_XQWPPC'\%!8SB<8+'(75?LU@ %><
MW5%D<Y@,6),XGZ'0TQ-!@.G%9K#XA9Y4:;I8DK;/QZ]^>1N]?OO++Y\^'+]^
M]_[G__SFT3?T[P_';]ZX?Q__\N[G]__YS>NW[S^__?A-?P$]-TDYQ4L?_>,Y
MO&T!,_$@SM-4S2U(G_L;'JTO/G]TMS_310GKF#HIAC,)?JSB4U <,%]X@[R
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M0TE^B$&<:>=YWAGD'H1KK<*E53G]R\C5^HS;8Y<:H@0>YV01!#)5C+H>8RJ
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M@"I$2X-^OZ0-M1'FM4;EWR@R::I/%-VQRG0&1T*LB96YQ;TQ7D@Y6U6 _J>
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MB_A]6R_1ASX"7PP#%8FWX0A_;IDP=8!$;;Z<K:6FU?01,<HA5^,_=$P6C9[
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M+QE,3L)Q)=X^%!UPKRGR1/V/N5R2)&H.\L>5U@DVGN;DE+>CS[%>F4[#%9'
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MR#7+.APK4*N8)$N:3Y#*,*PQ\8^IB[FQ'(U@\\LU('LN^B<D+7ATH^-NL=O
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MTP-.#CP)P.,%@:TR^@*\WAP&9\MO%=\)SH4_-,56X2$38V-D"%5Q_20Z^W
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M([?G!MJG7?@0EI'8&&2W2G7-JB >T:H0(8;1L,N9AVP'68NZ6L<5RV1<#MC
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MNHZ.ZL$G 3..@!>Y5D7+-7'6+B/_8D8^<AUDY9]HMU9+7U[&'YE  @.6-/>
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M)!LW&&M255_+.MNJ]UMT .I33>3OH2=.R%.";245[=/*2KO9I4;I/9WDE5E
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MD:=V-RQ6R C$B'4@4Z1E+&>?+;#,)E5/M WS*M7U1,[@!=TS;(;-Q4_=<,L
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M$!Q%.IU4\S'WNA4%W7KD7VV$_'U^PC"=K.G/X ?&IG!CL)J00%X>%JU@C,&
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M?F$'7DSV,D6)*=HEA3I TJ^$S.[0EWWR:;Q<(?964P%\GV0D<Q7RK#J9=85
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MGG7[H1#'\**U197T'5YR@X(!@3@%T)^VC9TG&S:&B]=YBEK?YB19=J^3@H/
M:CHE(2WUW_/LU(I^:>/M4S3Q=3(#;E@$$W^H!=MJ]KI?9LR5L@C$3"W4RB1#
M8KWJB:G=YH@FG?L'"[0[730'3N1*EY)-Z]DNSG[A'W1$%%.9CC+/4GW;DQL&
M$^C:''9X9\V8_8P?&-63(5NP]=2S,?/G599.33[OF^?,760<%D\XWYO\QP"I
MB;X,D)JBTRRITE+E1J9_2VRO*/L- F^CK#LK:JZ^.(SQ7"/UJ]/8YKYK)*I@
MJ5:.LWG43SYSIWRWO3>805O-9G\V,VC4LH&<<2*A%= J&3((_R#RV"L5)E$8
MD[NN$=1H>+!LB ".X["5A>@-\FU(C\DD$>#2!'VDN48S)_VM#T@QK7UJ4I7R
MN!)18_),6QCB^6XM,-QHE=M[/+^)_6J'(I#(6M!#;"*0]]>G L/DW]K(5U_4
MN^PLC8K*E&37+B-&^N%!1S965D32/XA4J)-]=L:*I$T\1MX%0>;S>D>_&WI'
M;ZAW]+NA=W3H'?W3Z=0-HMU="P,\' ,AQ2M$EZ1L CUGQ_/P_"J3HA;%3K"S
M0-P <S6D#/K,QJB56F'*2AYO2Q&+NH[28O+9!=1VLB\7=B/=KS <XW4]L<L"
M'%C,?QGG58U+ ;YKJ2\%Y1KKA>9I[9&JREF6TW'$]2OU:KU@#3;8RUO-V_=F
M\+%8I$DB'0II!M1&'6/NC L&,LRBF*=DCY(127]5$C)715'E7 12C]]:]BW_
MM5YHH;E]QP?GV>_U'#<$\K:=YH^V-)#G1\0-L;QM)Z#[F,J\4L;%TR2&=L$I
M%^<TT:>ZCRE 5DRNRRI/@[:/ICO=B-4-)L-64_\& =^O0OU1[1%(;Y[B@I$:
M:>;<[#ZRZE/T7:DB.M/R9VXQG#D)W\<S")8232N>2>D3^;(*.S![#- RC8R_
M@W.=$(4I ZO%>Q"V%I_,GXGN4_X=16)(&1("D](AI$V:E>;K]D/F*4D([BPC
MEP71,XN;+POJMY(UA0QCQ/=U]&^=9P?1;UG>=.8Z,K%>I%VE*X#^ X:/Q:;#
M7HQP$CB&*7F#,9KFGG]^,2O+1?'TX<.SL[.#"4J5)UFB)O)@^F#^\/G#SR]N
MN]ISL "O+<(>;ZD%N*C&B9D /TKG@Q&X[31T'XW 9MG:6 O$Q53G-9B8<VLG
MBK0#)Y80M/(34M:,$>BQD),\JQ:-&<ZR!.=?8]A#BMB<PU<_T:G.5>+80R)Y
M2S=HKRKDTIY#[4->&^S-K6:T>V9OKJM>"*<&V:;!U=X_9&77]1OVP?>0I*$I
MI25 EWAG&$LZGQ<.LM!/B)40&5=5 ,0PMT&SQ-3-D/-%3_Q$>A^;S)SX"+B@
MODDO0*,G =_QB%E!"9@D6OEHG5H@6(_!8_VB=>$)(,"-KK""ST*3N5RH?"E-
M.H7)92JHG9H6*00F>?"F) EX28'UV<?@GR.OP#E;W+1NP !2@=WQ,%!9K!(/
M]DG+? ?.@_>;JU;.#"<[\,:#E-MJ*7>_$%I#$H4RWCN;:>9NJ4KX:%N$#G\X
M^&%OO!^FL;P@P"2D?70AD0;O5[^[7GK*C*9NU@^;M6N'V_ZR9QL[W75*YH,;
MV4T^)QY3(&=GRV;JX56).K-RS'URDM$:4A;P0*F=L."MQ)\=N'2KN72#D*MW
M&_DEO5&/8FL,I.[Q> >*[$R(VBI86GQ__66-MB=UVU'==>5:3C_$B;MDI-3K
M_*D+ R-N-2-N#KCK1KQOY\#6<'M!M87G VG@:@U#+/2DRGFX>Q^75^Z.7WD'
MNGZV"P$LJKRHE(":P^=W=K^@.X3>@0L3]%A"DA%M-F><#HWQ6\UCW]]#'A.\
M$;:F,K+SQAF7B'0U4MKV!BDE:732N\ 375#EJE?')GC+N=P"&BN6KZ]-*2Q(
M2IW,0*V7"L>L-@M*HIZ]$_ XZ95JI+TSVI8BTS"8&VUSBK8"\3_+VQ8DA:N?
M.;DSRQ+=OZC:^J@=56Q90?;W'97)#)Q_/<[_X1YROD*@@TL+*HXH%69N$I6+
M<K.U_ T5YHBQ0QDO<N :Z;A/K.?2"MSIXJ6KR&Q(I0;H;6K*7@ ='R%FAAJT
MK>>P)W>4@7QC&YO[Y2$9K#A+1%79**6T]S3"MD.*<MN);(,IRJL,B/%M^)8
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M?M$3ER-0./4,P2C6*L:]([(&/8<II_1LU#LZ_!YE"V92HUQS VC/%7P^^'B
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MGN"BHT>/?L*G[Y3M]/DY42<CC VQJWV5*1GZZ" ,W95D?)-AI>>N%=B03.+
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M'$2<D<X&*59>#!3(LVXPN Y]M_=[T#;M0>_K&>TH56ID75^Z#W%<3I.MWZA
M;R3I=T_]*"6\MBU!*"]8]SI"+@1*=[_)8"=RF]T4>PV#6A*N)79.V!U\?LC?
M(W([<X@NCLJ&5#@=KO@@Q:!7NGLKLI:J%H"0?ML&YRS!2%,[T2XJIG=D* J+
M0!*Z>WB@8C)N#'J!PK%FC/?<YNTJ9P$!AP<5*.B(]'F@?RI<VB#X@7TS/8MY
M!.P^3EYU"67SPFO[= A: ]I-&L,'"I$YI&>(W(-N@R)5(LK!;&@"/5_O-,^I
M9!5:J;G>C(!G&Q'=@DA$R>JXGSV]GZ8^^^LS!HE/&&#MF6^&Y,&CDY,3()C<
M^IWRC#2(TLI:&-\,-<I.3Q$S]N8E_*V\UOG,BG2D6E!]F_2;EQZ5Y]91E!%Y
MT53E+'-S[.Q-61RIQ(F(\TW3W_-I,TV*!LD%[_]N6+@>@N/^\%]Y2+A95E6*
MTVQF+/AVP__V^^PN[[,[2O;Z73H=NG-R.H"M+$<CYU>\6J;%%.CF']T1=3)(
M?D[? :E5T./X9Y[-B_03;,:WSH]N)E4S CTM@G&F0"*5 7*=SM<5+ ="0H#R
MW-$['??SN$F&+A"Y41G&$Z4IH,*8YS:52,=O/.4+M*"YMOD$X1XQA; R$DP%
M54G0>8H=F3@&V,'(><&W0+/G->E(:S+%4AAEJU[!;>9[W2S[G")6\CY#^ $9
MPF<?F"&\H^K?VR4>[G")\6C$_SI+_>43+(0/:)!E%7M*_6\]7'^ZFT_ISA_3
M?E3TR;[/?JTM>O#7GY[_ROK)O[]^]<.W_P=02P,$%     @ 0G905/CUWDP.
M'@  *O   !    !E,C(P-S-?:V\M.&LN:'1M[5WI<]H\M__>F?X/>GEO[Z33
M$FRS!)(T=PB0A"Q 6+)]8006X,38Q O;7W^/9!L,V!"V)"UIGZ<)6,O167XZ
M1Y)UCO^OWY91EVBZI"I_ OP^%T!$J:NBI#3_!$RC$8P'_N_D^[?CE@'EH*RB
M_PFT#*-S& KU>KW]7GA?U9HA/I%(A/JT3, J=-CW+"=P'!]ZN+DNU5NDC8.2
MHAM8J9-1)5E27OS;IT]'16N:+$T4I=\XG81#,TW#4W%<P5TX%K(>3A0U/(M&
MK:*&4U32U8C '\RCPRHQJM#W*\M3FF&$Y.&T>#TN;GB7'Q<-&1I6](:JM;$!
M,J0M18.<$!1BKD:".JE/- 2?]YMJ=V$[\6"8=]J9$<[D2.GC&M9''!?)%+N=
M/N$!U!#XUXA35",-WX9C(7CJ%#3U8!/CSJAP ^LU5M!^P-H-<KR+:GBBJ3+1
M/>NP)QZ51$,+&H,.T;W)@L<A^IC6Y&A-852SKIJ*H0V\1VX_9!TZ%73-F"4-
MOO2@ZD4=E7Q1Z7-:)!9@YDFP"#\1_7-L2(9,3HY#UD]XVB8&1K1FD+R:4O=/
M(*4J!E&,8!D&$4!UZ].?@$'Z1LBRXA"M%[*;/?Y/,(C.)"*+AZA$C".4PVUR
MB/IB_PAET^R7*B<DJY72#R%]GDP6X >E#06#;ZT=3E=?5/J?,ZPEZD:X4:U5
MJD=350(Z"33#?QD%N#9( 3LT+&<5D?2OR*#*T3\"'XY$EFDWX6HWV2:*"/\;
M9S)N5AM8ULD23<5.@;?I*E^UX<1J$[Y:I@VA6FIAC>A5H<K0TVI$9]\MTTZ:
MTE*PVPK/D.3;>$T5!T@W!C+Y$VB RATBGNL8J"RUH4B.]%!1;6/EM_7%;R!
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M@-;&<N"$.E"4>T72434#[3F?"8;)D>@&(EWH"6GL,1%_'FY)K]<8WA@,#J;
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MLGKSOK"VI%>Z)%+32XF-Y&3SO;!V#F%ON*MVG,YC9T&BX;;Z[]\F-8FFZ[%
M!$UBB#232:4%"$%D4C< (125W<MJZH25 I+L?"U04I?87:T=H%P5J8A97_*
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M!   $!D   \   !K;RTR,#(R,#(Q-BYX<V3-5UMSXC84?FYG^A]4OW9\XY;
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MX.03N:7,AE!;YIH<DTD5F*8F*$X,QD \"BTJQ!ZI^.<&LYRPY*$3#$WIF@W
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M>F>ZX1M4>L%&MVJ$9BL+#QG-6Q<P(D#,;T2(;U3D9.N<73#Z/4XC>!H-R;U
M Y@VDJ-HP\/';+"+H7J27,7Y!JF<K'=^62J9G]ZF;=+<U12:\$!I&^OL9 JU
M;RPN:);CY#_QK761;A9[0<1HV A*2QD>+B9[7= 4,8@'^5ITE]B*'T",CZLI
M^YW]2FVR5?\TW=P9! @F1WI2_^+J2B'RT=2"548PT#.T=SMK:(.INIT;^\)H
M9MV0ULKR^\TUOK[0XLUAR<4U3>&;"W2)J]:&S%4MKNX/HM4!4VK+2QF2.H]7
M[L4;C#)S5][8YVRD5^W4 WNU(X@65MUHPW:UWT.+_L;BG!]=O!)FDY:_#)GN
M001TKEK::K-J=:,H" )LSE0:2BUJBSV@,:=)',5YG*X^\L4IB[&I9B:1*RA@
M@Q41NB(('$!;6C:96H@JI0<0+A@1,!+>&/*!0_$2.W9^=64<_6UB5V!T&ZX
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M/GF-9E'/7U-+ D+$Y,N2Q8:A2NN-A_D:)\F[31:G)(,')47EE@>CQ38/+4E
M/)A\ 3Q(*:JTWGCXL"9LQ8>[7QB]RZ_+'+)@_0"U6SZLEMN<&*4!\6+S!W!3
MA: BIDK[ZP^@^VT"]"(#)%Q;@]0Q.J!9A1M-%Q(TD#F-F(1$XGK,&<W1)46?
M,X+R:X+D[;%+OKV1N;XHQ^=;4J)(/'!1S-;3)68FC&QBYV], 0UK[TW1E$'
MU&D/?H=*'8&J$ _DG'.667.-)XV(]P."3U)TA[BBJ*_YBJ4N?1!$]32I<B7#
MV@MO&2C?]>@[JU(S(3\\[6N)',^6#0:5R7)#$00GH"UHJMQ\OX&_?'Z;11)'
MQPG%\%68EL9Q%C_=GI+ ;RL(B +=%92V3PJ15'ICX!U.;]CF-H\>+AB-"!%W
M:V5US]5UC:YGM%MN'E6E-E&]0@-B[3%^ 0JW1:!&&<\:HY?O"W[B9G2188Y&
M-_-KS$_B^2;/Q(C*S<%7S*U!CG^*Z%$!Y0<)2T1 ^/6P"?TX(2.1#'V&BF#4
MB/:X;LNVV0G)\MW#)W)%F'BFX9+<Y^_XP6XL*X\>L:Y7=;VKHR[R.@.# /&Q
M;J$E8(::!:"%N,^L+ )]%84@68KI/>W-3:?\$]]<;>)_+7!&^);_ U!+ P04
M    " !"=E!43?*"-3P)   Q=P  $P   &MO+3(P,C(P,C$V7W!R92YX;6S5
M75USVS86?>_,_@>M^JQO.XG=>#N.;'<T36*OY:;;?<E )"1A! %:@+2E?[\
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M]2CP['TG1]!4N3"?[CZQ_]GO-S7O_!]02P,$%     @ 0G905- VSFP#,@
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M"M9?RJ']/6[-'81FPC=*=4\B)<Q8R >'82+2EN850LREZDXPMQI+Z&CD-[Q
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MS=&U+AW&65Z%;>^GIWG!>&/&^XVIX=$+'S=D''^KDZT=F;V(J:>Y=V2ATBE
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M JVDUZTM)D&,RCS]I[90L"7G>5V*4XWJB5>AR"_3;\\JB),[*> 69,X<A5%
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M4$L! A0#%     @ 0G905+_!:Y$FA0  $8P# !$              ( !
M &4R,C W,U]E>#$P+3$N:'1M4$L! A0#%     @ 0G905'B^)QZFB0  !SD$
M !$              ( !584  &4R,C W,U]E>#$P+3(N:'1M4$L! A0#%
M  @ 0G905.(P1NADB   @1L$ !$              ( !*@\! &4R,C W,U]E
M>#$P+3,N:'1M4$L! A0#%     @ 0G905/CUWDP.'@  *O   !
M     ( !O9<! &4R,C W,U]K;RTX:RYH=&U02P$"% ,4    " !"=E!4LU+;
MC6D$   0&0  #P              @ 'YM0$ :V\M,C R,C R,38N>'-D4$L!
M A0#%     @ 0G905.Z%_Q\8"@  4GT  !,              ( !C[H! &MO
M+3(P,C(P,C$V7V1E9BYX;6Q02P$"% ,4    " !"=E!4F-B((*4-  !,K0
M$P              @ '8Q $ :V\M,C R,C R,39?;&%B+GAM;%!+ 0(4 Q0
M   ( $)V4%1-\H(U/ D  #%W   3              "  :[2 0!K;RTR,#(R
M,#(Q-E]P<F4N>&UL4$L! A0#%     @ 0G905- VSFP#,@  "C0   X
M         ( !&]P! &MO7V)W+6QO9V\N:G!G4$L%!@     )  D -P(  $H.
$ @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
